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ABSTRACT 
 
The Structure and Mechanism of Bacterial Dihydroorotase.  (December 2004) 
Tamiko Neal Porter, B.S., Michigan State University 
Chair Advisory Committee:  Dr. Frank Raushel 
 
Dihydroorotase (DHO) is a zinc metallo-enzyme that functions in the pathway 
for the biosynthesis of pyrimidine nucleotides by catalyzing the reversible 
interconversion of carbamoyl aspartate and dihydroorotate.  The X-ray crystal structure 
of the enzyme was obtained at a resolution of 1.7 Å.  The pH-rate profiles for the 
hydrolysis of dihydroorotate or thio-dihydroorotate demonstrated that a single group of 
DHO must be unprotonated for maximal catalytic activity.  The pH-rate profiles for the 
condensation of carbamoyl aspartate to dihydroorotate showed that a single group from 
the enzyme must be protonated for maximal catalytic activity.  The native zinc ions 
within the active site of DHO were substituted with cobalt or CADmium by 
reconstitution of the apo-enzyme with divalent cations.  The ionizations observed in the 
pH-rate profiles were dependent on the specific metal ion bound to the active site.  
Mutation of Asp-250 resulted in the loss of catalytic activity.  These results are 
consistent with the formation of a hydroxide bridge between the two divalent cations that 
functions as the nucleophile during the hydrolysis of dihydroorotate.  In addition, Asp-
250 is postulated to shuttle the proton from the bridging hydroxide to the leaving group 
amide during dihydroorotate hydrolysis.  The X-ray crystal structure of DHO showed 
that the side-chain carboxylate of dihydroorotate is electrostatically interacting with Arg-
20, Asn-44 and His-254.  Mutation of these residues resulted in the loss of catalytic 
activity, indicating that these residues are critical for substrate recognition.  The thio-
 iv
analog of dihydroorotate, (TDO) was found to be a substrate of DHO.  A comprehensive 
chemical mechanism for DHO was proposed based on the experimental data presented 
in this dissertation.  Armed with this understanding of the structure-function relationship 
of DHO, a rational approach was used to alter the substrate specificity of the enzyme.  
The R20/N44/H254 mutant of DHO was obtained and found to have increased activity 
on dihydrouracil compared to the wild-type enzyme.  The sequence of the gene PA5541 
from Pseudomonas aeruginosa has a glutamine at a position where most active DHO 
proteins have a histidine residue.  Results from the characterization of PA5541 indicate 
that it is a functional DHO. 
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CHAPTER I 
 
 
INTRODUCTION 
 
In protein science the term “superfamily” has been invoked to describe a group 
of enzymes that have conserved tertiary structure but have varying catalytic activities 
due to divergent or convergent evolution.  A specific example of an enzyme superfamily 
is the amidohydrolase group of metalloproteins.  The enzymes of the amidohydrolase 
superfamily adopt the (β/α)8-barrel fold.  The superfamily was first described by Holm 
and Sander based on structural alignments of three enzymes, adenosine deaminase, 
phosphotriesterase and urease (1). The superfamily was expanded based on amino acid 
sequence identity using database searches.  With a few exceptions, members of the 
amidohydrolase superfamily conserve five active-site residues found at the C-terminal 
end of the β-strands.   These residues are four histidines and an aspartic acid.  Members 
of the superfamily bind either one or two metal ions per active-site.  Since the original 
Holm and Sander description of the superfamily, the knowledge base has expanded as 
there are to date at least eighteen additional X-ray structures of amidohydrolase 
superfamily members.   Analysis of the structure-function relationship of members of the 
superfamily will increase our knowledge of how Nature has evolved these enzymes.  
The more that is understood about how Nature has evolved protein function will better 
our ability to engineer proteins to capitalize on their usefulness for biotechnology and 
drug therapies.   
 
 
_____________ 
This dissertation follows the style of Biochemistry. 
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Dihydroorotase (DHO) is a member of the amidohydrolase superfamily.  DHO 
functions in the pyrimidine biosynthesis pathway by catalyzing the reversible cyclization 
of N-carbamoyl aspartate to form L-dihydroorotate and a molecule of water.  The 
reaction is shown in Scheme 1.1.   Extensive analyses of the primary structure of DHO 
clearly show that there are two classes of the enzyme (2).  DHO proteins comprising 
Class I are found in higher organisms and are much larger than their Class II 
counterparts that are found in many bacteria and fungi.  A Class I DHO is expressed in 
CAD, a multi-functional enzyme complex found in mammals, insects and molds, that 
consists of the first three enzymes of the pyrimidine biosynthesis pathway, carbamoyl 
phospate synthetase (CPS), aspartate transcarbamoylase (ATC) and DHO (3, 4).   
Monofunctional Class I DHO enzymes are also found in gram-positive bacterial strains.   
Class II enzymes consist of monofunctional proteins from gram-negative bacteria and 
yeast.  Table 1.1 shows which class the known DHO sequences fall into.  Class I 
proteins typically have subunit molecular weights of ~45 kDa compared to ~38 kDa for 
the Class II proteins.   
 
 
 
 
 
 
 
Within each class, the primary sequence identity is quite high (>40%), but poor 
sequence identity (<20%) is seen when one compares proteins between classes.  An 
alignment of the human and E. coli proteins is shown in Figure 1.1.   The two proteins  
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Table 1.1:  DHO Classificationa 
 
Class I g.i. 
number 
Class II g.i.  
number 
Aquifex aeolicus 3914514 Agrobacterium tumefaciens 15887748 
Archaeoglobus fulgidus 3914507 Arabidopsis thaliana 15235865 
Bacillus anthracis 21401873 Azotobacter vinelandii 23103669 
Bacillus caldolyticus 1172784 Beta vulgaris 17977977 
Bacillus halodurans 10175158 Bordetella pertussis 33566830 
Bacillus subtilis 2633923 Bordetella bronchioseptica 33603376 
Bifidobacterium longum 23465368 Buchnera aphidicola 15616940 
Caenorhabditidis elegans 17532699 Burkholderia fungorum 22988480 
Chlorobium tepidum 21673868 Campylobacter jejuni 15791630 
Clostridium acetobuytlicum 23821990 Chloroflexus aurantiacus 22971316 
Corynebacterium glutamicum 19552823 Emericella nidulans 1870226 
Deinococcus radiodurans 9087183 Escherichia coli 16129025 
Desulfovibrio desulfuricans 23473834 Helicobacter pylori 15645206 
Dictyostelium discoideum 400909 Microbulbifer degradans 23026307 
Drosophila melanogaster 391583 Neisseria meningitidis 15676580 
Enterococcus faecalis 22992871 Nitrosomonas europaea 22954697 
Fusobacterium nucleatum 19703762 Novosphingobium aromaticivoans 23107613 
Homo sapiens 33989959 Oryza sativa 14209529 
Lactobacillus leichmannii 1346930 Plasmodium falciparum 23509919 
Lactobacillus gasseri 23002207 Plasmodium yoelii yoelii 23479248 
Leuconostoc mesenteroides 23024490 Pseudomonas fluorescens 23063090 
Listeria innocua 21542203 Pseudomonas syringae pv. 23471210 
Listeria monocytogenes 21542200 Pseudomonas aeruginosa 15598723 
Mesocricetus auratus 131696 Ralstonia solanacearum 17545206 
Methanococcus jannaschii 3122658 Ralstonia metallidurans 22978905 
Mycobacterium bovis 31792575 Rhodobacter sphaeroides 22957385 
Mycobacterium leprae 21542206 Saccharomyces cerevisiae 6323452 
Mycobacterium tuberculosis 9087175 Salmonella typhimurium 16764519 
Oceanobacillus iheyensis 23098944 Salmonella enterica 16760039 
Oenococcus oeni 23037312 Schizosaccharomyces pombe 19115483 
Pyrococcus abyssi 9087185 Shewanella oneidensis 24375192 
Pyrococcus horikoshii 3914511 Shigella flexneri 24112473 
Rattus rattus 2506025 Sinorhizobium meliloti 15964233 
Squalus acanthias 3024509 Synechocystis sp. 16329543 
Staphylococcus aureus 21204251 Toxoplasma gondii 21309874 
Streptococcus mutans  24379638 Ustilago maydis 400913 
Streptococcus pneumoniae 15901032 Vibrio cholerae 21542209 
Streptococcus pyogenes 15674928 Wigglesworthia brevipalpis 24323648 
Streptomyces coelicor 21219987 Yersinia pestis 16121855 
Sulfolobus acidocaldaricus 34978387   
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Table 1.1:  continued 
 
Class I 
 
g.i. 
number 
 
Class II 
 
g.i. 
number 
Thermatoga maritime 9087186   
Thermoanaerobacter 
tengcongensis 
20807969   
Thermobifida fusca 23017985   
Thermus aquaticus 3122654   
Thermus thermophilus 46198734   
Trypanosoma cruzi 7494090   
aThe sequences were all obtained from the database at NCBI (http://www.ncbi.nih.gov) 
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HUMAN   --TSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDGPALALAQKLA 
E. coli MTAPSQVLKIRRPDDWHLHLRD-----GDMLKTVVPYTSEI-YGRAIVMPNLAPPVTTVEAAVAYRQRI 
                        
HUMAN   EAGARCDFAL-FLGASSE------NAGTLGTVAGSAAGLKLYLNETFSELRL-DSVVQWMEHFETWPSH 
E. coli LDAVPAGHDFTPLMTCYLTDSLDPNELERGFNEGVFTAAKLYPANATTNSSHGVTSIDAIMPVLERMEK  
 
HUMAN   --LPIVAHAEQQTVAAVLMVAQLTQ--------------RSVHICHVARKEEILLIKAAKARGLPVTCE 
E. coli IGMPLLVHGEVTHADIDIFDREARFIESVMEPLRQRLTALKVVFEHITTKDAADYVRDGN---ERLAAT 
  
HUMAN   VAPHHLFLSHDDLERLGP-GKGEVRPELGSRQDVEALWEDMA---VIDCFASDHAPHTLEELPLKCGSR 
E. coli ITPQHLMFNRNHMLVGGVRPHLYCLPILKRNIHQQALRELVASGFNRVFLGTDSAPHARHR---KESSC 
                              
HUMAN   PPPG-FPGLETMLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAH 
E. coli GCAGCFNAPTALGSYATVFEEMNALQHFEAFCSVNGPQFYGLPVNDTFIELVREEQQVAESIALTDDTL 
 
HUMAN   WTPFEGQKVKGTVRRVVL 
E. coli VPFLAGETVRWSVKK 
 
Figure 1.1:  Alignment of human and E. coli DHO sequences.  The shaded residues are 
those that are conserved among an alignment of DHO sequences from over 30 
organisms. 
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have a 17 % sequence identity.  An alignment of DHO sequences from 39 bacterial 
sources is provided in Appendix I.  Each class is represented in this master alignment.  
There are 17 conserved residues among DHO sequences and these are listed in Table 
1.2.  Generally, the conserved metal-binding HXH motif of the amidohydrolase 
superfamily is found in an DXHXHXR (residues 14-20 in E. coli) sequence.  There are 
several bacterial organisms that contain sequences where the HXH motif is replaced by 
QXH (2).  It is not known whether these enzymes are active.  Among DHO proteins, 
there are also three additional conserved histidine residues (residues His-77, His-139 and 
His-254 in E. coli), the first two corresponding to the third and fourth conserved residues 
of the amidohydrolase superfamily.  The conserved aspartate residue of the 
amidohydrolase superfamily is found in all DHO proteins.  This aspartate (Asp-250) is 
found in a DXAPH motif.   
In several organisms there are multiple DHO sequences.  There are three 
situations where this is observed: organisms have an inactive DHO domain associated 
with a CAD-like multi-functional protein; organisms have an inactive DHO domain 
associated with ATC; or in addition to an active DHO with a HXH motif, the organism 
contains a DHO with a QXH motif.  In Saccharomyces cerevisiae (yeast) and 
Neurospora crassa, a psuedo-CAD is found.  While the enzyme has functional CPS and 
ATC domains, the DHO domain (encoded by ura2) is inactive (5).  The sequence of the 
defective ura2 gene product contains several mutations of residues that are now known 
to be important for metal binding.  The functional DHO protein in yeast is a Class I 
protein, is monofunctional and encoded by the gene ura4 (6).  Shown in Figure 1.2 is a 
representation of the various forms of DHO.  
Similar to DHO, there is more than one class of prokaryotic ATC proteins (7).  In 
Class A, the catalytic subunit, pyrB, of ATC is associated with an active (pyrC) or  
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Figure 1.2:  Organization of the genes for CPS, DHO and ATC in various organisms. 
PyrA              PyrC       PyrB  
PyrC’   PyrB              PyrC  
Ura 4Ura 2
CAD
CPS  DHO ATC 
H. sapiens
CPS  pDHO  ATC         DHO 
S. cerevisiae
 pDHO  ATC          DHO 
P. aeruginosa
CPS     DHO      ATC 
E. coli 
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Table 1.2:  Conserved Residues of DHOa. 
Residue Probable Role 
Asp-14 Hydrogen bonds to H17 
His-16 Metal ligand 
His-18 Metal ligand 
Arg-20 Substrate-binding 
Met-42 Unclear 
Pro-43 Structural 
Asn-44 Substrate-binding 
Lys-102 Metal ligand 
His-139 Metal ligand 
His-177 Metal ligand 
His-202 Unclear 
Pro-223 Structural 
Asp-250 Metal ligand and catalysis 
Ala-252 Unclear 
Pro-253 Structural 
His-254 Substrate-binding 
Lys-259 Unclear 
aThe numbers presented are those for the E. coli enzyme. 
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 inactive (pyrC’)  regulatory domain (8, 9). The DHO domain, pyrC- or pyrC’-encoded, 
is believed to be required for assembly of the pyrB gene product into a stable 
dodecameric holoenzyme (8, 10).  Class B ATC enzymes are associated with 
pyrIregulatory subunits.  In this class, the holoenzyme is a dodecamer formed from two 
catalytic trimers and three dimers of pyrI-encoded regulatory subunits.  The third class 
of ATC enzymes, Class C, consists of proteins that are trimers of only the catalytic 
domain (11).   
Pseudomonas aeruginosa and Pseudomonas flourescens contain three DHO-like 
sequences: an inactive DHO, a functional enzyme and an uncharacterized protein (2, 12).  
The inactive 45 kDa DHO protein of P. aeruginosa is associated with a 36 kDa ATC, 
which forms a dodecameric complex with a molecular weight of 486 kDa.  The 
holoenzyme consists of six ATC catalytic chains (a dimer of trimers) and six pseudo-
DHO (pDHO) chains (a trimer of dimers) (12).  The ATC is encoded by pyrB while the 
gene pyrC’ codes for pDHO.   Vickrey et al. reported that plasmids containing only the 
gene for the ATC catalytic subunit did not complement E. coli strains deficient in ATC.  
The expressed protein was not soluble and was found in inclusion bodies.  This 
suggested that pDHO is required for correct folding of the catalytic ATC domains.  
Similar ATC complexes are found in P. putida, P. flourescens and Helicobacter pylori 
(8, 13).  In these systems, the inactive proteins are Class I proteins.  In Streptomyces 
griseus, however, the ATC is associated with an active DHO (9).   The functional DHO 
proteins of P. aeruginosa and P. flourescens are Class II proteins and are encoded by the 
gene pyrC.   
In several organisms, including P. aeruginosa,  P. flourescens, and Xylella 
fastidiosa, there is an uncharacterized protein that appears to be a Class I DHO that is 60 
amino acids longer than sequences from organisms such as E. coli.  These sequences all 
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contain the unusual QXH motif discussed above but contain all of the perceived residue 
requirements for DHO activity.  This is in contrast to URA2 of yeast or the previously 
described pDHO, which do not have the necessary conserved residues.  
Scheme 1.2 
 
The regions of the gene encoding CAD are organized in the following order: 
pyr1 (CPS), pyr3 (DHO) and pyr 2 (ATC).  The gene from humans is very large, with 
over 6,679 base pairs (4).  The trifunctional enzyme consists of 2,225 amino acids and is 
243 kDa.  The reactions catalyzed by this enzyme are shown in Scheme 1.2.  The CPS 
domain of CAD is the rate-limiting step in the pyrimidine synthesis pathway (3, 14).  
CPS is allosterically activated by adenine triphosphate (ATP) or 5-phosphoribosyl-1-
pyrophosphate (PRPP) and is feedback inhibited by uridine and cytidine nucleotides.  It 
has been shown in Drosophila melanogaster that mutation in the CPS domain of CAD 
results in loss of feedback inhibition and thus an accumulation of large amounts of 
uridine triphosphate (UTP) (15).  CAD is also regulated by Myc-dependent 
transcriptional changes, phosphorylation and caspase-mediated degradation.  Myc is a 
family of transcriptional regulators involved in regulation of cell proliferation.  Myc 
expression peaks in dividing cells and is suppressed as cells differentiate or exit the cell 
cycle.  Myc has been shown to have oncogenic potential and is overexpressed in many 
human tumors (16, 17).   In human and hamster CAD it was demonstrated that Myc 
binds to the E-box region of the CAD promoter increasing CAD transcription, which led 
to cell proliferation (18).  When Myc was mutated, growth-factor stimulated increases of 
CAD promoter activity was blocked.  Thus CAD expression is dependent on Myc and 
HCO3
- + 2 ATP + L-GLN
2 ADP, Pi L-ASP
Carbamoyl phosphate Carbamoyl aspartate Dihydroorotate
Pi
ATCaseCPS DHO
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intact E-box sequences (19, 20).  Myc-dependent increase in CAD expression is one 
mechanism that activity of this enzyme is increased in tumor cells.  CAD is also 
regulated by reversible phosphorylation by mitogen-activated protein kinase (MAPK) in 
response to growth factors.  When CPS is treated with MAPK, a loss of feedback 
inhibition by UTP and a gain of allosteric activation by PRPP is seen (21).  CAD is also 
phosphorylated by cyclic AMP-dependent protein kinase (PKA)(22).   Unlike what is 
found in mammalian CAD, there are no phosphroylation sites in ura2 (23).  This 
suggests that CAD and ura2 regulation is different.   Caspases, proteases that are 
activated during apoptosis, have been shown to target CAD (24).  CAD is rapidly 
degraded in the early onset of apoptosis.  Two caspase-3 sites have been located in CAD.  
Cleavage at these sites results in the loss of CPS activity and PRPP activation. 
 
Scheme 1.3 
  
An inhibitor of CAD is N-(phosphononacetyl)-L-aspartic acid (PALA).    PALA, 
shown in Scheme 1.3, is a transition state analog inhibitor of ATC with a Ki of 27 nM 
(25).  PALA was found to block the proliferation of mammalian cells in culture and thus 
is studied in clinical trials of various cancers alone or in combination with other 
compounds (26, 27).  The effect of PALA on CAD is diminished as carbamoyl 
O
O
O
O
N
H
P
O
O
OO
PALA
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phosphate accumulates in the reaction mixture (28).  The effect of PALA is also 
prevented if sufficient uridine is present (27).    
Substrate channeling in CAD has been observed (28-30).  For the hamster 
enzyme, experiments were conducted using 14C-labeled HCO3- to initiate the reaction 
and allow for the determination of the concentration of the intermediates (28, 29).  When 
dihydroorotate dehydrogenase was used to trap dihydroorotate as orotate, there was no 
carbamoyl phosphate accumulation in the assay mixture and carbamoyl aspartate was 
found at a concentration that was 12% of the value expected if the enzymatic activities 
were unlinked (29).  The rate of dihydroorotate formation was 4 times the rate that 
would be attained from an unlinked system.   Simply stated, the carbamoyl phosphate 
produced from the CPS reaction is channeled directly to the ATC active site where it is 
used as a substrate followed by the partial channeling of carbamoyl aspartate to the 
active site of DHO.     
Early mechanistic studies of DHO were done on the hamster enzyme.  The gene 
was first isolated from hamster by Kelly in 1986 (31).  Unfortunately, the 46 kDa gene 
product did not have DHO activity.  Later, other researchers found that there were 
additional residues at the C-terminal end required for activity (32-34).  This discovery 
allowed for the successful subcloning of DHO into a cloning vector for expression in E. 
coli.  An early study was the demonstration of inactivation of the enzyme by treatment 
with diethylpyrocarbonate (DEPC). This implicated one or more histidine residues in 
catalysis.  The metal dependence of DHO was reported to be a single zinc ion.  Using 
site-directed mutagenesis and 65Zn2+-binding studies, Christopherson proposed that DHO 
had the same metal coordination geometry as carbonic anhydrase (CA).  In CA, the 
single active site zinc ion adopts a tetrahedral geometry (Kannan, 1984).  From the X-
ray crystal structure of CA, the metal ligands have been determined to be three histidine 
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residues and a hydroxide (35).  The model proposed by Christopherson for DHO had 
three histidine residues assigned as metal ligands, His-16, His-18, and His-177 (numbers 
given are those that correspond to the E. coli enzyme) (36).  A fourth active site histidine 
(His-139) played a role in catalysis.   Mutation of the histidine residues to alanine, 
glycine or asparagine resulted in inactive enzymes.  In CA, when the active-site metal is 
varied, the pKa of the attacking hydroxide is altered (37).  If a water molecule or a 
hydroxide were the ionizing group, one would expect that the acidity of this group would 
vary as the metal involved is altered.  Christopherson did not find this when he 
substituted the native zinc for other divalent cations and determined the apparent pKa 
values (38).  The activity trend reported for the metal-substituted enzymes was 
Co2+>Zn2+>Mn2+>Cd2+.  From the pH rate profile for the hydrolytic activity of the wild-
type enzyme, he obtained an apparent kinetic pKa on kcat of 6.6 for the ionizable group 
involved in catalysis (39).  Christopherson found that the apparent pKa was relatively 
unchanged (6.6-6.9) when the active site metal was substituted.  Also, in contradiction to 
what is found in CA, the visible absorption spectrum of the Co2+-incorporated hamster 
DHO was consistent with penta-coordination (38).   These findings indicated that CA 
may not be the appropriate model system for DHO.   
Several inhibitors of the mammalian enzyme have been described including 
cysteine and orotate analogs(28, 36, 40-43).  Scheme 1.4 shows the most potent 
inhibitors with their Ki values for the hamster enzyme.  These inhibitors were designed 
for possible anti-tumor or anti-malarial uses although none are used clinically.  Two 
potent transition-state analogues of mammalian DHO have also been described, 
borocarbmoylethyl aspartate (Ki = 5 µM, pH 6) and cis-4-carboxy-6-(mercaptomethyl)-
3,4,5,6-tetrahydropyrimidine-2(1H)-one (Ki = 140 nM, pH 7.4, 8.5) (44, 45).  None of 
the inhibitors described for the hamster enzyme inhibited the bacterial enzyme (36, 41).  
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The explanation for this is unclear, although one would suppose that the difference is 
due to subtle perturbations in the active site or in how the substrate is recognized for 
binding.   
DHO has been implicated in the hydrolysis of the cardioprotective drug 
dexrazoxane [ICRF-187; (+)-1,2-bis(3,5-dioxopiperazin-1-yl)propane] (46).  Cleaveage 
of dexrazoxane results in an active metal-binding compound ADR-925 [N,N’-[1S)-1-
methyl-1,2-ethanediyl]bis[N-(2-amino-2-oxoethyl)glycine].  Scheme 1.5 illustrates how 
DHO, in conjunction with dihydropyrimidinase, cleaves dexrazoxane.  ADR-925 
reduces the cardiotoxicity of the anticancer drug doxrubicin by preventing oxygen 
radical formation by binding free iron or removing iron from the iron-doxrubicin 
complex (47).   After dihydropyrimdinase acts on dexrazoxane to produce the two single 
ring containing metabolites B and C, DHO cleaves them to produce ADR-925 with a 
Vmax that is 11- and 27- fold greater than that for the hydrolysis of dihydroorotate (46).  
The Km values are 240- and 550- fold higher than that for dihydroorotate.   
The DHO isolated from E. coli is homodimeric with a molecular weight of 76 
kDa.  It was also thought to bind a single molecule of zinc (48).   It was reported by 
Collins that the cation could be substituted with cobalt to yield a more active enzyme 
(48).  As found for the hamster enzyme, the Co2+-substituted enzyme was more active 
than the native enzyme.  Characterization of the enzyme was complicated by the fact that 
the enzyme was very unstable due to air oxidation (49, 50).  Collins chemically modified 
the cysteines in the enzyme to conduct the experiments.  A mass spectrometry and 
chemical derivatization experiment by Daniel proposed that two of the six cysteines, 
(C221 and C265), in the enzyme were responsible for the air oxidation (51).   
Two weak noncompetitive inhibitors have been described for the bacterial 
enzyme, 4-chlorobenzenesulfonamide (Ki = 200 µM) and 4-nitrobenzenesulfonamide 
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(Ki = 1.1 mM) (52).  In the study where dexrazoxane was reported as a substrate for 
DHO, 4-chlorobenzesulfonamide was reported to not inhibit the mammalian enzyme 
(46).   However, furosemide, a  sulfonamide derivative with a carboxylate group, did 
inhibit the mammalian enzyme by 80 %.   
In this dissertation a detailed study of the structure and mechanism of the E. coli 
DHO is presented.  The X-ray crystal structure of the enzyme was determined.   The 
structure allowed for the proposal of a novel mechanism for DHO.  The mechanism of 
action and role of individual amino acids in binding and/or catalysis and the rate-limiting 
steps in substrate turnover were probed using mutagenesis and kinetic experiments.  The 
roles of the metal ions in catalysis were studied by substituting the active site zinc for 
other divalent cations.   
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CHAPTER II 
 
THE X-RAY CRYSTAL STRUCTURE OF DIHYDROOROTASE FROM 
ESCHERICHIA COLI 
  
Dihydroorotase (DHO) catalyzes the reversible cyclization of N-carbamoyl-L-
aspartate to form L-dihydroorotate in the de novo pyrimidine biosynthetic pathway.  In 
bacteria and fungi, DHO is a monofunctional enzyme (2, 49, 53).  In most eukaryotes, 
DHO is found in a multi-functional protein (CAD) that is composed of the first three 
enzymes of the de novo pyrimidine biosynthesis pathway (3, 33).  CAD consists of 
carbamoyl phosphate synthetase (CPS), aspartate transcarbamoylase (ATC) and 
dihydroorotase (DHO).  DHO from E. coli is a monofunctional, homodimeric zinc-
containing metalloenzyme with a subunit molecular weight of 38,300 Daltons (49). 
The amidohydrolase superfamily consists of metalloenzymes that all adopt a 
“TIM” barrel fold (1).  Members of this superfamily generally catalyze hydrolysis 
reactions at a carbon or phosphorus center.  An additional characteristic shared by most 
members of the amidohydrolase superfamily is that there are five conserved residues 
found at the C-terminus of β-strands 1, 5, 6, and 8.  These residues include four 
histidines and an aspartic acid.  The first two histidines are found in a metal-binding 
HxH motif.  The members of the amidohydrolase superfamily are organized into two 
subgroups according to the number of metal ions that each enzyme coordinates per 
subunit.  Phosphotriesterase (PTE) and urease (URE) contain two molecules of zinc and 
nickel respectively (54, 55).  Most members of this subgroup contain a conserved 
carboxylated lysine residue that bridges the two metal ions found at the C-terminus of β-
strand 4.  A few enzymes, like the bacterial PTE homology protein, contain a glutamate 
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residue at this position instead (56).  The five conserved residues of the amidohydrolase 
superfamily are all metal ligands in this subgroup.  A key representative of the subgroup 
of enzymes coordinating a single metal ion is adenosine deaminase (ADA) (1, 55).  In 
adenosine deaminase, three of the histidines coordinate to the zinc ion, while the fourth 
conserved histidine serves as a general base in the active site.   
Holm and Sander placed DHO in the adenosine deaminase subfamily based on 
previous assertions that DHO bound only a single zinc ion (1).  Metal reconstitution 
experiments in the hamster and E. coli enzymes supported this belief (36, 38, 48).    
Also, the carboxylated lysine residue was not identified in primary sequence alignments.  
Here, the X-ray crystal structure of DHO is presented.  Surprisingly, there was a 
binuclear metal center in the active site with a caboxylated lysine bridging the two zinc 
cations.  Additionally, dihydroorotate was bound in one subunit of the crystallized 
dimer, while carbamoyl aspartate was bound in the other subunit.  This discovery 
allowed for the proposal of a novel mechanism for the enzyme.   
 
Materials and Methods 
 
The gene for DHO, pyrC, was cloned from E. coli and ligated into the pBS+  
expression vector from Stratagene.  The recombinant protein was expressed in E. coli.  
DHO was purified using a modified procedure adapted from Collins (49).  The seleno-
methionine derivative of DHO was also prepared.  The seleno-methionine was 
incorporated using a method that inhibits the pathway used by cells to produce 
methionine (57, 58).  This method requires that the cells are grown in minimal media.  
MALDI mass spectra of the native and derivative proteins were obtained to confirm the 
incorporation of the seleno-methionine.  The mass spectroscopy was done by the 
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Laboratory for Biological Mass Spectrometry at Texas A & M University. The crystal 
structure was solved by our collaborators from the University of Wisconsin (59). 
 
Results 
 
Structure of DHO.  The X-ray crystal structure of native DHO isolated from E. 
coli was obtained at a resolution of 1.7 Å.  Contrary to expectations, each subunit of the 
dimer coordinated two ions of zinc.  The overall dimensions for the dimer are 73 Å x 77 
Å x 80 Å and it is shown in Figure 2.1.  The two active sites are 25 Å apart.  Each 
subunit of the dimer contains the conserved “TIM” barrel motif of the amidohydrolase  
superfamily.  The eight β-strands of the “TIM” barrel are composed of residues Asp14 – 
His-18, Arg-38 – Val-41, Thr-73 – Leu-80, Phe-98 – Leu-130, Leu-136 – His-139, Lys-
172 – Phe-175, Ala-195 – Ile-198 and Val-245 – Leu-247.  In addition to a “TIM” barrel 
motif, each subunit of the dimer contains five extra β-strands, three α-helices and 
various type I, II and III turns.  The dimensions of each subunit are 51 Å x 51 Å x 54 Å.  
The monomer is shown in Figure 2.2.  
 Subunit Interface.  Three loop regions, His-144 – Arg-152, Arg-207 – Arg-227 
and Asp-260 – Gly-264, define the interface between the two subunits.  The surface lost 
by dimerization is approximately 2,300 Å2 and the two subunits overlay with a root 
mean square deviation of 0.22 Å.  The overlay of the α-carbons of each subunit is shown 
in Figure 2.3.  The only movement seen is in loop 4, which is defined by residues Pro- 
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Figure 2.1:  Ribbon representation showing the distribution of secondary elements in the 
DHO dimer (PDB 1J79).  The strands are shown in yellow and the helices are in red.  
The overall dimensions of the dimer are 73 Å x 77 Å x 80 Å.  The active sites are 25 Å 
apart.    
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Figure 2.2:  Representation of the TIM-barrel of the DHO monomer (PDB 1J79).  In 
addition to the core TIM barrel, there are five additional β-strands and three α-helices.  
The binuclear metal center and the ligands His-16, His-18, Lys-102, His-139, His-177 
and Asp-250 are highlighted.   
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Figure 2.3:  Overlay of the α-carbon backbone of the two subunits of DHO (PDB 1J79).  
Subunit I coordinating dihydroorotate is shown in blue while Subunit II with bound 
carbamoyl aspartate is shown in red/pink.  The only movement between the two subunits 
appears to be in loop 4.  
Loop 4:  
P105 -T117
Dimer 
Interface 
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105 – Thr-117.   The subunit interface is stabilized by two salt bridges between Asp-148 
(subunit I) and Arg-207 (subunit II) and between Asp-151 (subunit I) and Arg-227 
(subunit II).  Hydrogen bonds are also formed between the side chain carboxamide 
group of Asn-208 (subunit II) and the backbone carbonyl oxygen of Ile-147 (subunit I) 
and the peptidic nitrogen of Ile-149 (subunit I).   
 Active Site of DHO.  The crystallized dimer of DHO contained bound substrate 
and product.  The overlay of the active sites of the two subunits is shown in Figure 2.4.  
In the active site of subunit I, dihydroorotate is bound as shown in Figure 2.5A.  The 
location of the active site residues in the secondary structure is highlighted in Figure 2.6.  
The two metal ions are separated by 3.5 Å and are bridged by the carboxylated Lys-102 
and a solvent molecule (believed to be a hydroxide ion).  The more buried α-metal ion is 
coordinated to His-16, His-18, Lys-102, Asp-250 and the bridging solvent molecule.  
The α-metal ion is in a distorted trigonal bipyrimidal coordination sphere.  The more 
solvent-exposed β-metal ion is distorted tetrahedrally and is coordinated by Lys-102, 
His-139, His-177 and the bridging solvent molecule.  The carbonyl oxygen (O4) of 
dihydroorotate of the formed amide is coordinated to the β-metal ion at a distance of 2.9 
Å and is 2.7 Å from the solvent molecule.  N3 of dihydroorotate is 3.1 Å from the 
backbone carbonyl oxygen of Leu-222 and 2.9 Å from the bridging solvent molecule.  
O2 of dihydroorotate is coordinated to the backbone amide of Leu-222 with a distance of 
2.7 Å, while N1 of dihydroorotate is 3.0 Å from the backbone carbonyl group of Ala-
266.  The carboxylate side chain of C6 appears to be stabilized by interactions with Arg-
20, Asn-44 and His-254.  Additionally, there are seven water molecules within 4.5 Å of 
the bound dihydroorotate.  The active site of subunit II of DHO contained bound 
carbamoyl aspartate as shown in Figure 2.5B.   The bridging active site water has been 
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Figure 2.4:  Overlay of the active sites of the two subunits of DHO (PDB 1J79).  Subunit 
I coordinating dihydroorotate is shown in blue while Subunit II with bound carbamoyl 
aspartate is shown in red/pink.  
Asp-250
His-18 
His-139 
Lys-102
His-177
His-16
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Figure 2.5:  The active sites of DHO with bound carbamoyl aspartate (A) and 
dihydroorotate (B).  The distances reported are in Å. 
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HUMAN   --TSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDGPALALAQKLA 
E. coli MTAPSQVLKIRRPDDWHLHLRD-----GDMLKTVVPYTSEI-YGRAIVMPNLAPPVTTVEAAVAYRQRI 
                       β1           α1   β2  α2 
 
HUMAN   EAGARCDFAL-FLGASSE------NAGTLGTVAGSAAGLKLYLNETFSELRL-DSVVQWMEHFETWPSH 
E. coli LDAVPAGHDFTPLMTCYLTDSLDPNELERGFNEGVFTAAKLYPANATTNSSHGVTSIDAIMPVLERMEK 
        β3          α3        β4      
α4      
 
HUMAN   --LPIVAHAEQQTVAAVLMVAQLTQ--------------RSVHICHVARKEEILLIKAAKARGLPVTCE 
E. coli IGMPLLVHGEVTHADIDIFDREARFIESVMEPLRQRLTALKVVFEHITTKDAADYVRDGN---ERLAAT 
      β5                     α5       β6        α6       β7 
 
HUMAN   VAPHHLFLSHDDLERLGP-GKGEVRPELGSRQDVEALWEDMA---VIDCFASDHAPHTLEELPLKCGSR 
E. coli ITPQHLMFNRNHMLVGGVRPHLYCLPILKRNIHQQALRELVASGFNRVFLGTDSAPHARHR---KESSC 
            α7          β8         α8 
                   
HUMAN   PPPG-FPGLETMLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAH 
E. coli GCAGCFNAPTALGSYATVFEEMNALQHFEAFCSVNGPQFYGLPVNDTFIELVREEQQVAESIALTDDTL 
                                 
 
HUMAN   WTPFEGQKVKGTVRRVVL 
E. coli VPFLAGETVRWSVKK 
 
 
Figure 2.6:  Alignment of DHO sequences from human and E. coli.  The conserved 
residues of DHO proteins are highlighted in purple.  The residues composing the β-
strands are highlighted in black, while those forming the α-helices are in grey.  The 
secondary structure elements are numbered according to those that constitute the core 
TIM-barrel.  The underlined residues are those comprising the subunit interface. 
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displaced by the side chain carboxylate group of carbamoyl aspartate.  The backbone 
NH and CO groups of Leu-222, at 2.7 Å away, are within hydrogen bonding distance of 
the carbamoyl moiety of carbamoyl aspartate.  N3 of the substrate is 3.0 Å from the 
carboxylate group of Asp-250.  The α-carboxylate group of carbamoyl aspartate is 
stabilized by electrostatic interactions with Arg-20, Asn-44 and His-254.  The two metal 
ions are separated by 3.7 Å. 
 Seleno-methionine DHO.  The seleno-methionine derivative of DHO was 
successfully prepared.  The MALDI mass spectra confirming the incorporation of the 
unnatural amino acid is shown in Figure 2.7.  The mass of the native protein is 38,941 
Daltons while the seleno-methionine derivative has a molecular weight of 39,408  
Daltons.  The mass difference between the two enzymes is 467 Da, which is consistent 
with the substitution of all 10 methionine residues with seleno-methionine. 
 
Discussion 
 
Comparison with Other Amidohydrolase Superfamily Members.  The active sites of 
DHO, PTE and urease overlay very well as shown in Figure 2.8 (59-61).  The root-
mean-square deviation of DHO and urease is 1.24 Å (between the backbone of 56 
residues of the 8 β-strands), while for PTE and DHO it is 2.9 Å (between 72 structurally 
equilavent α-carbons) (59, 62).  The four histidine residues, the aspartic acid and the 
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Figure 2.7:  Mass spectra of native DHO (A) and the seleno-methionine derivative  
of DHO (B).  The mass difference of 467 Daltons is representative of the incorporation 
of 10 seleno-methionine residues.    
B
A
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carboxylated lysine of all three enzymes align nicely.  It is interesting that although the 
primary sequence identity is rather low (less than 20 %) for the three proteins, the active 
sites are so highly conserved.     
Since the Holm and Sander paper there have been many additional X-ray crystal 
structures added to the amidohydrolase superfamily.  Some of the structures fit nicely in 
the mold of the superfamily in that they have the requisite residues at the appropriate 
positions.  Examples are the E. coli proteins isoaspartyl dipeptidase (IAD) and cytosine 
deaminase (CDA) (63, 64).  Like DHO, IAD contains a binuclear zinc center (63).   The 
structure has bound product, aspartate, in the active site.  This enzyme is interesting as it 
is an octamer that is formed from a tetramer of dimers.  Each subunit has two domains, 
the N-terminal region contains eight strands of β-sheet and the C-terminal region 
consisting of the TIM barrel.  The active site of CDA is reminiscent of the active site of 
murine ADA as several substrate binding residues are conserved (55).  The substrates of 
the two enzymes are bound in a similar orientation and position.  CDA coordinates a 
single atom of iron, unlike the zinc-binding ADA.  It is important to note that only the 
bacterial CDA proteins are members of the amidohydrolase superfamily.  The fungal 
counterpart has a different fold that is similar to the one adopted by the bacterial cytidine 
deaminase (65, 66).  The active sites of human renal dipeptidase and uronate isomerase 
differ from the other enzymes of the amidohydrolase superfamily (67, 68).  In renal 
dipeptidase there is an HxD motif instead of the HxH from strand 1.  Also, as seen in the 
PTE homology protein, there is a glutamate residue bridging the two metal ions in lieu 
of the carboxylated lysine at strand 4 (56).  There also is the absence of an aspartate 
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Figure 2.8:  Overlay of the active sites of DHO (blue), PTE (green) and Urease (red).  
The structures were reported in Thoden et al. (59), Benning et al. (60) and Jabri et al. 
(61).  The coordinates were obtained from the PDB (1J79, 1HZY, 2KAU). 
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residue bound to the α-metal ion as seen in DHO, PTE and urease.  Uronate isomerase 
(UAI) is an unusual member in that it does not catalyze a hydrolysis reaction.  The 
structure of the Thermotoga maritima enzyme revealed that there is a tryptophan residue 
from strand 7.   There are two domains of UAI (A and B) and only domain A contains 
the TIM barrel domain.  The role of the helical domain B is unclear as the active site of 
the enzyme is found in domain A.  The crystallographers saw electron density consistent 
with a metal ion.  As they were unclear on the identity of the metal ion, they 
conservatively modeled a water molecule into the active site.   Our unpublished data on 
the E. coli UAI indicates that the enzyme coordinates a single zinc ion.  As more 
structures of amidohydrolase superfamily members are added, it will be interesting to 
see if these examples are outliers or more the norm than might be expected.   
 Cyclic Amidases.  The enzymes of the amidohydrolase superfamily with the 
highest primary sequence similarity to DHO are other cyclic amidases catalyzing the 
hydrolysis of five or six-membered rings (1, 69).  Scheme 2.2 shows the reactions of 
dihydropyrimidinase (DHP), hydantoinase and allantoinase.  DHP functions in the 
second step of pyrimidine degradation.  The enzyme catalyzes the reversible hydrolysis 
of 5,6-dihydrouracil (DHU) or 5,6-dihydrothymine (DHT) to form N-carbamoyl-β-
alanine (NCBA) or N-cabamoyl-β-aminoisobutyrate respectively.  DHP also hydrolyzes 
various 5’-mono-substituted hydantoins to 3-ureido acids (70).  Hydantoinase is the 
microbial counterpart to DHP.  Substrates for these enzymes are D- or L- isomers or 
racemic mixtures.  The X-ray crystal structure for the mammalian DHP has not been  
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Scheme 2.3 
 
obtained yet, but as will be discussed later, researchers have developed a structural 
model of the enzyme.  The structure of three hydantoinases has been determined, D-
hydantoinase from Thermus sp., L-hydantoinase from Arthobacter aurescens and D-
hydantoinase from Bacillus stearothermophilus (71-73).        
Proposed Catalytic Mechanism.  The proposed mechanism suggested by the 
crystal structure of DHO is illustrated in Scheme 2.3.   In the direction of dihydroorotate 
hydrolysis, Asp-250 initiates the reaction by activating the bridging hydroxide ion to 
attack at C-4 of the substrate.  The β-metal ion polarizes the carbonyl group of the 
substrate making it more susceptible to attack.  The ensuing tetrahedral intermediate 
collapses to form the product. In the biosynthesis of dihydroorotate, Asp-250 initiates 
the reaction by deprotonating the amide nitrogen of carbamoyl aspartate.  The amide 
nitrogen attacks the carboxylate of carbamoyl aspartate to form the tetrahedral adduct. 
The intermediate collapses upon protonation of the amide nitrogen to produce 
dihydroorotate.   
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Comparison to Dihydropyrimidinase.  DHP is another enzyme previously 
thought to have one active site metal ion, a zinc ion. Gojkonvic et al. were the first to 
present experimental data showing that DHP proteins, specifically those from 
Saccharomyces kluyveri and Dictyostelium discoideum, contained two ions of zinc per 
subunit (74).  Additionally, Gojkonvic et al. modeled the human DHP sequence onto the 
DHO structure.  The active site of DHP overlays with the DHO active site very well.  
Consequently, the mechanism proposed for DHP is highly reminiscent of that for DHO.   
Subunit Interface.  The observation of bound substrate and product in the 
crystallized dimer poses the question: Do the two subunits communicate with each other 
during catalysis?  Or was the presence of both carbamoyl aspartate and dihydroorotate a  
fortunate coincidence?  The topic of subunit communication has been studied before in 
the E. coli protein biotin carboxylase (75).  Responsible for catalyzing the ATP-
dependent carboxylation of the vitamin biotin, biotin carboxylase is a component of 
acetyl-CoA carboxylase.  The multi-functional enzyme complex acetyl-CoA carboxylase 
is involved in fatty acid biosynthesis and is composed of biotin carboxylase, biotin 
carboxyl carrier protein and carboxyltransferase.  As is the case with DHO, the enzyme 
is a homodimer with each subunit containing a complete active site.   
Janiyani et al. used N-terminal tags to determine the significance of each subunit 
to the catalytic activity of biotin carboxylase (75).  Hybrid molecules of the enzyme 
were formed in which one subunit of the dimer was wild-type and the other subunit a 
variant with active site mutations.  To do this, the gene encoding for the wild-type 
(accC) or mutant enzyme was manipulated to incorporate a poly-histidine or FLAG tag.  
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The genes were ligated into expression vectors.  The plasmids were used to coexpress 
the differently tagged subunits.  Three types of dimers could form:  one with two His-
tagged subunits (HH); a dimer that contained two FLAG-tagged subunits (FF); or one 
that was composed of a subunit with the His-tag and one with the FLAG-tag (HF).  
Affinity chromatography was used to purify the hybrids.  The FF could be separated 
from the HH and HF dimers by running the sample through an immobilized nickel 
affinity column.  Then the HF could be isolated by running an anti-FLAG affinity 
column.  N-terminal protein sequencing results confirmed that the purified protein was 
indeed the HF hybrid as both tag sequences were observed.  Four different HF biotin 
carboxylase hybrid dimers were used in kinetic analyses.  In the hybrid dimers, one 
subunit was wild-type while the other contained one of four mutations to an active site 
residue (R292A, N290A, K238Q or E288K).  The kinetic parameters of these hybrids 
were compared to the HF dimer in which both subunits were wild-type.  Biotin 
carboxylase activity was greatly reduced in all mutant differentially tagged biotin 
carboxylases.  The Vmax of the R292A/WT HF hybrid was 2.54 min-1 compared to a 
value of 99.8 min-1 for the WT/WT HF hybrid.  The values for Vmax were 3.6, 1.06 and 
0.35 min-1 for the N290A/WT, K238Q/WT and WT/E288K hybrid proteins respectively.  
These results suggest that two active subunits are required for maximum  catalytic 
function.      
 Crystallization of Other DHO Proteins.  Two papers have been published that 
report on the crystallization of DHO.  Purcarea et al. crystallized the enzyme from the 
hyperthermophilic bacterium Aquifex aeolicus (76).  The crystallization of the hamster 
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enzyme was reported by Maher et al. (77).  The X-ray crystal structure has not been 
published for either enzyme.  The authors of the hamster enzyme paper report the 
formation of crystals containing a tetrameric form of DHO (77).  The tetramer is 
believed to be linked through disulfide bonds.  This was tested by reacting the dimer and 
tetramer with DTNB.  The dimeric form of the enzyme gives an absorbance change at 
412 nm that is consistent with one cysteine residue per monomer.  No absorbance 
change is seen with the tetramer indicating that there are no free surface cysteines.  Thus, 
the tetramer is formed from two disulfide linkages between two DHO dimers.  The 
significance of this tetrameric species is unclear as the authors report that the activity is 
similar to that of the native form.    
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CHAPTER III 
  
MECHANISM OF THE DIHYDROOROTASE REACTION 
 
Dihydroorotase (DHO) functions in the biosynthesis of pyrimidine nucleotides 
by catalyzing the reversible cyclization of N-carbamoyl L-aspartate to L-dihydroorotate 
as shown in Scheme 3.1.   An analysis of the amino acid sequences of DHO from 
multiple species reveals that there are two general classes of this enzyme (2).  Members 
of Class I are found in higher organisms and are larger than their Class II counterparts 
that are found in many bacteria and fungi.  Examples of the Class I form of DHO are 
exemplified by CAD, a multi-functional enzyme found in mammals, insects and molds.  
The CAD protein consists of the first three enzymes of the pyrimidine biosynthetic 
pathway - carbamoyl phosphate synthetase (CPS), aspartate transcarbamoylase (ATC) 
and DHO (3, 4).   Monofunctional examples of Class I DHO are found in gram-positive 
bacterial strains including Bacillus subtilis, Lactobacillus plantarum, Enterococcus 
faecalis, Clostridium acetobutylicum and Streptococcus aureus.   The Class II enzymes 
are all monofunctional proteins from gram-negative bacteria and yeast.  Class I proteins 
have typical subunit molecular weights of ~45 kDa compared to ~38 kDa for the Class II 
proteins.  Within each class of enzymes, the amino acid sequence identity is quite high 
(>40%), but poor sequence identity (<20%) is observed in a comparison of proteins 
between these two classes.  For example, the sequence identity between the human 
(Class I) and E. coli (Class II) forms of DHO is only 17%.  There are approximately 17 
residues that are fully conserved within the DHO enzymes sequenced to date in both 
classes of enzyme.   
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Scheme 3.1 
 
The DHO from hamster was initially reported to contain a single zinc ion that 
could be replaced by Co2+, Mn2+, or Cd2+ with retention of catalytic activity (38).   
However, the X-ray crystal structure of the E. coli enzyme demonstrated that the 
bacterial DHO contains two zinc ions per active site (59).  The high resolution structure 
also confirmed the assignment of DHO as a member of the amidohydrolase superfamily 
with a (βα)8-barrel protein fold and whose binuclear metal center was identical to that 
previously observed for phosphotriesterase and urease (1, 59).  The amidohydrolase 
superfamily of metalloenzymes functions primarily, but not exclusively, as catalysts for 
hydrolytic reactions at carbon and phosphorus centers.  A representation of the binuclear 
metal center in DHO is presented in Figure 3.1.  The six conserved residues found at the 
C-terminus of the central β-strands are His-16, His-18, Lys-102, His-139, His-177, and 
Asp-250.  The two zinc ions are bridged by a carbamate functional group formed from 
the post-translational carboxylation of Lys-102 with CO2 and a molecule from solvent 
that is most likely hydroxide.     
 The reversible reaction catalyzed by DHO is pH-dependent and the equilibrium 
constant of the overall reaction as written in Scheme 3.1 is 1.5 x 106 M-1 (39).  At pH 
6.2, the equilibrium between carbamoyl aspartate and dihydroorotate is unity.  At lower 
pH values the formation of dihydroorotate is favored.  Conversely, at higher pH values 
the formation of carbamoyl aspartate is dominant.  DHO was first crystallized at a pH 
where the equilibrium constant for the interconversion between substrate and product 
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Figure 3.1:  Representation of the binuclear metal center within the active site of DHO.  
The structure was obtained by Thoden et al. (59) and the coordinates obtained from the 
PDB (1J79).   
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was approximately one (59).  This fortuitous event enabled the structural elucidation of 
the specific molecular interactions between substrate/product and the metal center in 
individual subunits to be unveiled within the same dimer of DHO in the crystalline state.  
In one subunit of the dimer, dihydroorotate was bound to the active site while in the 
adjacent subunit, carbamoyl aspartate was bound.  Carbamoyl aspartate coordinates to 
the binuclear metal center via a bridging interaction through the side chain carboxylate 
of the substrate.  In contrast, the amide carbonyl group of dihydroorotate interacts with 
the binuclear metal center by direct coordination to the β-metal ion.  The bridging 
hydroxide is more closely associated with the α-metal ion.  Electrostatic interactions 
with the backbone atoms of Leu-222, Ala-266 and Gly-267 stabilize the binding of the 
substrate and product in the active site of DHO.  The most specific contacts between 
protein and substrate originate from the side chains of Arg-20, Asn-44 and His-254 via 
the formation of electrostatic interactions with the free α-carboxylate group of 
dihydroorotate and carbamoyl aspartate.   
 Here, we provide direct biochemical support for the chemical mechanism first 
suggested by the molecular contacts observed in the X-ray crystal structure of DHO.  
The role of Asp-250 in proton transfer reactions is assessed via mutation of the side 
chain carboxylate of this residue to functional groups that are unable to serve this 
function.  Mutagenesis of specific residues was implemented to probe the functional 
requirement for the electrostatic interactions between the side chains of Arg-20, Asn-44 
and His-254 with the α-carboxylate of dihydroorotate and carbamoyl aspartate.  Metal-
substituted variants of DHO were prepared to elucidate the roles of the metals in 
catalysis and to identify the role the bridging hydroxide plays in catalysis.  The sulfur 
analog of dihydroorotate was analyzed as a substrate for DHO and used to probe the 
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interactions between the amide bond that is formed and broken with the binuclear metal 
center of DHO.   
 
Materials and Methods 
Materials.  N-Carbamoyl aspartate was purchased from Research Organics.  
Deuterium oxide was obtained from Cambridge Isotope Laboratories.  Platinum pfx 
DNA polymerase was acquired from Invitrogen, while the remainder of the molecular 
biology products were from Promega or Stratagene.  The buffers, substrates and other 
chemicals were acquired from Sigma-Aldrich.  The Gene Technology Laboratory of 
Texas A&M University performed the DNA sequencing reactions and oligonucleotide 
synthesis.  Thio-dihydroorotate (TDO) was synthesized using a protocol adapted from 
Christopherson (42).   
Site-Directed Mutagenesis.  The DHO used as the wild-type enzyme in these 
experiments was altered from the native pyrC gene isolated from E. coli.  Four cysteine 
residues that are thought to cause sensitivity to oxidation were substituted for serine 
residues with no loss of activity or change in any other enzymatic property (50, 51).  
These residues are Cys-63, Cys-65, Cys-121 and Cys-179.  The single point-mutations at 
any one of these sites did not consistently produce protein that was stable with maximum 
catalytic activity for an extended period of time.  The quadruple mutant 
(C63S/C65S/C121S/C179S) was stable and had kinetic parameters consistent with 
previously reported values (49, 50).  The DNA template for the mutagenesis experiments 
described in this paper utilized the altered sequence with the mutation of four cysteine 
residues to serine and designated as the QM protein.   
The mutagenesis protocol was PCR-based and involved the use of four primers 
that produced two over-lapping fragments (78).  The cloning vector in all cases was 
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pBS+ from Stratagene.  A typical reaction contained 2 ng of template DNA, 4 µM of 
each primer, 1X pfx buffer, 2.0 mM dNTP mix and 5 units of platinum pfx DNA 
polymerase.  The PCR protocol was used as follows: 2 minutes at 95 °C, 25 cycles of 1 
minute at 95 °C, 1 minute at 50 °C, and 4 minutes at 68 °C, followed by 1 cycle of 10 
minutes at 68 °C.  The PCR products were digested with EcoRI and HindIII for two 
hours at 37 °C, purified and then ligated with similarly digested pBS+.  XL1 Blue cells 
were transformed with the ligation reactions.  Cells containing plasmid were selected on 
LB plates containing ampicillin.  Individual colonies were used to inoculate 5 mL LB 
cultures, which were grown overnight at 37 °C.  The plasmids were isolated from the 
overnight cultures using the Wizard Mini-Prep SV kit (Promega).  The desired mutations 
were confirmed by sequencing of the isolated DNA. 
Protein Purification.  The wild type and mutant forms of DHO were all purified 
in the same manner.  The E. coli strain, X7014a, that lacks a functional gene for 
dihydroorotase was obtained from the Yale E. coli Genetic Stock Center and 
transformed with the pBS+ plasmids containing the gene for DHO.  For each preparation, 
large cultures were incubated at 37 °C until they reached mid-log phase at which point 
IPTG was added to a concentration of 1.0 mM.  After overnight incubation, the cells 
were collected by centrifugation and resuspended in 50 mM Tris-phosphate, pH 7.0, 100 
µM ZnCl2 and 5.0 mM carbamoyl aspartate.  The cells were lysed by sonication and the 
nucleic acids precipitated by the addition of a 2.0% proteamine sulfate solution.  After 
centrifugation, the cell extract was saturated to 60% in ammonium sulfate.  After 
centrifugation, the pellet was resuspended in a minimal amount of buffer and then 
chromatographed with the aid of an AKTA Purifier (Pharmacia) using a Superdex-200 
26/60 column.  The buffer used for the gel filtration column was 50 mM bis-tris propane, 
pH 7.0, containing 5.0 mM carbamoyl aspartate.  The flow rate was 1.0 mL/min with 1.5 
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mL fractions being collected.  The fractions containing DHO activity were pooled and 
loaded onto a  Resource-Q anion exchange column with the AKTA system.   Buffer A 
was 20 mM bis-tris propane, pH 7.0, while Buffer B was the same buffer with 1.0 M 
NaCl.  The protein was eluted from the column by the use of a salt gradient (0-30% 
buffer B in 30 column volumes). The flow rate was 4.0 mL/minute with 1.0 mL fractions 
being collected.  Fractions were assayed for activity and those containing DHO were 
pooled.  The purified enzyme was typically stored at –80 ºC in 20 mM bis-tris propane, 
pH 7.0, with 20% glycerol, 100 µM ZnCl2 and 5.0 mM carbamoyl aspartate.   
Preparation and Reconstitution of Apo-enzyme.  Chelex 100 (BioRad) was used 
to remove contaminating metals from buffers.  The buffers were degassed with argon 
prior to the addition of enzyme.  The apo-enzyme was prepared by incubating DHO at a 
concentration of 1.5 mg/mL for 24 hours with 25 mM dipicolinate in 50 mM sodium 
acetate, pH 5.5, containing 50 mM sodium sulfate, 2.0 mM sodium hydrosulfite and 
30% glycerol. The dipicolinate was removed by dialysis using three changes, 24 hours 
each, of 20 mM sodium acetate, pH 5.8, containing 2.0 mM sodium hydrosulfite and 
20% glycerol.  To reconstitute the apo-enzyme, the protein solution was made 100 mM 
in Hepes, pH 8.0, 2.0 mM sodium hydrosulfite and 100 mM potassium bicarbonate.  
Typical protein concentrations were 0.5-1.0 mg/mL.  Excess divalent metal chloride 
salts at concentrations of 26-130 µM were added to the apo-enzyme for reconstitution of 
catalytic activity.  Maximum recovery of activity required three days of incubation at 4 
°C.   Atomic absorption (AA) spectroscopy was used to measure the concentration of 
each cation in the protein samples.  Prior to performing AA analysis, the protein solution 
was passed through a PD10 column (Pharamacia) equilibrated with metal-free buffer to 
remove excess metal ions.   
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Enzyme Assays.  DHO activity was determined by a direct spectrophotometric 
assay at 230 nm (13).  The assays were performed in a 96-well plate using a 
SPECTRAmax-340 (Molecular Devices) plate reader.  Dihydroorotate absorbs at 230 
nm with an extinction coefficient of 1.17 mM-1 cm-1 (14).  TDO absorbs at 280 nm with 
an extinction coefficient of 17 mM-1cm-1.   The assay volume was 250 µL which 
corresponds to a path length of 0.69 cm.  The buffers for the pH-rate profiles were the 
potassium salts of MES from pH 5-6.75, HEPES from 6.75-8.5 and TABS from 8.5-9.5.  
The buffer concentration in each assay was 50 mM and the pH was varied in 0.25 unit 
increments.  The pH was measured at the completion of the enzymatic reaction.  For the 
variation of carbamoyl aspartate, the concentration range was 0.05-20 mM.  A range of 
0.025-1.75 mM was used for the variation of dihydroorotate and TDHO.  For 
measurement of the solvent isotope effects, the same reaction conditions were used 
except that the buffers were prepared in D2O.  Enzyme dilutions were performed in 20 
mM Hepes, pH 7.0, prepared with D2O.  The pD of each reaction was measured after 
completion of the assay by adding 0.4 to the pH electrode reading (79).  The solvent 
deuterium isotope effects were determined over the pH range of 5.5-7.0 for the synthesis 
reaction and 8.0-9.8 for the hydrolysis reaction. 
Data Analysis.  The kinetic parameters, kcat and kcat/Km, from the initial velocity 
experiments were determined from a fit of the data to equation 1, where v is the initial 
velocity, kcat is the turnover number, Et is the enzyme concentration, A is the substrate 
concentration and Km is the Michaelis constant.  For the pH-rate profiles, the effect of 
pH on kcat and kcat/Km was determined for each substrate by a fit of the data to equations 
2 and 3 using the computer programs of Cleland (16).  Equation 2 was used to fit the 
data when the activity diminished at low pH whereas equation 3 was used when the 
activity was lost at high pH.  In these equations, y is the value of kcat or kcat/Km, c is the 
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pH-independent value of y, H is the hydrogen ion concentration and Ka is the 
dissociation constant of the ionizable group. 
 
v/Et  =  kcatA/(Km + A)                                                          (1) 
log y  =  log[c/(1 + H/Ka)]                                                      (2) 
  log y  =  log[c/(1 + Ka/H)]                                                      (3) 
 
Results 
 Kinetic Parameters.  The kcat, Km and kcat/Km kinetic constants for the 
biosynthesis and hydrolysis of dihydroorotate by the zinc-substituted form of DHO are 
presented in Table 3.1.  Consistent with previously reported data with the DHO from E. 
coli, the maximal rate of formation for the synthesis of dihydroorotate from carbamoyl 
aspartate is slightly faster than the rate of the hydrolysis reaction (49).  However, the Km 
value for dihydroorotate is about 10-fold lower than that of carbamoyl aspartate and thus 
kcat/Km for dihydroorotate is about an order of magnitude higher than it is for carbamoyl 
aspartate.  Although the thio-substituted form of dihydroorotate has been reported to be a 
potent inhibitor of the eukaryotic DHO from hamster, this compound was found to be a 
reasonably good substrate for the bacterial enzyme (42).  Shown in Figure 3.2 are the 
time courses for the changes in absorbance after the addition of DHO to a solution of 
TDO.  There is a disappearance of the absorbance at 280 nm that is coupled with the 
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Table 3.1:  Kinetic Parameters for Metal-Substituted Forms of Dihydroorotasea. 
Enzyme Substrate kcat  
(s-1) 
Km  
(mM) 
kcat/Km 
(M-1 s-1) 
Zn/Zn-DHO Carbamoyl Aspartate 160 + 8 1.70 + 0.2 1.0 (0.1) x 105 
 Dihydroorotate 100 + 1.6 0.080 + 
0.001 
1.2 (0.1) x 106 
 Thiodihydroorotate 4.4 + 0.2 0.030 + 
0.001 
1.5 (0.3) x 105 
Co/Co-DHO Carbamoyl Aspartate 25 + 1.4 15 + 0.2 1.6 (0.2) x 103
 Dihydrorotate 15 + 1.4 0.70 + 0.03 2.1 (0.2) x 104
Cd/Cd-DHO Carbamoyl Aspartate 8.2 + 0.2 4.0 + 0.9 4.3 (0.1) x 103
 Dihydrorotate 1.9 + 0.3 0.23 + 0.06 8.3 (0.1) x 103
 Thiodihydroorotate 0.42 + 
0.01 
0.009 + 
0.001 
4.8 (0.9) x 104
aThese data were collected at pH 5.8 with carbamoyl aspartate as the substrate and at pH 
8.0 with dihydroorotate or thiodihydroorotate as the substrate.   
  
47
Wavelength (nm)
240 260 280 300 320
O
D
0.0
0.2
0.4
0.6
0.8
1.0 
 
 
 
 
 
 
 
 
Figure 3.2:  Time course for the hydrolysis of TDO at pH 8.0.  TDO absorbs with a pH-
maximum at 280 nm.  After the addition of 0.2 µM DHO, spectra were recorded at 2, 4, 
and 12 minutes.  The absorbance maximum at 280 nm diminishes with time and is 
replaced by an absorbance maximum at 250 nm that is consistent with the formation of 
the thio-acid analog of carbamoyl aspartic acid. 
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appearance of a new species that absorbs at ~250 nm. This observation is consistent with 
the formation of the thioacid analog of carbamoyl aspartate since the absorbance 
maximum of thioglycine is reported to be 247 nm (80).  At pH 8.0, TDO is hydrolyzed 
at a rate that is 23-fold less than the rate of dihydroorotate hydrolysis and the kinetic 
constants are presented in Table 3.1.  The equilibrium constant for the hydrolysis of 
TDO was determined by measuring the relative magnitude of the absorbances at 280 and 
250 nm as a function of pH from 6.0 to 8.0.  The data were fit to a modified form of 
equation 2 and the equilibrium constant was found to be 1.2 x 106 M-1.  During these 
experiments there was no indication for the formation of bisulfide.  In addition, 
incubation of the enzyme with bisulfide (SH-) and either carbamoyl aspartate or 
dihydroorotate did not generate a species that absorbs at either 280 nm or 250 nm at pH 
6.0 or 8.0.  Therefore, once the thioamide bond of TDO is hydrolyzed the reverse 
reaction does not form dihydroorotate with the liberation of bisulfide as illustrated in 
Scheme 3.2.   
 
 
 
 
 
   
Scheme 3.2 
 
Metal Substitution.  The functional role of the two divalent metal ions within the 
binuclear metal center of DHO was probed via metal substitution experiments.  The zinc 
ions of the native protein were removed by chelation with dipicolinate at pH 5.8 to make 
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the inactive apo-enzyme.  The binuclear metal center was reconstituted at pH 8.0 by the 
addition of 2-5 equivalents of Zn2+, Co2+, or Cd2+.  The metal substituted variants of 
DHO were catalytically active according to the following trend: Zn2+ > Co2+ > Cd2+.  The 
values for kcat, Km and kcat/Km of the reconstituted Zn2+, Co2+ and Cd2+ enzymes are 
shown in Table 3.1. The Cd-substituted DHO was also utilized as a catalyst for the 
hydrolysis of TDO and the kinetic constants are presented in Table 3.1.  With Cd-DHO 
the Km for TDO is significantly lower than it is for the hydrolysis of dihydroorotate.  In 
addition, the value of kcat/Km for the hydrolysis of TDO is 5-fold higher than it is for the 
hydrolysis of dihydroorotate.   
 pH-Rate Profiles.   Ionizations within the active site of DHO that are critical for 
the maintenance of catalytic activity were identified by measuring the kinetic constants 
in both the forward and reverse directions as a function of pH.  The pH-profiles showing 
the dependence of the kinetic parameters, kcat and kcat/Km, were determined for all three 
substrates and the plots are presented in Figure 3.3.  The log kcat and log kcat/Km versus 
pH profiles (Figures 3.3A and 3.33B) with carbamoyl aspartate as the substrate shows 
that a single group must be protonated for optimal activity.  The pH-rate profiles for the 
hydrolysis of either dihydroorotate or TDO indicates that a single group that must be 
unprotonated for activity is critical for catalytic activity (Figures 3.3C, 3.3D, 3.3E and 
3.3F).  The pH-rate profiles for the hydrolysis and synthesis of dihydroorotate was 
measure for the Co/Co-substituted enzyme and the results are also presented in Table 
3.2.  For the hydrolysis of dihydroorotate, the kinetic pKa values observed for the effect 
of pH on kcat and kcat/Km are shifted to higher values relative to the pKa values 
determined with the Zn/Zn-substituted enzyme.    
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Figure 3.3:  pH dependence of the reactions catalyzed by Zn/Zn-DHO with carbamoyl 
aspartate (A, B), dihydroorotate (C, D) or thiodihydroorotate (E, F) as the varied 
substrate.    
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Solvent Deuterium Isotope Effects.  The pH-rate profiles for the Zn-substituted 
enzyme for the hydrolysis and synthesis of dihydroorotate were measured in the 
presence of D2O and the kinetic pKa values are presented in Table 3.2.  In general, the  
kinetic pKa values are shifted to slightly higher values relative to the values obtained for 
the same parameter measured in H2O.   Similar trends are observed for the hydrolysis of 
TDO.  The pH-dependent equilibrium constant for the interconversion of carbamoyl 
aspartate and dihydroorotate precluded the accurate measurement of the kinetic 
constants for formation of dihydroorotate at pH values greater than 8.2 in D2O.  The 
solvent deuterium isotope effects were measured for all three substrates in the pH-
independent region of the pH-rate profiles and the results are presented in Table 3.2.    A 
solvent deuterium isotope effect of ~2.1 was obtained on kcat for all three substrates.  The 
largest effect was found on the kcat for the hydrolysis of dihydroorotate and somewhat 
smaller effects were obtained for carbamoyl aspartate and TDO.  The solvent isotope 
effects were slightly smaller on kcat/Km with values ranging of 1.1 to 1.7.   
Site-Directed  Mutagenesis.  The role of specific amino acids in the binding and 
catalytic interconversion of substrates in DHO was addressed by site-directed 
mutagenesis.  The X-ray structure of DHO shows that the α-carboxylate group of 
dihydroorotate is coordinated to the active site via multiple electrostatic interactions to 
Arg-20 Asn-44 and His-254 as illustrated in Figure 3.4.  Mutation of the substrate-
binding residues Arg-20, Asn-44 and His-254 had a significant affect on catalytic 
activity and the kinetic constants are presented in Table 3.3.  The H254N variant had less 
than 1% of the activity possessed by the wild-type enzyme.  A similar reduction in 
catalytic activity was obtained with the N44A mutant enzyme.  The R20M mutant was 
inactive but the R20K variant retained significant activity, with a kcat value of 15 s-1.   
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Figure 3.4:  Representation of the electrostatic interactions between the α-carboxylate of 
dihydroorotate and the side chains of Arg-20, Asn-44, and His-254.  The coordinates 
were taken from Thoden et al. (59) and obtained from the PDB (1J79). 
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Table 3.3:  Kinetic Parameters for Mutants of Dihydroorotasea. 
DHO Variant kcat   
(s-1) 
Km  
(mM) 
kcat/Km  
(M-1s-1) 
Wild-type 160 + 8 1.7 + 0.2 1.5 (0.2) x 105 
ASP-250A < 0.01b ndb ndb 
ASP-250E 12 + 1 1.9 + 0.3 6.3 (0.3) x 103 
ASP-250H < 0.01b ndb ndb 
ASP-250N < 0.01b ndb ndb 
ASP-250S 0.022 + 0.002 0.51 + 0.1 4.3 (0.1) x 101 
ARG-20Q < 0.01b ndb ndb 
ARG-20K 15 + 1 0.9 + 0.1 1.7 (0.1) x 104 
ARG-20M < 0.01b ndb ndb  
ASN-44A < 0.01b ndb ndb 
HIS-254N < 0.01b ndb a ndb 
aThe kinetic constants reported here are for the cyclization of carbamoyl aspartate.  
bNot determined because of the detection limit of the assay.  These experiments 
were conducted at a carbamoyl aspartate concentration of 10 mM. 
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It has been postulated that the side chain carboxylate of Asp-250 shuttles the proton 
from the bridging hydroxide to the leaving group amide of carbamoyl aspartate during 
the interconversion of substrate and product (59).  Five variations of the residue at 
position 250 of DHO were constructed and characterized using carbamoyl aspartate as 
the substrate.  The conservative replacement in the D250E mutant had the highest 
activity with a kcat of 6 s-1, relative to a turnover number of 160 s-1 for the wild-type 
enzyme.  The catalytic activity of the D250S mutant was diminished by a factor of 4000 
in comparison with the wild type enzyme.  The turnover numbers for D250A, D250H, 
and D250N were reduced by more than four orders of magnitude relative to the wild 
type enzyme.  The kinetic constants are presented in Table 3.3.   The pH-rate profile for 
the D250S mutant was measured using carbamoyl aspartate as the substrate.  The kinetic 
pKa for the group that must be protonated for activity was found to be 7.0 + 0.1. 
 
Discussion 
The three-dimensional X-ray structure of DHO has provided a unique view of the 
active site of this enzyme and the manner in which dihydroorotate and carbamoyl 
aspartate are associated with the binuclear metal center (5).  The trapping of the substrate 
and product within a single protein crystal has enabled a relatively rare glimpse of the 
molecular interactions of the two reactants in an enzymatic transformation immediately 
before and after the bond-making and bond-breaking events.  This image of the active 
site has laid the groundwork for the proposed reaction mechanism and subsequent 
biochemical verification.  The reversible hydrolysis of dihydroorotate likely requires 
three modes of catalysis by DHO: (i) the hydrolytic water molecule must be activated for 
nucleophilic attack, (ii) the amide bond of the substrate must be made more electrophilic 
by polarization of the carbonyl-oxygen bond, and (iii) the leaving group nitrogen must 
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be protonated as the carbon-nitrogen bond is cleaved.  The catalytic properties of the 
wild type enzyme and selected mutants of DHO are consistent with a chemical 
mechanism that incorporates all three forms of substrate activation.         
Activation of Solvent Water.  The X-ray structure of DHO in the presence of 
bound dihydroorotate reveals that there is a single solvent molecule associated with the 
binuclear metal center.  The lone molecule from solvent is found bridging the two 
divalent cations as illustrated in Figure 3.1.  The pH-rate profile for the enzymatic 
hydrolysis of dihydroorotate shows that a single group associated with the protein must 
be unprotonated for catalytic activity.  The loss of catalytic functionality as the pH is 
lowered is consistent with the protonation of the hydroxide that is proposed to bridge the 
two divalent cations within the active site of DHO.  In the direction of dihydroorotate 
hydrolysis, the kinetic pKa for the Zn-substituted DHO is ~6.1 for kcat and kcat/Km and is 
elevated to 6.9 and 7.6 for kcat and kcat/Km, respectively, for the Co-substituted DHO.  
Therefore, the specific metal ion associated with the binuclear metal center dictates the 
pKa for the bridging hydroxide.  These results differ from what was found with the 
hamster enzyme as it was reported that the kinetic pKa in the direction of dihydroorotate 
hydrolysis did not change significantly as the divalent cation was substituted with other 
metal ions (38).       
The pH-rate profile is different in the direction for the synthesis of 
dihydroorotate from carbamoyl aspartate.  Activity is lost as some group within the 
active site loses a proton.  Microscopic reversibility dictates that this is the same group 
that must be unprotonated for catalytic activity during the hydrolysis reaction.  
Optimization of the biosynthetic reaction would require the protonation of the bridging 
hydroxide followed by dissociation of the resulting water molecule upon the binding of 
carbamoyl aspartate.  This conclusion is supported by the X-ray structure of DHO in the 
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presence of carbamoyl aspartate (59).  In this enzyme-substrate complex the carboxylate 
group of carbamoyl aspartate was found bridging the two divalent cations.  There was no 
other water molecule coordinated to either metal ion.  The kinetic pKa values measured 
for kcat/Km with the Zn-substituted DHO in the two directions are not the same and thus 
the apparent ionization constant for the bridging water/hydroxide must be influenced by 
the stickiness of one or both of the substrates (18). 
Polarization of the Substrate.  The activation of dihydroorotate as an electrophile 
is expected to be enhanced through polarization of the carbonyl group of the substrate.  
Complexation of dihydroorotate in the active site of DHO via a direct interaction of the 
carbonyl oxygen with the metal center would diminish the electron density at the carbon 
center and facilitate nucleophilic attack by the bridging hydroxide.  This type of 
substrate activation is observed in the crystal structure of dihydroorotate bound to the 
Zn-substituted DHO.  In this structure the carbonyl oxygen is 2.9 Å from the β-metal 
ion.  The direct interaction of the metal center with the carbonyl oxygen of the amide 
bond to be cleaved is also supported by the kinetic properties of DHO upon substitution 
of sulfur for oxygen in the substrate using TDO.  The more easily polarized sulfur is 
expected to complex better with the softer CADmium than with the harder zinc.  In the 
CADmium-substituted enzyme the kcat/Km for TDO is 5-fold higher than with the Zn-
substituted DHO, whereas with the Zn-substituted DHO, the kcat/Km for dihydroorotate is 
an order of magnitude higher than it is for TDO.   
Protonation of the Leaving Group.    During the hydrolysis of dihydroorotate the 
amide nitrogen must be protonated.  Conversely, during the synthesis of dihydroorotate a 
proton must be abstracted from the attacking amide nitrogen.  In the X-ray structure of 
DHO there are no acid/base groups that can facilitate this proton transfer except for Asp-
250 from strand 8 that is also ligated to the α-metal ion.  This residue has been proposed  
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Figure 3.5:  Relative orientation of Asp-250 and the hydroxide that bridges the two 
divalent cations within the active site of dihydroorotase (PDB 1J79).  The proposed 
orientation of the hydrogen is shown for discussion purposes only. 
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as the group that shuttles the proton from the bridging hydroxide to and from the 
substrate and product during the course of the reaction (5).  Shown in Figure 3.5 is a 
representation of the active site of DHO showing the relative positions of dihydroorotate, 
Asp-250, the two divalent cations, and the bridging hydroxide.  In this structure the 
hydroxide that bridges the two divalent cations is poised to attack the carbonyl carbon of 
the bound dihydroorotate.  If one positions the hydroxide bound hydrogen and the 
remaining lone pair attached to the oxygen in a tetrahedral arrangement with regard to 
the ligation to the two divalent cations, then the hydrogen is logically placed in a 
hydrogen bonding interaction with the carboxylate from Asp-250 and the lone pair is 
orientated directly toward the carbonyl carbon of dihydroorotate.  The essential nature of 
Asp-250 for proton transfer reactions was addressed via site-directed mutagenesis.  This 
residue was substituted with alanine, glutamate, histidine, asparagine and serine.  Of 
these residues, the substitution by glutamate was the only perturbation that was tolerated 
at this position with any significant catalytic activity.  In the hamster enzyme, mutation 
of the homologous aspartate residue to glutamate resulted in an enzyme that had a kcat 
that was less than 10% of wild-type enzyme and had a 14-fold increase in Km (36). The 
aspartate from strand 8 that resides in the active site of the related enzyme 
phosphotriesterase has also been demonstrated to be involved in proton transfer reactions 
with the bridging hydroxide (20).  The solvent isotope effects measured for the 
formation and hydrolysis of dihydroorotate are modest.  At this point it is not possible to 
determine if this reflects the effect of deuterium on the proton transfer during substrate 
attack or whether this is a reflection of the recharging of the binuclear metal center from 
water after each turnover of the substrate. 
   Substrate Binding Interactions.  The exocyclic α-carboxylate group of 
dihydroorotate is bound to the protein via electrostatic interactions with the side chains 
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of Arg-20, Asn-44, and His-254.  Mutation of any one of these residues abolishes the 
ability to cyclize carbamoyl aspartate to dihydroorotate with the single exception of the 
replacement of Arg-20 with lysine.  Loss of enzymatic activity was also seen when the 
homologous residues were mutated in the hamster enzyme (36, 81).   It is clear from this 
result that the active site of DHO has a rather stringent requirement for substrate binding.  
In this regard we have attempted to hydrolyze dihydropyrimidine with the wild type 
DHO without success. 
Mechanism of Action.  The characterization of the catalytic properties of the wild 
type and mutated forms of DHO coupled with the high resolution X-ray crystal structure 
has provided sufficient insights to assemble a self consistent chemical mechanism for the 
interconversion of substrate and products within the active site of this enzyme.  The 
reaction mechanism is presented in Scheme 3.3.  For the hydrolysis of dihydroorotate the 
active form of the enzyme is one in which a hydroxide is bridging the two divalent 
cations within the enzyme active site.  Dihydroorotate binds to the binuclear metal center 
where the carbonyl oxygen is ligated to the β-metal which polarizes the carbonyl group.  
This orientation is supported by the X-ray structure of the bound dihydroorotate and the 
relative kinetic properties of the thio-substituted dihydroorotate (5).  Nucleophilic attack 
by the bridging hydroxide is facilitated by the transfer of the proton from the hydroxide 
to the carboxylate coordinated to the α-metal ion.  A tetrahedral adduct is formed that 
bridges the two divalent cations.  Collapse of the tetrahedral adduct occurs with 
protonation of the amide nitrogen and cleavage of the carbon-nitrogen bond.  The 
resulting carbamoyl aspartate is coordinated to the binuclear metal center via the newly 
formed carboxylate group.  This structure is supported by the X-ray structure of the 
bound carbamoyl aspartate (5).  The product is released and the binuclear metal center is 
recharged with hydroxide via a process that has not been addressed by the experiments 
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presented in this paper.  In the reverse direction, the carbamoyl aspartate binds to the 
protonated form of the enzyme with the release of a bound water molecule.  In this 
direction the reaction is initiated by the abstraction of a proton from the amide nitrogen 
by the carboxylate of Asp-250 concomitant with nucleophilic attack of the amide 
nitrogen on the carboxylate of carbamoyl aspartate that is bridging the binuclear metal 
center.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3.3 
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 CHAPTER IV 
 
THE ISOLATION OF A PROBABLE DIHYDROOROTASE FROM 
PSEUDOMONAS AERUGINOSA AND THE EVOLUTION OF 
DIHYDROOROTASE INTO A DIHYDROPYRIMIDINASE 
  
  Involved in the de novo biosynthesis of pyrimidines, dihydroorotase (DHO), is 
an essential enzyme to the viability of microbial organisms.  Unlike mammalian systems 
where there is a salvage pathway, there are no other pathways for the synthesis of uracil, 
cytosine and thymine nucleotides in pyrimidines.  The full alignment of DHO proteins 
from 71 bacterial organisms is shown in Appendix I.  There are six regions that are 
highly conserved.  Due to the X-ray crystal structure of the E. coli enzyme, it is 
understood that these regions are important in delivering the active site residues (59).  
Four histidines, a lysine and an aspartic acid coordinate the binuclear zinc center of 
DHO in E. coli.  Two of the histidines are found in an HXH motif.  In some organisms 
including Trichodesmium erythraeum, Nostoc punctiforme, Thermosynecoccus 
elongatus, Rhodopseudomonas palustris, Brucella suis, Rhodospirillum rubrum, 
Magnetospirillum magnetotacticum, Ralstonia metallidurans, Xanthomonas axonopodis,  
Xyllela fastidiosa, Pseudomonas fluorescens, Pseudomonas aeruginosa and Cytophaga 
hutchinsonii  this motif is replaced by a QXH motif, however, the four other active site 
residues are present.  It is unclear whether these proteins are active because in some 
organisms there is only the one DHO sequence with the QXH motif.  However, in P. 
fluorescens and P. aeruginosa, representatives of both sequences, QXH and HXH are 
present.       
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The bacterium P. aeruginosa is a pathogen that is a leading cause of human 
infections.  Due to its resistance to antibiotics and disinfectants, P. aeruginosa infections 
are impossible to eradicate and cause heart failure and death (82).  Due  
to its clinical significance, there is great interest in understanding the biochemistry of the 
organism.  To that end, the genome of P. aeruginosa PA01 has recently been sequenced 
(83).  As annotated by the institute for genomic research (TIGR) the P.  aeruginosa has 
three DHO sequences:  the inactive pyrC’ (PA0401), a probable DHO (PA5541), and 
pyrC (PA3527) which encodes for the active enzyme.  PA0401 has been shown to be 
associated with aspartate transcarbamoylase (ATC) (12).  Without complexation with 
pyrC’, ATC is inactive and insoluble.  Thus, it appears that the inactive dihydroorotase 
assists in the folding of ATC.  The probable DHO contains the QXH motif in lieu of the 
more typical HXH.  It is known that the histidines of the HXH bind the α-metal ion in E. 
coli, or more buried zinc of DHO.  Replacement of the first histidine with a glutamine 
could have an effect on metal-binding.  PA5541 is a larger protein than the pyrC gene 
product with a molecular weight of 49,295 Da compared to 38,406 Da.  Figure 4.1 
shows the alignment between the proteins and highlights the shared residues.  The 
sequence identity between PA5541 and PA3257 is 21 %.  As previously mentioned, all 
the other residues that are known to be involved in binding the metal and substrate, as 
well as those involved in catalysis, are conserved between the two proteins.  To further 
understand the function/structure relationship of DHO, the isolation and characterization 
of PA5541 was attempted. The goal is to determine whether it is an active DHO and if 
so, try to draw some conclusions on why the organism would have two active enzymes.  
That would answer why some organisms are viable even though they only have the 
QXH containing sequence.   
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PA3527 MSDRLT----------------LLR----------------------------P---DDW 
PA5541 MQSLLIRNARMVNEGQVREGDLLVRHGRIERIAGCLENCGASREIDAAGRYLLPGMIDD-         
                            
PA3257 HIHLRD-GAALANTVGDAART-----FGRAIVMPNLVPPVRNAAEADAYRQRILAARPAA 
PA5541 QVHFREPGYPQKGSIASESRAAVAGGITSFMDMPN-TRPATLSLEALAEKKRLAAAHSVA     
 
PA3527 SRFEPLMVLYLTDRTSTEEIRTAKASGFVHAAKLYPAGATTNSDSGVTRIDNIFEALEAM 
PA5541 NYGFHFGV----SRDNLDTV-AALDPREVAAVKVF-MGAST----GDMLVDDLPTLERLF 
 
PA3527 AEVGMPLLVHGEVT-RAEVDVFDREKQFIDE-----HLR---------------RVVERF 
PA5541 ASVPTLLLSHCEDTPRIEANLARWRQRFGERIPAAAHPRIRDAEACYRSTALAVELAQRH 
 
PA3527 PTLKVVFEHITTGDAAQFVREAP---ANVGATITAHHLLYNRNHMLVGGIRPHFY-CLPI 
PA5541 GTLLHVL-HLSTARELALFEDKPLCQKRITAEVCVHHLLFDDSDYARLG---HLLKCNPA 
       
PA3527 LKRNTHQEALLDAAVSGNPKFFLGTDSAPHARHAKEAA-----CGCAGCYSAYAAI-ELY 
PA5541 IKSREDRDAL-RRALAGNRLDVIGTDHAPHAWAEKQQAYPQAPAGLPLVQHALPALLELV 
 
PA3527 AEAFEQRNAL--DKLEGFASLHGPDFYGLPRN---TDRITLVREEWQAPAS-LPF-GDFD 
PA5541 REGWLSLATLVAKTSHRVAELFAIADRGFLREGYWADLVLVSELEHPALASAMPLLSRCN 
 
PA3527 VVPLR-------------AGETLRWK------------LLEAG 
PA5541 WTPFRHRAFHHRIDTTIVSGQ-LAWHAGRLSDDCQGLPLRFSR 
 
Figure 4.1:  Alignment of P. aeruginosa DHO sequences, PA3527 and PA5541.  The 
gray highlighted residues are the conserved residues of over 60 bacterial DHO proteins.  
The red highlighting is used to point out the His for Gln substitution in PA5541. 
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Scheme 4.1 
 
Dihydropyrimidinase catalyzes the reversible hydrolysis of dihydrouracil or 
dihydrothymine to form N-carbamoyl-β-alanine or N-carbamoyl-β-aminoisobutyrate.  
Both dihydropyrimidinase and DHO are members of the amidohydrolase superfamily  
and conserve their overall structural TIM-barrel fold and active site residues.  Like 
DHO, dihydropyrimidinase coordinates two molecules of zinc per active site (74).  Due 
to the lack of an X-ray structure of the enzyme, dihydropyrimidinase was modeled onto 
the structure of DHO.   The active site residues of the two enzymes overlayed very well.  
The model allowed for the proposal of the mechanism for dihydropyrmidinase, shown in 
Scheme 4.1, which is identical to that proposed for DHO (Sheme 2.3) in which an 
aspartate residue and a catalytic water mediate catalysis.  The only difference between 
the structures of the substrates for the two enzymes, dihydrouracil and dihydroorotate, is 
that the latter has a side-chain carboxylate at C-6.  The X-ray crystal structure of DHO 
provided details on how dihydroorotate is bound in the active site of the enzyme (59).  
As shown in Figure 2.5, each heteroatom of the substrate is coordinated by a group from 
the enzyme.  The peptidic groups of Leu-222 and Ala-266 contribute electrostatic 
interactions with dihydroorotate.  Arg-20, Asn-44 and His-254 are the only DHO 
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residues with side-chain interactions with the bound substrate.  The three residues appear 
to anchor dihydroorotate in the active site by forming hydrogen bonds with the 
carboxylate group at C-6.   Gojkovic et al. aligned the primary sequences of several 
dihydropyrimidinases and the E. coli DHO (74).  There is divergence, as expected, at the 
positions of Arg-20, Asn-44 and His-254 of DHO.  At these positions, the 
dihydropyrimidinases conserve glutamine, aspartate and lysine residues, respectively.  
To further explore the evolution of the enzymes within the amidohydolase superfamily, 
the task of altering the substrate specificity of DHO is undertaken using a rational 
approach.  The R20Q/N44D/H254K triple mutant of DHO was constructed and 
characterized to determine if dihydropyrimidinase functionality is gained.     
 
Materials and Methods  
 Materials.  The P. aeruginosa DNA was purchased from ATCC.  Platinum pfx 
DNA polymerase was purchased from Invitrogen.  All other molecular biology materials 
were purchased from Promega or Stratagene, while all chemicals were from Sigma.  
DNA sequencing and oligonucleotide synthesis was performed by the Gene 
Technologies Lab at Texas A & M University.   
 Amplification of PA5541 from P. aeruginosa.  The sequence for the PA5541 
gene (PA5541) was obtained from the TIGR website.  The PA5541 gene was PCR-
amplified using pfx polymerase.  The gene-specific primers contained engineered 
restriction sites at the appropriate ends.  At the 5’end of the gene, there was an NdeI site, 
while at the 3’ end an EcoRI site was placed.  The gene was digested and then ligated 
into similarly digested pet28 or pet30 vectors (Novagen).  The pet28 construct produces 
the His-tagged protein.           
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 Purification of His-tagged Protein.  BL21 DE3 cells were transformed with the 
pet28 vector containing the PA5541 gene.  Large cultures of the cells were incubated at 
30 ºC and induced with IPTG upon reaching mid-log phase.  The cells were collected by 
centrifugation after overnight incubation and suspended in 20 mM Tris, pH 7.9 
containing 500 mM NaCl and 5 mM imidazole (Buffer A).  The resuspended cells were 
lysed by sonication.  After centrifugation, the cell extract was run on the AKTA Purifier 
(Pharmacia) using a 5 mL Hi-Trap Chelating Sepharose Column (Pharmacia).  The 
column was loaded with Co2+ and equilibrated with buffer A.  The column was washed 
with 2 column volumes of Buffer A followed by an additional wash of 5 column 
volumes of Buffer A with a 5 % step gradient of 20 mM Tris, pH 7.9 containing 500 
mM NaCl and 250 mM imidazole (Buffer B).  Elution of the protein was by a 5 – 100 %  
gradient of Buffer B in 5 column volumes.   
 Site-Directed Mutagenesis of DHO.  The DHO used as the wild-type enzyme 
was the quadruple mutant (C63S/C65S/C121S/C179S).   The four cysteine residues are 
believed to be responsible for the sensitivity to oxidation  seen in the native enzyme(50, 
51).  The quadruple mutant was stable and had kinetic parameters consistent with 
previously reported values (49, 50).  In the mutagenesis experiments, the DNA template 
is this altered gene.  The protocol for mutagenesis was the overlap extension method 
previously described (78).  The single mutations, R20Q, N44D and H254K were 
completed first using the QM-DHO (C65S/C68S/C121S/C179S) in the PBS+ vector 
from Stratagene as wild type.  The R20Q mutant was used as the template for the 
production of the double mutants R20Q/N44D and R20Q/H254K.  The latter was used 
as the template for the triple mutant, R20Q/N44D/H254K.  The mutant genes were 
digested with HindIII and EcoRI restriction enzymes and then ligated into similarly 
digested PBS+ plasmid.   
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 Preparation of Crude Extracts.  The E. coli cell strains BL21 or the DHO- 
X7014a (Yale E. coli Genetic Stock Center) was transformed with the plasmid 
containing the DHO gene.  Small 45 mL cultures were grown in LB at 37 ºC to mid-log 
phase and then induced with IPTG (final concentration of 1.0 mM).  After incubation 
overnight, the cells were collected by centrifugation and then resuspended in 50 mM bis-
tris propane, pH 7.0 containing 2 % (v/v) of Bugbuster (Novagen).   
Purification of R20Q/N44D/H254K Mutant.  Large cultures were grown and 
induced in the same manner as previously described.  The cells were collected by 
centrifugation, resuspended in 50 mM bis-tris propane, pH 7.0 with 100 µM ZnCl2 and 
10 mM N-carbamoyl-β-alanine.  The cells were lysed by sonication and the nucleic 
acids precipitated by addition of a 2.0% proteamine sulfate solution.  After 
centrifugation, the cell extract was made 60% in ammonium sulfate.  After 
centrifugation, the pellet was resuspended in a minimal amount of buffer and then run on 
the AKTA Purifier (Pharmacia) using a Superdex 200 26/60 column.  The buffer used 
for the gel filtration column was 50 mM bis-tris propane, pH 7.0 containing 10 mM N-
carbamoyl-β-alanine.  The flow rate used was 1.0 mL/min with 1.5 ml fractions being 
collected.  The fractions containing DHO activity were pooled and loaded unto the 
Resource-Q anion exchange column on the AKTA system.   Buffer A was 20 mM bis-
tris propane, pH 7.0, while Buffer B was the same buffer with 1M NaCl.  The protein 
was eluted from the column by the use of a salt gradient (0 - 30% B in 30 column 
volumes). The flow rate used was 4.0 mL/min with 1.0 mL fractions being collected. 
Fractions were assayed for activity and those containing DHO were pooled.  Purified 
enzyme was typically stored at –80 ºC in 20 mM bis-tris propane, pH 7.0 with 20% 
glycerol, 100 mM ZnCl2 and 10 mM N-carbamoyl-β-alanine.   
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 Kinetics.  The direct spectrophotometric assay for DHO is measured at 230 nm 
for the native reaction and 225 nm for the dihydropyrimidinase activity (74, 84).  To 
measure thiodihydroortate hydrolysis, 280 nm is used.  The extinction coefficients are 
1.17 mM-1cm-1 for dihydroorotate, 1.3 mM-1cm-1 for dihydrouracil and 17 mM-1cm-1 for 
thiodihydroorotate (74, 85).  Using a SPECTAmax plate reader from Molecular Devices, 
the assays were performed in a 96-well plate.  For the synthetic activities, the standard 
assay contained 10 mM carbamoyl aspartate or N-carbamoyl-β-alanine in 100 mM 
potassium phosphate, pH 6.0.  The standard assays to monitor the hydrolysis reactions 
contained 1.0 mM dihydroorotate, 1.0 mM dihydrouracil or 60 µM thiodihydroorotate in 
50 mM potassium phosphate, pH 8.0.  The reaction mix was added to an aliquot of the 
enzyme to initiate the reaction.   
For the substrate saturation curves, the substrate range was 0.24-10 mM for 
carbamoyl aspartate and 0.024-1.0 mM for dihydroorotate.  When thiodihydroortate was 
the substrate, the concentration range was 4.4-53 µM.  To determine the kinetic 
parameters, kcat and kcat/Km, the initial velocities were fit to equation 1, where v is the 
initial velocity, kcat is the turnover number, Et is the enzyme concentration, A is the 
substrate concentration and Km is the Michaelis constant. 
 
v/Et = kcatA/(Km + A)                                (1) 
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Results and Discussion 
 
 Isolation and Characterization of PA5541.  The agarose gel showing the 
successful amplification of the PA5541 gene from P. aeruginosa is shown in Figure 4.3.  
The fragment obtained was consistent with the expected size of 1338 base pairs and 
sequencing confirmed that the desired gene was obtained.  The resultant recombinant 
plasmids, pet28/PA5541 (produces His-tagged protein) and pet30/PA5541, exhibited 
overexpression in BL21 DE3 cells.  The SDS-PAGE gel of the overexpression is shown 
in Figure 4.2.  The His-tagged protein was purified and assayed for DHO activity.  The 
kinetic parameters kcat, Km and kcat/Km for the synthesis and hydrolysis reactions are 
provided in Table 4.1.  The values obtained for the activity of PA5541 are much lower 
than those for the E. coli DHO enzyme.  The values obtained for kcat for the synthesis 
and hydrolysis of dihydroorotate were 0.66 s-1 and 0.57 s-1 respectively.  These values 
are 240-fold and 2000-fold less than the values for the E. coli enzyme.  Shown in Figure 
4.5 and Figure 4.6 are the substrate saturation curves for PA5541 with dihydroorotate or 
carbamoyl aspartate as the substrate.  PA5541 also hydrolyzes thiodihydroorotate as 
illustrated in the UV scans shown in Figure 4.4.  At pH 8.0, thiodihydroorotate absorbs 
at 280 nm.  Upon the addition of PA5541, the absorbance at 280 nm is absent while a 
species absorbing at 250 nm is present.  This species is the product, the thio-analog of 
carbamoyl aspartate. Thiodihydroorotate hydrolysis by PA5541 is slower than the 
cleavage of dihydroorotoate.  This trend is also seen in the E. coli enzyme.  However, 
the value of kcat for the E. coli enzyme (4.4 s-1), is more than 80 times greater than that of 
PA5541 (0.048 s-1).  The Km values for each substrate obtained from PA5541 are much 
closer to those for the E. coli enzyme than the kcat values.  With carbamoyl aspartate, 
dihydroorotate and thiodihydroorotate as the substrate, the Km values are 1.2, 0.5 and 
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Figure 4.2:  1.0 % Agarose gel demonstrating the amplification of PA5541.  The gene, 
PA 5541, is 1338 bp and is shown in Lane 1.  The marker is the 1 kbp molecular weight 
ladder (Promega).      
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Figure 4.3:  SDS-Page gel of the overexpression of PA5541.  To prepare the samples for 
the gel, a small amount of culture was centrifuged, and the pellet was resuspended in 
sample buffer.  In lane 1 is the marker protein, uronate isomerase, which has a MW of 
53,000 Da.  Lane 2-4 are the cell extracts of BL21/pet 28/PA5541, while lanes 5-7 show 
the extracts of BL21/pet 30/PA5541.  Lanes 4 and 5 are from uninduced cultures while 
IPTG was added to the cultures that the remainder samples were made from.  PA5541 
has an expected MW of 49,295 Da.  The His-tagged protein from BL21/pet28/PA5541 
has a MW of 51,459 Da.   
     1      2      3      4      5      6      7 
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Table 4.1:  Kinetic Parameters for PA5541a.  
Substrate kcat (s-1) Km (mM) kcat/Km (M-1s-1) 
Carbamoyl Aspartate 0.66 + 0.056 1.2 + 0.33 5.7 (1.3) x 102 
Dihydroorotate 0.57 + 0.060 0.47 + 0.11 1.2 (0.16) x 103 
Thiodihydroorotate 0.048 + 0.013 0.099 + 0.037 4.8 (0.053) x 102 
aThe synthesis of dihydroorotate was measured at pH 6.0 while the hydrolysis 
reactions were measured at pH 8.0. 
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Figure 4.4:  UV scan of the hydrolysis of thiodihydroorotate by PA5541.  The 
absorbance versus wavelength was measured for: (1) 80 µM substrate, (2) the product 
formed from incubation of 80 µM substrate with 4.0 µM enzyme for 3 hours and (3) 4.0 
µM enzyme only.  Determined at pH 8.0, the scans clearly show the decrease in the 
absorbance of thiodihydroorotate at 280 nm and the appearance of product which 
absorbs at 250 nm.    
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Figure 4.5:  Substrate saturation curve for the hydrolysis of dihydroorotate by PA5541.  
The reaction was monitored at pH 8.0 with 0.02 µM enzyme in the assay.   
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Figure 4.6:  Substrate saturation curve for the synthesis of dihydroorotate by PA5541.  
The reaction was monitored at pH 6.0 with 0.02 µM enzyme in the assay.   
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0.099 mM respectively.  These compare with values of 1.7, 0.08 and 0.03 mM for the E. 
coli enzyme.   
  His-tags, at the N-terminus in this case, can possibly affect protein folding and 
thus activity.  This does not appear to be the case here as the activities obtained from 
crude extracts containing the tagged and untagged protein are within 5 % of each other.  
In the E. coli enzyme, when the metal is removed by the addition of a chelator, activity 
is lost.  Both metal ions of the binuclear zinc center appear to be essential for activity. 
Thus, the low activity levels of PA5541 might be due to the lack of complete metal 
occupation of the active site.  A decrease in the affinity for metal may be a consequence 
of the QXH for HXH substitution.  It doesn’t appear that any differences in activity 
between PA5541 and HXH containing enzymes are due to differences in substrate 
binding.  The experiment to determine the metal concentration of PA5541 has yet to be 
completed but would be imperative in understanding why the protein has the level of 
activity seen.   
Evolutionary Implications of PA5541.  Comparison of PA5541 to the DHO of P. 
aeruginosa that has the HXH motif, PA3527, is also important in delineating the role of 
the protein in the organism.  Though not characterized, PA3527 should have two metal 
ions per active site.  All other active site residues are conserved between the proteins.  
Thus, comparison of the metal content of the two P. aeruginosa DHO enzymes is critical 
in understanding the role of PA5541.   
It is unclear why there would be two functional DHO proteins in the same 
organism.  The QXH motif of PA5541 is approximately 60 amino acids into the 
sequence, much later than the HXH motif appears in the sequence of PA3527 or the E. 
coli enzyme.  This trend is also seen in the sequences of the other organisms that have 
the QXH motif.  In fact, in many gram-positive bacteria and higher organisms with the 
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HXH motif, it appears later in the sequence and is a larger protein as in PA5541.  These 
sequences form Class I of DHO proteins, while the enzymes of gram-negative bacteria 
and fungus form Class II.  The possibility then arises that PA5541 evolved divergently 
from its PA3527 relative.  At any rate, it would appear that PA5541 is not just an 
evolutionary artifact as the homologous protein in Xyllela fastidiosa and several other 
organisms is the only DHO sequence in the organism.   
 Evolution of DHO into a Dihydropyrmidinase.  The PBS+ plasmid containing the 
DHO triple mutant R20Q/N44D/H254K was successfully constructed as confirmed by 
sequencing.  The protein was overexpressed in X7014a and BL21 as seen in the SDS-
PAGE gel shown in Figure 4.4.  Cell lysis was more efficient when BL21 cells were 
used as compared to X7014a, so only that strain was used.  The values obtained from the 
crude assay of the triple mutant and wild type protein are in Table  4.1.  The triple 
mutant is 5 times more active against N-carbamoyl-β-alanine than wild-type.  For 
dihydrouracil, the mutant is about twice as active as the wild-type enzyme.  The 
background rates obtained from the BL21 cell extracts are due to the contribution of the 
chromosomally derived DHO. Sensitivity is a problem in assays utilizing dihydroorotate 
and dihydrouracil because of the intrinsic complexity of monitoring a reaction in the 
225-230 nm region.  There are many other things that absorb in a crude assay.  This is 
quite limiting as dihydroorotate and dihydrouracil absorb with extinction coefficients 
greater than 1.  The amount of extract has to be maintained at a level that keeps the 
absorbance value of the reaction mix in a readable range for the spectrophotomer.  Even 
after attempts to optimize the assay, the value for the rate of dihydrouracil hydrolysis by 
the triple mutant is only twice that of background.   A method of minimizing the 
background would be to increase the quantity of the overexpressed protein in the cell.  
This could be accomplished by subcloning the gene into a different expression vector.  
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Figure 4.7:  12 % SDS-Page gel of the purification of the DHO mutant protein 
R20Q/N44D/H254Q.  Lane 1 contains the cell extract of X7014a/pBS+/WT DHO, while 
in lane 2 is extract containing the mutant construct.  Lanes 3 and 4   show the purified 
WT and mutant proteins respectively.  The MW of DHO is approximately 38,000 Da.  
           1        2                        3        4 
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Table 4.2:  Rates Obtained from Crude Assay of Cell Extractsa  
 Cell strain/DHO 
(µmol/min/mg protein) 
Substrate BL21 BL21/WT BL21/ R20Q/N44D/H254K 
Carbamoyl aspartate 0.21 24 0.84 
Dihydroorotate 1.2 24 1.9 
N-carbamoyl-β-alanine 0.035 0.085 0.43 
Dihydrouracil 0.036 0.055 0.13 
aThe assays were performed at pH 6.0 when carbamoyl aspartate and N-carbamoyl-β-
alanine were the substrates, and at pH 8.0 to monitor the hydrolysis of dihydroorotate 
and dihydrouracil. 
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 PBS+ is not the optimal vector for overexpression and other expression systems, such as 
the pet system (Novagen), are frequently referenced more in recent literature.  Another 
solution may be to switch back to the DHO- strain but use sonication to lyse the cells.   
The triple mutant was purified to further characterize its activity.  Unfortunately, 
the protein appears to be unstable. In a typical purification, the activity of the mutant 
would consistently decrease after each purification step.  The protein was purified in the 
presence of 10 mM N-carbamoyl-β-alanine which appeared to stabilize the protein.  No 
activity was seen in the purified protein prior to the addition of N-carbamoyl-β-alanine 
to the buffers.  Although activity is seen, the numbers are much lower than the crude 
data would suggest.  For N-carbamoyl-β-alanine turnover, the rate determined using 10 
mM of substrate at pH 6.0 was 0.028 µmol/min/mg protein.  This is only 1/15 of the 
activity seen in the crude assay.  The instability could be due to the number of mutations 
in the protein from the native DHO.   
The crude triple mutant data definitely suggest that it is possible to make DHO 
more promiscuous in its preference for substrate.  A next step may be to backtrack and 
characterize the single point mutations, R20Q, N44D and H254K, or the double mutants 
to determine if fewer steps could be taken to reach the same goal.  Fewer mutations may 
result in a more stable protein.  Of particular interest would be to further develop the 
crude assay and apply it to screen potential substrate analogues or inhibitors. The 
combinatorial screen would be used to assay DHO and its mutants against compounds of 
interest. 
Two approaches can be used to develop DHO variants for screening.  A rational 
approach manipulates the knowledge of the structure-function relationship of DHO to 
alter substrate specificity.  This method was utilized in the R20K/N44D/H254K mutant 
to gain dihydropyrimidinase activity.  An additional way to produce variants with 
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desired activities is through directed evolution techniques.  Directed evolution involves 
using mutagenesis and/or recombination of one or more parent sequence to introduce 
genetic diversity (86).  One method of directed evolution is to undergo several 
generations of single amino acid substitutions, selecting genes with the desired 
phenotype as the template for the next generation (87, 88).  Another strategy is to use a 
gene shuffling technique (89).  Here, structurally related genes are used in recombination 
events to produce a chimeric gene library for evolution of desired characteristics.    
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Dihydropyrimidinase is a good target for directed evolution shuffling 
experiments due to its structural and mechanistic similarity to DHO.  Also, 
dihydropyrimidinase has clinical significance.  In addition to its role in the breakdown of 
dihydrouracil and dihydrothymine, dihydropyrimidinase is involved in the degradation 
of the chemotherapeutic agent 5-flourouracil.  The catabolic pathway of 5-flourouracil is 
shown in Scheme 4.2.  Deficiency in dihydropyrimidinase leads to severe 5-flourouracil 
toxicity which can cause death (90).   
Dihydrouracil and 5-flourouracil are just two of the compounds that could be 
used in DHO directed evolution experiments.  A series of dihydroorotate analogs with 
substituents at C-5 and C-6 could be synthesized or purchased and screened.  A 
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collaboration with Dr. Gary Sulikowski of Texas A & M University has already 
produced two compounds.  Dihydroorotate analogs with a phenyl- or a methyl- group  
have been synthesized.  
 A success story of manipulating an enzyme to introduce a new reactivity is seen 
in the work reported by Schmidt et al. (91).  In this work, proteins of the enolase 
superfamily were altered to introduce new activities.  L-Ala-D/L-epimerase (AEE) from 
E. coli and muconate lactonizing enzyme II (MLE II) from Pseudomonas sp. were 
mutated to gain the functionality of o-succinylbenzoate synthase (OSBS).  OSBS, AEE 
and MLE II are members of the same subgroup of the enolase superamily of TIM-barrel 
proteins.  The enzymes also share similar active site geometries with OSBS.  However, 
the three enzymes all perform different reactions and do not share substrates or products.  
Native AEE and MLE II do not catalyze the OSBS reaction.  A rational approach was 
used to change AEE into an OSBS.  The crystal structures of the two enzymes were 
superimposed.  Asp-297 was targeted because in the superimposition, the residue was 
positioned where the succinyl moiety of o-succinylbenzoate was bound in the OSBS 
structure.  The homologus residue to Asp-297 in OSBS is Gly-288.  The D297G mutant 
indeed had OSBS activity.  While WT-AEE had unmeasurable OSBS activity, a kcat 
value of 0.0025 was obtained for the mutant.  The value of kcat for the wild-type OSBS 
was reported to be 24 s-1.  However, the mutation did result in loss of AEE activity, a 
decrease in kcat to 0.043 s-1 from 10 s-1 for wild-type.  Random mutagenesis was 
implemented to alter the specificity of MLE II.  With a kcat value of 1.5 s-1, the E323G 
mutant was capable of catalyzing the OSBS reaction.  In these experiments, the known 
structure-function relationships were manipulated to alter substrate specificity of 
structurally but mechanistically diverse enzymes.  This work and the direction that the 
studies of DHO are leading utilizes the ability of the TIM-barrel fold to bring the active-
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site residues to an optimal position.  This allows for the ability to change reactivities of 
enzymes with very few mutations.   
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CHAPTER V 
 
SUMMARY AND CONCLUSIONS 
 
Dihydroorotase (DHO) from Escherichia coli catalyzes the interconversion of N-
carbamoyl aspartate to dihydroorotate with a loss of a molecule of water.  The enzyme is 
a member of the amidohydrolase superfamily of metalloproteins.  The X-ray crystal 
structure of DHO, obtained at 1.7 Å resolution, ascertained that the enzyme is indeed a 
member of the superfamily as it has the requisite core TIM-barrel domain (1, 59).  In 
addition, the five conserved active site residues of the amidohydrolase superfamily are 
found at the C-terminus of the β-strands 1, 5, 6 and 8 as is seen in other members like 
phosphotriesterase, adenosine deaminase and urease.  The conserved residues are four 
histidines and an aspartic acid. Contrary to previous assertions, the enzyme has a 
binuclear zinc center.  This aligned the enzyme with phosphotriesterase and urease, 
proteins that form a subgroup of the amidohydrolase superfamily that coordinate two 
metal ions per subunit.  Members of this subgroup generally conserve a carboxylated 
lysine residue that bridges the two metal ions.  An exception is the bacterial PTE 
homology protein which has a bridging glutamate.  Adenosine deaminase exists in a 
second subgroup where only a single catalytic metal ion is present.  As new X-ray 
crystal structures have been solved in recent years, the general theme of the 
amidohydrolase superfamily has been expanded slightly.  While most members catalyze 
a hydrolysis reaction at a carbon or phosphorus center, not all do.  This is the case in 
uronate isomerase which catalyzes the isomerization of glucuronate to fructuronate.   
The X-ray crystal structure of DHO provided was solved to a resolution of 1.7 Å.  
Views of the active sites with bound substrate or product were important in identifying 
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the residues and/or groups involved in catalysis.  In subunit I of the homodimer, 
carbamoyl aspartate was bound, while subunit II coordinated dihydroorotate.  In subunit 
I, the carboxylate group of carbamoyl aspartate coordinates and bridges the two metal 
ions.  Electrostatic interactions with the backbone atoms of Leu-222, Ala-266 and Gly-
267 stabilize the substrate in the active site.  Three side chains, from Arg-20, Asn-44 and 
His-254, form hydrogen bonds to the carboxylate group at C-6 of the substrate.  In 
subunit II, the carbonyl oxygen, O4, of dihydroorotate is coordinated to the β or more 
solvent exposed metal ion. 
The pH rate profile obtained for the hydrolysis of dihydroorotate by DHO shows 
that a single group must be unprotonated for catalytic activity.  The group with a kinetic 
pKa of 6.1 for kcat and kcat/Km was assigned to the bridging hydroxide.  Supporting data 
includes the increase in the pKa values when the active site zinc center is substituted for 
cobalt.  In the direction of dihydroorotate synthesis, the pH rate profile shows that 
catalytic activity is lost as a single group, the hydroxide ion, on the enzyme is 
deprotonated.  The synthetic reaction is dependent on the protonation of the bridging 
hydroxide and the subsequent dissociation of water.   The kinetic pKa values of the two 
reactions are not equal suggesting that the ionization constant is affected by substrate 
stickiness.     
The sulfur analog of dihydroorotate, thiodihydroorotate (TDO), was found to be 
a substrate for the enzyme.  At pH 8.0, the rate of TDO hydrolysis is 23-fold less than 
that of dihydroorotate hydrolysis.  The TDO reaction appeared to be irreversible.    In the 
zinc-substituted DHO, the value of kcat/Km for TDO was significantly lower than with 
CADmium-substituted enzyme.  This was expected as both sulfur and CADmium are 
softer than the zinc.  Zinc is better suited for harder ligands such as oxygen.  This is seen 
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in the higher value of kcat/Km for dihydroorotate than that of TDO in the zinc-substituted 
enzyme.         
Site-directed mutagenesis experiments confirmed the roles of Asp-250, Arg-20, 
Asn-44 and His-254 in catalysis and substrate binding.  Mutation of Asp-250 was 
generally not tolerated by the enzyme.  The data and the X-ray crystal structure support 
the involvement of Asp-250 in proton transfer events in the catalytic mechanism of 
DHO.  The mutagenesis of Arg-20, Asn-44 and His-254 to residues that cannot form 
hydrogen bonds with the carboxylate side chain of the substrate abolishes activity.  Thus, 
interactions provided by the functional groups of these residues are required for substrate 
recognition and binding.  
The X-ray crystal structure and the biochemical data provided insight into the 
catalytic mechanism of DHO.  This is insight that could be applied to less understood 
members of the superfamily. For the hydrolysis of dihydroorotate, nucleophilic attack by 
the bridging hydroxide is facilitated by the transfer of the proton from the hydroxide to 
Asp-250.  A tetrahedral intermediate is formed that bridges the two divalent cations and 
collapses with protonation of the amide nitrogen and cleavage of the carbon-nitrogen 
bond to form carbamoyl aspartate.  In the reverse direction, the reaction is initiated by 
the abstraction of a proton from the amide nitrogen of the substrate by Asp-250.  The 
deprotonated amide nitrogen nucleophilically attacks the carboxylate of carbamoyl 
aspartate forming a tetrahedral adduct that collapses to form the product. 
The active site residues of DHO are generally conserved among active DHO 
proteins.  An exception is seen in a few organisms where the first conserved histidine is 
replaced by a glutamine.  The DHO sequence with this substitution from Pseudomonas 
aeruginosa was isolated.  The protein is able to catalyze the reactions of DHO.  Future 
work will need to determine the metal content of the protein.  Additionally, the P. 
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aeruginosa DHO sequence that contains the conserved histidine residue needs to be 
isolated and characterized for comparison.  A rational design method was implemented 
in altering the substrate specificity of DHO.  A gain in dihydropyrimidinase activity was 
seen in the crude lysates of cells overexpressing the R20Q/N44K/H254K DHO mutant.  
Future directions include screening the single and double mutants at these positions for 
the ability to catalyze the interconversion of N-carbmoyl-β-alanine to dihydrouracil.  
Also, the optimization of the crude assay would allow for the development of a 
combinatorial screen.   Libraries of compounds of clinical or biotechnological 
significance could be screened against libraries of DHO proteins.  Directed evolution 
techniques would be an efficient way of producing enzyme libraries for the 
combinatorial screens.  
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APPENDIX 
 
MASTER ALIGNMENT OF DHO SEQUENCES 
 
List of Organisms in Alignment 
 
Trichodesmiumerythraeum 
Nostoc punctiforme 
Thermosynecoccuselongatus 
Rhodopseudomonas palustris 
Brucella suis 
Rhodospirillum rubrum  
Magnetospirillum magnetotacticum 
Ralstonia metallidurans 
Xanthomonas axonopodis 
Xyllela fastidiosa 
Pseudomonas flourescens  
Cytophaga hutchinsonii 
Saccharomyces cerevisiae 
Schizosaccharomyces pombe 
Ustilago maydis 
Helicobacter pylori 
Chloroflexus aurantiacus 
Neisseria meningitidis 
Beta vulgaris  
Arabidopsis thaliana 
Oryza sativa 
Vibrio cholerae 
Shewanella oneidensis 
Microbulbifer degradans 
Pseudomonas flourescens  
Pseudomonas syringae  
Pseudomonas aeruginosa  
Azotobacterium vinelandii 
Ralstonia solanacearum 
Burkholderia fungorum 
Agrobacterium tumefaciens 
Sinorhizobium meliloti 
Rhodobacter sphaeroides  
Escherichia coli  
Shigella flexneri  
Salmonella typhimurium 
Salmonella enterica  
Yersinia pestis 
Novosphingobium aromaticivoans 
Buchnera aphidicola 
Wigglesworthia brevipalpis 
Plasmodium falciparum 
Plasmodium  yoelii 
Toxoplasma gondii  
Sulfolobus tokodaii  
Streptococcus mutans 
Geobacter  
Clostridium acetobuytlicum  
Thermoanaerobacter  
Magnetococcus  
Thermobifida fusca  
Streptomyces coelicor 
Corynebacterium glutamicum 
Desulfovibrio desulfuricans 
Bifidobacterium longum 
Chlorobium tepidum 
Thermus aquaticus  
Bacillus caldolyticus 
Enterococcus faecalis 
Oceanobacillus iheyensis 
Fusobacterium nucleatum 
Lactobacillus leichmannii 
Oenococcus oeni 
Leuconostoc mesenteroides 
Clostridium acetobuytlicum
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Clustal W Protein Alignment 
 
 
Trichodesmium   ---------- ---------- ---------- ------MAPI SS--LLIRRA 
Nostoc    ---------- ---------- ---------- ------MSSP QI--LLIRRA 
Thermosynecoccus   ---------- ---------- ---------- ---------- MA--IAIQNA 
Rhodopseudomonas    ---------- ---------- ---------- ------MTGT FD--TILKGG 
Brucella   ---------- ---------- ---------- ------MAAT FD--TILKGA 
Rhodospirillum   ---------- ---------- ---------- -MERRDVAQS YD--LILKGG 
Magnetospirillum   ---------- ---------- ---------S GSFAVFMAPV YEGWLYLKSG 
Ralstonia   ---------- ---------- ---------- ----MSVAPT LHAATRNRGG 
Xanthomonas   ---------- ---------- ---------- ---------- -MSRTVIVNA 
Xyllela    MVSSTSAGTL PSVATGWPRP GTRQHQHTGQ SPFSSLYRTP PMNPTLIVNA 
P. floruescens  ---------- ---------- ---------- ---------- -MSSVLIRNA 
Cytophaga   ---------- ---------- ---------- ---------- -MGSIKISNA 
Saccharomyces   ---------- ---------- ---------- ---------- ---------- 
Schizosacch. ---------- ---------- ---------- ---------- ---------- 
Ustilago maydis   ---------- ---------- ---------- ---------- ---------- 
Helicobacter   ---------- ---------- ---------- ---------- ---------- 
Chloroflexus   ---------- ---------- ---------- ---------- ---------- 
Neisseria   ---------- ---------- ---------- ---------- ---------- 
Beta vulgaris   ---------- ---------- ---------- ---------- ---------- 
Arabidopsis   ---------- ---------- ---------- ---------- ---------- 
Oryza    ---------- ---------- ---------- ---------- ---------- 
Vibrio    ---------- ---------- ---------- ---------- ---------- 
Shewanella   ---------- ---------- ---------- ---------- ---------- 
Microbulbifer   ---------- ---------- ---------- ---------- ---------- 
P. flourescens ---------- ---------- ---------- ---------- ---------- 
P. syringae ---------- ---------- ---------- ---------- ---------- 
P. aeruginosa  ---------- ---------- ---------- ---------- ---------- 
Azotobacterium   ---------- ---------- ---------- ---------- ---------- 
Ralstonia   ---------- ---------- ---------- ---------- ---------- 
Burkholderia   ---------- ---------- ---------- ---------- ---------- 
A. tumefaciens ---------- ---------- ---------- ---------- ---------- 
Sinorhizobium   ---------- ---------- ---------- ---------- ---------- 
Rhodobacter sp. ---------- ---------- ---------- ---------- ---------- 
E. coli    ---------- ---------- ---------- ---------- ---------- 
Shigella   ---------- ---------- ---------- ---------- ---------- 
S. typhimurium     ---------- ---------- ---------- ---------- ---------- 
S. enterica   ---------- ---------- ---------- ---------- ---------- 
Yersinia   ---------- ---------- ---------- ---------- ---------- 
Novosphingobium   ---------- ---------- ---------- ---------- ---------- 
Buchnera   ---------- ---------- ---------- ---------- ---------- 
Wigglesworthia   ---------- ---------- ---------- ---------- ---------- 
Pl. falciparum   ---------- ---------- ---------- ---------- ---------- 
Pl. yoelii   ---------- ---------- ---------- ---------- ---------- 
Toxoplasma gondii   ---------- ---------- ---------- ---------- ---------- 
Sulfolobus   ---------- ---------- ---------- ---------- ---------- 
Streptococcus   ---------- ---------- ---------- ---------- ---MLLIKNG 
Geobacter   ---------- ---------- ---------- ---------M N---LLIQGG 
Clostridium   ---------- ---------- ---------- ---------M R---VLIKGG 
Thermoanaerobacter ---------- ---------- ---------- ---------M R---IVIKNG 
Magnetococcus   ---------- ---------- ---------- --------MM RTESLFIRGA 
Thermobifida   ---------- ---------- ---------- --------MT TTTRYLIRNA 
Streptomyces   ---------- ---------- ---------- ---------- -MSKTLIRGA 
Corynebacterium   ---------- ---------- ---MVDSNTQ YPETGALAPA PADSLLISNV 
Desulfovibrio   ---------- ---------- ---------- ------MSDH ISGTLFVSGA 
Bifidobacterium   ---------- ---------- ---------- ---------- --MSITLRNI 
Chlorobium   ---------- ---------- ---------- ---------- -MSTLFLN-A 
Thermus aquaticus   ---------- ---------- ---------- ---------- ---MILIRNV 
Bacillus   ---------- ---------- ---------- ---------- ---MNYLFKN 
Enterococcus   ---------- ---------- ---------- ---------- ---MKTLIKN 
Oceanobacillus   ---------- ---------- ---------- ---------- ---MKTILLN 
Fusobacterium   ---------- ---------- ---------- ---------- ------MLLK 
Lactobacillus   ---------- ---------- ---------- ---------- ---MATVIKN 
Oenococcus   ---------- ---------- ---------- ---------- --MNSTLIKN 
Clostridium   ---------- ---------- ---------- ---------- ---MNLLIKN 
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Trichodesmium   RILLPDG--- -----TFLIG DVQTQGR--- ---------- -----EIIQV 
Nostoc    CIVLPNG--- -----EMMIG DVLTRDR--- ---------- -----QIVEV 
Thermosynecoccus   VICTPEG--- -----ELRQQ QVRLEGD--- ---------- -----RIAEV 
Rhodopseudomonas    TIVNQDG--- ------EGVG DIGIKDG--- ---------- -----RIAAL 
Brucella   TIVNHDG--- ------IGQR DIGIRNG--- ---------- -----RIAAI 
Rhodospirillum   TAVLPG---- -----RTMRA DIAVCGG--- ---------- -----KVVRV 
Magnetospirillum   NSSLSGGIFP F-LGPRLLSS AAGEAGPTPF SVL------- -----RPFRF 
Ralstonia   HSVTDGTVPG VGLPSARRHA DLLVIGGALV TPNGVERADV ACAAGRIVAL 
Xanthomonas   RLVNEGK--- ------EFDA DLLIEGG--- ---------- -----RIAKI 
Xyllela    RLVNEGR--- ------EFDS DLRIENG--- ---------- -----RIARI 
P. flourescens RLVNEGR--- ------EFDA DLLVSHG--- ---------- -----RIVKI 
Cytophaga   NIVNEGQ--- ------IFQA DIWIEEG--- ---------- -----LIKQI 
Saccharomyces   ---------- ---------- ---------- ---------- ---------- 
Schizosacch. ---------- ---------- ---------- ---------- ---------- 
Ustilago maydis   ---------- ---------- ---------- ---------- ---------- 
Helicobacter   ---------- ---------- ---------- ---------- ---------- 
Chloroflexus   ---------- ---------- ---------- ---------- ---------- 
Neisseria   ---------- ---------- ---------- ---------- ---------- 
Beta vulgaris   ---------- ---------- ---------- ---------- ---------- 
Arabidopsis   ---------- ---------- ---------- -----MIKTL VSPYSGFGSQ 
Oryza    ---------- ---------- ---------- ---------- ---------- 
Vibrio    ---------- ---------- ---------- ---------- ---------- 
Shewanella   ---------- ---------- ---------- ---------- ---------- 
Microbulbifer   ---------- ---------- ---------- ---------- ---------- 
P. flourescens ---------- ---------- ---------- ---------- ---------- 
P. syringae    ---------- ---------- ---------- ---------- ---------- 
P. aeruginosa  ---------- ---------- ---------- ---------- ---------- 
Azotobacterium   ---------- ---------- ---------- ---------- -----MPPEA 
Ralstonia   ---------- ---------- ---------- ---------- ---------- 
Burkholderia   ---------- ---------- ---------- ---------- ---------- 
A. tumefaciens ---------- ---------- ---------- ---------- ---------- 
Sinorhizobium   ---------- ---------- ---------- ---------- ---------- 
Rhodobacter sp. ---------- ---------- ---------- ---------- ---------- 
E. coli    ---------- ---------- ---------- ---------- ---------- 
Shigella   ---------- ---------- ---------- ---------- ---------- 
S. typhimurium  ---------- ---------- ---------- ---------- ---------- 
S. enterica   ---------- ---------- ---------- ---------- ---------- 
Yersinia   ---------- ---------- ---------- ---------- ---------- 
Novosphingobium   ---------- ---------- ---------- ---------- ---------- 
Buchnera   ---------- ---------- ---------- ---------- ---------- 
Wigglesworthia   ---------- ---------- ---------- ---------- ---------- 
Pl. falciparum   ---------- ---------- ---------- ---------- ---------- 
Pl. yoelii   ---------- ---------- ---------- ---------- ---------- 
Toxoplasma gondii   ---------- ---------- ---------- ---------- ----MAMTGE 
Sulfolobus   ---------- ---------- ---------- ---------- ---------- 
Streptococcus   RVLDPKSGLD RVLDVLLDGK KVVKIA---- ---------- -----ENIES 
Geobacter   RVIDPSQGID EVLDILVENG AVKELG---- ---------- -------KGV 
Clostridium   HVVDPKTNTN GIMDILVEDG IITEIG---- ---------- -------KDI 
Thermoanaerobacter IVIDG-FGGE EKADILINYG IIKGID---- ---------- -------KNI 
Magnetococcus   RVVDPANERD EIADILIVDG VIREIG---- ---------- -------K-L 
Thermobifida   RILG-----G EPTDLLLAHG RIDAI----- ---------- -------GPD 
Streptomyces   KVLG-----G EPQDVLIDGT VVEAV----- ---------- -------GTN 
Corynebacterium   LVYGE----G EPTNVFVKDG VIAAI----- ---------- -------GGT 
Desulfovibrio  LLSG------ RTVDVTVSGG RIAAVS---- ---------- -----EHGAA 
Bifidobacterium   KVWNTGEVID LVVPGTAAAY FADTSV---- ---------- -----VADG- 
Chlorobium   RLLNPAENLD -TVGSIKIGD DGLIEA---- ---------- -----VATGG 
Thermus aquaticus   RLVDAMGERG --PLDVLIGE -GRILS---- ---------- -----LEGG- 
Bacillus   GRYMNEEGKI VATDLLVQDG KIAKVA---- ---------- -----ENIT- 
Enterococcus   GQINTRKNMT TPAEIWIEDG RIKAIG---- ---------- -----TGFSE 
Oceanobacillus   ANRLLPSNEL EKVEVLIEDN KIIKIA---- ---------- -----SQIP- 
Fusobacterium   NCKILKNTKF EKVDILIRDN KIEKIS---- ---------- -----ENID- 
Lactobacillus   GTVYQN-GRL IKADVLIEGK KIKAIG---- ---------- -----TDLD- 
Oenococcus   AQILVGENSF LKRDLFIEKG KISAIG---- ---------- -----DGLS- 
Clostridium   VNLIDESNNF FG-DIYIEKG VIKELG---- ---------- -----TELN- 
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Trichodesmium   APEISSSEAP EKIIDAEGLT LLPGVIDPQV HFREPGLEHK EDLFTASRAC 
Nostoc    APEISQT-AV VTEIDAEGLT LLPGVIDPQV HFREPGLEHK EDLFTASCAC 
Thermosynecoccus   AETVTVN-PS DTVIDATGLT LLPGVIDPQV HFREPGLEHK EDLFTASCAC 
Rhodopseudomonas    G-SLGA-EKA GETIDCRGLH VLPGVIDTQV HFREPGLTHK EDLETGSRSA 
Brucella   G-SLAG-NSA GEVIDCTGLH ILPGVVDSQV HFREPGLEHK EDLETGSLAA 
Rhodospirillum   G-FLDA-GSA RQTIDCAGLH VLPGVIDTQV HFREPGLEHK EDLESGTRAA 
Ralstonia   G-DLQCSWTA DATLDAKGLH VLPGVIDSQV HFREPGLTHK ETLEAGTRGA 
Xanthomonas   DSKIVP-APG DTVVDAAGRW VLPGMIDDQV HFREPGLTHK GDIATESGAA 
Xyllela    DTGLSA-QSK DIVIDAAGRR LLPGMIDDQV HFREPGLTHK GDIVSESAAA 
P. flourescens AGSIEG-ENA TREIDATGQW LLPGMIDDQV HFREPGAPAK GSVHTESRAA 
Cytophaga   G-KITA-IA- DQTIDASGKY LFPGVIDDQV HFREPGLTHK ATIYTEAKAA 
Saccharomyces   ---------- -----MVQEI DLGLTCDMHV HVREGAMCEL VTPKIRDGGV 
Schizosacch. ---------- -----MSLKI PG--LADMHV HLRQDNMLKA VVPTVAEGGV 
Ustilago maydis ---------- ----MSVQEI TIPAPGDFHV HLRQGKMSEL VTPHVAEGGV 
Helicobacter   ---------- -------MEI TLFDPIDAHL HVRENALLKA VLGYSSEP-F 
Chloroflexus   ---------- -------MTV TLFAPLDMHL HLREGAMLRL VAPFSAAQ-F 
Neisseria   ---------- ------MQTL TIIRPDDMHL HLRDGDALKA VAPYTARQ-M 
Beta vulgaris   ---------- -------MEL TLTRPDDWHL HLRDGDLLAA VAPHSARH-F 
Arabidopsis   KLKFDRSSEK VKTRAVRMEL TITQPDDWHL HLRDGDLLHA VVPHSASN-F 
Oryza    -------MAA SPSPPPLQEL TITRPDDWHL HLREGDVLAA VLPHSAMH-F 
Vibrio    --MTT----- ---------L TITRPDDWHV HLRDGDVLAD TVRDISRY-N 
Shewanella   --MKT----- ---------L TITRPDDWHI HLRDGAQLTD TVRDISRY-M 
Microbulbifer   --MATGLNAN KQQELMSEKI TLTAPDDWHI HLRDGDALAY TVSDAARN-F 
P. flourescens ---------- -----MSDRL TLLRPDDWHI HLRDGAVLTN TVADVART-F 
P. syringae   ---------- -----MSDRL TLLRPDDWHI HLRDGAVLPH TVADVART-F 
P. aeruginosa  ---------- -----MSDRL TLLRPDDWHI HLRDGAALAN TVGDAART-F 
Azotobacterium   FSGRMHGSLT FLEVSMPDRL ILLRPDDWHI HLRDGAALSR TVTDAART-F 
Ralstonia   ---------- -----MIDTL TIVRPDDWHL HLRDGDALAD VVGDTARQ-F 
Burkholderia   ---------M TASNASLDSI TLARPDDWHL HVRDGAMLAA VLPDTARQ-F 
A. tumefaciens ---------- ------MKSL TLRRPDDWHL HLRDGAMLEG VIGDTSRH-F 
Sinorhizobium   ---------- ------MQDL VIRRPDDWHL HLRDGGMLRG VIADTSRH-F 
Rhodobacter sp. ---------- -----MTQSL TLRRPDDWHL HLRDGAMLEG VLPETTRH-F 
E. coli    ---------- --MTAPSQVL KIRRPDDWHL HLRDGDMLKT VVPYTSEI-Y 37 
Shigella   ---------- --MTAPSQVL KIRRPDDWHL HLRDGDMLKT VVPYTSEI-Y 
S. typhimurium  ---------- --MTAPSQVL KIRRPDDWHV HLRDGDMLKT VVPYTSEI-Y 
S. enterica   ---------- --MTAPSQVL KIRRPDDWHV HLRDGDMLKT VVPYTSEI-Y 
Yersinia   ---------- --MTAQPQTL KIRRPDDWHI HLRDDEMLST VLPYTSEV-F 
Novosphingobium   ---------- -----MTETL TIRRPDDWHV HLRDRDVLRG VVPYTARQ-F 
Buchnera   ---------- --MSKFVKKI KIIKPDDWHV HLRDNEILNQ VIKYTGKF-Y 
Wigglesworthia   ---------- -------MLL KIIKPDDFHI HLREKEILKK ILPYTSQF-F 
Pl. falciparum   ---------- -----MKNYF YIPIADDMHC HLRQGDMLDF TVNSIRRGGC 
Pl. yoelii   ---------- -----MENGF SIPLADDMHC HLRQDEMLKF TVPAIKKGGC 
Toxoplasma gondii   EKGGNGASNS CCGQARAKPL VMPLISDMHT HLRQDEMAEF VTPMIKKGGC 
Streptococcus   VD-------- AQVIDAEGLV VAPGLVDVHV HFREPGQTHK EDIHTGALAA 
Geobacter   KAPSGT---- -ETIDASGLI VTPGLIDMHV HLRDPGHEYK EDIVSGTKAA 
Clostridium   EISNG----- -DIIYAEGKL VLPGLVDAHC HLRDPGFEYK EDIETGTMSA 
Thermoanaerobacter DVSDA----- -IVIDAEGKY VLPGFVDMHT HLRQPGFEEK ETIRTGTESA 
Magnetococcus   DAPAHV---- -PVIEADGLI AAPGLVDMHV HLREPGYEYK ETIAGGTRAA 
Thermobifida   LPADGA---- -EVVDAAGAI ALPGLVDLHT HLREPGREDA ETVATGSRAA 
Streptomyces   LSAEGA---- -EVVEADGKV LLPGLVDLHT HLREPGREDS ETVLTGTRAA 
Corynebacterium   HEAD------ -RTIDGNGGV LLPGFVDMHV HLREPGREDT ETIATGSAAA 
Desulfovibrio   PAPQHA---- -ETVEAAGKI LFPSFIDCHV HLREPGFEYK EDIASGLAAA 
Bifidobacterium   ---------- -ADIDATGLT VAPGFEDPHV HFRDPGQTYK ESMVSGCRAS 
Chlorobium   ESIPAK--AE DNVIDLAGKV LAPGLFDMHC HFREPGQEYK ETLETGSAAA 
Thermus aquaticus   --------EA KQVVDGTGCF LAPGFLDLHA HLREPGEEVK EDLFSGLLAA 
Bacillus   -------ADN AEVIDVNGKL IAPGLVDVHV HLREPGGEHK ETIETGTLAA 
Enterococcus   -------AEF DEVFDAKGQL ITPGLVDVHV HLREPGFTYK ETIEAGTRSA 
Oceanobacillus   -------DKV ENYIDIEGKL LLPGLIDVHI HLREPGGEHK ETIKTGTMAA 
Fusobacterium   -------ITD ENIIDIKNRF VTAGFIDVHV HWREPGFSKK ETVYTASRAA 
Lactobacillus   -------AE- -KIIDAQGML VSPGLVDVHV HYRDPGQTYK EDIKTGSEAA 
Oenococcus   -------NKA DFIVDAKGAL LLPGLIDVHV HFREPGFPEK ETIASGSKVA 
Clostridium   --------KE CETLDGKGLV LMPAFIDTHA HFRDPGFEYK EDIESGSKAA 
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Trichodesmium   VKGGVTSFLE MPNTKPLTT- ----TQGALD DKLRRAEQKC VAN------- 
Nostoc    AKGGVTSFLE MPNTRPLTT- ----TQQALD DKLERASQKS LVN------- 
Thermosynecoccus   AKGGVTSFLE MPNTRPLTI- ----DQASLE NKLARAAAKC VVN------- 
Rhodopseudomonas    VMGGVTAVFE MPNTNPLTI- ----TEETFT DKVKRAEHRM HCD------- 
Brucella   VLGGVTAVFE MPNTKPLTT- ----SAEMLE DKIRRGRHRM HCD------- 
Rhodospirillum   VLGGVTGVFE MPNTAPATD- ----SPEALE EKLTRAQGRT WCD------- 
Magnetospirillum   AQAGVVAIFE MPNTKPSTT- ----TADAIL DKLARAKGRA WVD------- 
Ralstonia   ALGGVTAVFE MPNTQPLTL- ----RAEDLR AKLDAAQGRA WCD------- 
Xanthomonas   VAGGLTSFMD MPNTNPPTL- ----DAAALQ AKYDAAAGRA WAN------- 
Xyllela    VAGGLTSFMD MPNTNPPTL- ----GAAALQ AKYDAARGRA WGN------- 
P. flourescens VAGGITSFMD MPNTHPATL- ----TLEALA DKKRRAAINS VAN------- 
Cytophaga   VAGGVTSYME MPNTKPAAV- ----TQELLE QKYEIAAKTS LAN------- 
Saccharomyces   SIAYI----- MPNLQPPITTLDRV- ----IEYKKT LQKLAP---K TTF-- 
Schizosacch. SVAYV----- MPNLIPPITTVDAC- ----LQYKKE IEQLDS---K TTY-- 
Ustilago maydis   SLAYV----- MPNLVPPITSTQQA- ----MEYLER LAAVAP---Q TMF-- 
Helicobacter   SAAVI----- MPNLSKPLIDTPTT- ----LEYEEE ILNHSS---N FKP-- 
Chloroflexus   AGAVI----- MPNLV PPVDNADRL- ----ARYHEE IRAAVDP-YP FLP- 
Neisseria   GRAVI----- MPNLK PPVVSVADA- ----LAYKAR IMAALPEGSA FEP- 
Beta vulgaris   GRAIV----- MPNLR PPVTTTGAA- ----IAYRKS IMEVLPDDSD FNP- 
Arabidopsis   KRAIV----- MPNLK PPVTSTAAA- ----IIYRKF IMKALPSESS FDP- 
Oryza    GRAIV----- MPNLK PPVTTTARA- ----LEYREE ILRALPPGSN FVP- 
Vibrio    GRALI----- MPNTV PPVTTTEMA- ----LAYRER IMAAQPQ-AH FEP- 
Shewanella   GRAIV----- MPNLV PPAIDTETA- ----LAYYDR IKARVPAGSQ FEP- 
Microbulbifer   RRAII----- MPNLV PPVLNAKQA- ----LDYKAR ILAHAPEDAD FTP- 
P. flourescens GRAII----- MPNLV PPVRNAAEA- ----DGYRQR ILAARPAGSR FEP- 
P. syringae    GRAII----- MPNLV PPVRNAQQA- ----DAYRQR ILAARPATSR FEP- 
P. aeruginosa  GRAIV----- MPNLV PPVRNAAEA- ----DAYRQR ILAARPAASR FEP- 
Azotobacterium   GRAIV----- MPNLV PPVRNASEA- ----GAYRQR IQAARPADSR FEP- 
Ralstonia   GRAII----- MPNLK PPVTTTAQA- ----RAYRER ILAALPAGTR FEP- 
Burkholderia   GRAII----- MPNLK PPVTTTAMA- ----QAYRER IVTAIPEGAK FEP- 
A. tumefaciens   ARAII----- MPNLV PPVVTTADA- ----SAYRER ILKAIPEGDR FEP- 
Sinorhizobium   ARAII----- MPNLV PPVVTSADA- ----AAYRER ILAAIPAGDR FEP- 
R. sphaeroides   ARAIV----- MPNLV PPVVTAAEA- ----QAYRAR ILRALPEGAR FEP- 
E. coli    GRAIV----- MPNLA PPVTTVEAA- ----VAYRQR ILDAVPAGHD FTP- 75 
Shigella   GRAIV----- MPNLA PPVTTVEAA- ----VAYRQR ILDAVPAGHD FTP- 
S. typhimurium  GRAIV----- MPNLA SPITTVDAA- ----IAYRQR ILDAGPAGHD FTP- 
S. enterica   GRAIV----- MPNLA SPITTVDAA- ----IAYRQR ILDAVPAGHD FTP- 
Yersinia   ARAIV----- MPNLA QPITTVASA- ----IAYRER ILAAVPAGHK FTP- 
Novosphingobium   ARAIV----- MPNLS PPMTDVAGV- ----AAYRDR ILAALPQGSA FTP- 
Buchnera   KRAVI----- MPNLN SPITSCLKS- ----IAYRNR ILKSMHLNYK FKP- 
Wigglesworthia   GRALV----- MPNLN QPIINSHFA- ----SVYKKE ICSFIPKLHK FNP- 
Pl. falciparum   NRVLV----- MPNTH PIISTCSDA- ----QKYLYQ LKSRDD---D IEY- 
Pl. yoelii   NRVLV----- MPNTT PIISSCEEA- ----KKYRDE LIKYDN---S IEY- 
Toxoplasma gondii   RCVLV----- MPNTI PPVTTCAQA- ----AAYRER LVRIDP---N VDY- 
Streptococcus   AAGGVTTVVM MANTTPTIS- ----DVATLT EVLESAAKEN -IH------- 
Geobacter   AAGGFTSVAC MPNTKPVND- ----NKAVTS YIIAKAKAEG SVN------- 
Clostridium   AMGGFTSIAC MPNTDPVCD- ----NKAVVK YIINKAKQDG YVN------- 
Thermoanaerobacter AAGGFTTVAC MPNTNPPID- ----SEVVVE YVKAVAQREG VVK------- 
Magnetococcus   AAGGVTSVAA MPNTKPVND- ----DPSVTG YMLDKARVAG FAN------- 
Thermobifida   AMGGYTAVFA MANTDPVAD- ----TAGVVE QVWRLGRDAG YCD------- 
Streptomyces   ASGGYTNVFA MANTFPVAD- ----TAGVVE QVWRLGQESG YCD------- 
Corynebacterium   AKGGFTAVFT MANTTPVMD- ----QPVIAE SVWFKGQNIG LCD------- 
Desulfovibrio   AHGGFGAVLP MANTSPVND- ----QGSVTE LMLERARKAW PHGP------ 
Bifidobacterium   ASGGYTNVLI MPNTLPALDG QTVSGPEATG AKEVLDAGFD NVIDFLQQYD 
Chlorobium   VAGGFTGVAL MPNTRPVID- ----SPLGVA YIRHHSAGL- ---------- 
Thermus aquaticus   VRGGYTDLVS MPNTNPPVD- ----TPEAVR ALKEKAKALG ---------- 
Bacillus   AKGGFTTICA MPNTRPVPD- ----CREHME DLQNRIKEKA HVN------- 
Enterococcus   ARGGFTTVCA MPNLNPVPD- ----TAEKLR QVYDIIRKDA VVK------- 
Oceanobacillus   ARGGYTTVCA MPNTNPVPD- ----HPEALT SLLSKIADDA HIR------- 
Fusobacterium   ARGGFTTVMT MPNLNPVPD- ----SVETLN KQLEIIKKDS VIR------- 
Lactobacillus   ARGGFTTVGA MPNVTPVPN- ----TPELMK KMVEENKHKG VVH------- 
Oenococcus   ARGGFTTVFA MPNLNPVID- ----NVEVFK QVQALNQQDG IIK------- 
Clostridium   VRGGYTTVTL MPNTKPVCS- ----SKEILD YVVNKGKEVG LVD------- 
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Trichodesmium   ---------- -FGFFIGATA ENLPDLLTAN P---TPG--- ---------- 
Nostoc    ---------- -YGFFIGATA ENLPDLLLAK P---TPG--- ---------- 
Thermosynecoccus   ---------- -YGFFIGATK DNLAVLNTVH P---VCG--- ---------- 
Rhodopseudomonas    ---------- -FAFFIGGTR DNVEELPKLE RARGCCG--- ---------- 
Brucella   ---------- -FAFWVGGTR DNAKDVAELE RLPGAAG--- ---------- 
Rhodospirillum   ---------- -HAFFLGASA ANAAALGGWE RRDGCAG--- ---------- 
Magnetospirillum   ---------- -HAFFIGAAS DNVDHLAQWE RIPGCAG--- ---------- 
Ralstonia   ---------- -HAFYIGGSS VNAEHLEYLE SLPGCAG--- ---------- 
Xanthomonas   ---------- -YGFYMGASN DNLAHIQSLD PKT-APG--- ---------- 
Xyllela    ---------- -YGFYLGASN DNLAAIQALD PKT-SPG--- ---------- 
P. flourescens ---------- -YGFHFGVSH DNLDTVAALN PSE-VAG--- ---------- 
Cytophaga   ---------- -YSFFMGTTN SNINELLKTN PAT-VCG--- ---------- 
Saccharomyces   ---------- -LMSFYLSKD LTPDLIHEAA QQHAIRG--- ---------- 
Shizosaccharomyces ---------- -LMSLYLSPE TTPEVIYEAA KK-GIRG--- ---------- 
Ustilago maydis   ---------- -VGTLYLSPD LTPAEIAEGA QN-GVRG--- ---------- 
Helicobacter   ---------- -LMSLYFNDG LTLEELQCAK EKG-VRF--- ---------- 
Chloroflexus   ---------- -LMTLFFRP- YDAQTLQALR EH--IFA--- ---------- 
Neisseria   ---------- -LMTLYLTDN ATPELVREAK AAGIV-A--- ---------- 
Beta vulgaris   ---------- -LMTLYLTDT TSPNEIKLAR KSEVVYA--- ---------- 
Arabidopsis   ---------- -LMTLYLTDK TLPEEIRLAR ESGVVYA--- ---------- 
Oryza    ---------- -LMTLYLTDN TSPEEIKLAK KSGVVFA--- ---------- 
Vibrio    ---------- -LMALYLTDN TSPEEIRKAK ASGKVVA--- ---------- 
Shewanella   ---------- -LMVLYLTDK TSPDEIRKAK ASGKVFA--- ---------- 
Microbulbifer   ---------- -LMVLYLTEK TSPADIAEAA AKG-IVA--- ---------- 
P. flourescens   ---------- -LMVLYLTDR TQPEEIREAK ASGFVHA--- ---------- 
P. syringae   ---------- -LMVLYLTDQ TTPDDIRTAK ASGFVYA--- ---------- 
P. aeruginosa   ---------- -LMVLYLTDR TSTEEIRTAK ASGFVHA--- ---------- 
Azotobacterium   ---------- -LMTLYLTDK TSPEDIRTAK AQGFVHA--- ---------- 
Ralstonia   ---------- -LMTLYLTDN TTPEEVRAAR ASGFVHG--- ---------- 
Burkholderia   ---------- -LMTLYLTDN TPPDEIRRAR ESGFVHG--- ---------- 
A. tumefaciens ---------- -LMTLYLTED TVADDVEEGK KSGLITA--- ---------- 
Sinorhizobium   ---------- -LMTLYLTEG TDPGDVEAGF RSGLVKA--- ---------- 
Rhodobacter sp. ---------- -LMVLYLTET TDPADVRAAA ASGLVTA--- ---------- 
E. coli    ---------- -LMTCYLTDS LDPNELERGF NEGVFTA--- ---------- 101 
Shigella   ---------- -LMTCYLTDS LDPNELERGF NEAVFTA--- ---------- 
S. typhimurium  ---------- -LMTCYLTDS LDADELERGF HEGVFTA--- ---------- 
S. enterica   ---------- -LMTCYLTDS LDADELERGF HEGVFTA--- ---------- 
Yersinia   ---------- -LMTCYLTNS LDAKELTTGF EQGVFTA--- ---------- 
Novosphingobium   ---------- -LMTLYLTDS TDIEEVARGF AEGVFVA--- ---------- 
Buchnera   ---------- -LMTCYLTNS TSPKELEFGF SKKIFVA--- ---------- 
Wigglesworthia   ---------- -LMTLYLTEN CDKKMLVDGF LNKIFIA--- ---------- 
Pl. falciparum   ---------- -LMTLYLNKN TDENDILSNY YKCNLQG--- ---------- 
Pl. yoelii   ---------- -LMTLYLNKK TDENDILNNY KECNLQG--- ---------- 
Toxoplasma gondii   ---------- MMTLFLSPEV SADDLRQNAK MCHVTGFENY SRTDFGIYSG 
Sulfolobus   ---------- -IGLIIDMPN TLPPVNTYER VIERIRE--- ---------- 
Streptococcus   ---------- VFPVGSITQG SKGELLSEMG EL-------- ---------- 
Clostridium   ---------- VYPIGAISKG QKGEELSEIG EL-------- ---------- 
Thermoanaerobacter ---------- VLPIGAMTKG MKGEEITEMA KLK------- ---------- 
Magnetococcus   ---------- LFPIGAVSKG LQGKEITEMG LLQ--AAG-- ---------- 
Thermobifida   ---------- VHPVGAVTVG L-- --- ---------- 
Streptomyces   ---------- VQPIGAVTVG LEGAKLAELG AMHESAAGVT VFSDDG---- 
Corynebacterium   ---------- VHPVGSITKG LEGKELTEFG MMARSEAKVR MFSDDG---- 
Desulfovibrio   ---------R VHPVGAATKG L--------- ---------- ---------- 
Bifidobacterium   TAHDVQLPVR YDLCVCASKD RAGHEASDVA DWLKYVPGFE DDA------- 
Chlorobium   -------PID LEVIGAMTVE SRGEALAPYG KYASYS---- ---------- 
Thermus aquaticus   -------LAR LHPAAALTEK QEG------- ---------- ---------- 
Bacillus   ---------- VLPYGAITVR QAGSEMTDFE TL-------- ---------- 
Enterococcus   ---------- VLQYAPITEN LRSE------ ---------- ---------- 
Oceanobacillus   ---------- VLPYASITKS L--------- ---------- ---------- 
Fusobacterium   ---------- AIPYGAITKE EYGRELSDME AIASN----- ---------- 
Lactobacillus   ---------- IFQYGPITND ETTDIIPDYA AL-------- ---------- 
Oenococcus   ---------- IKQYAAISTG LTAN------ ---------- ---------- 
Clostridium   ---------- LYQTVSITKN LSGEEINHLR EFEGNPN--- ---------- 
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Trichodesmium   --IKIFMGSM HGPLLVDTEE KLEPIFARGK RLIAVHAENQ ARIDE----R 
Nostoc    --IKIFMGSM HGQLLVDGET TLETIFAKGD RLIAVHAEDQ ARINQ----R 
Thermosynecoccus   --IKIFMGSM HGPLLVDEEP ILDRIFSEGK RLIAVHAEDQ GRIRA----R 
Rhodopseudomonas    --VKVFIGSS TGSLLVEDDP SLKRILSVIQ RRAAFHAEDE YRLND----R 
Brucella   --IKVFMGSS TGDLLVEDDD GVRSILRNTR RRAAFHSEDE FRLKE----R 
Rhodospirillum   --VKIFMGSS TGSLLVDQDE AIARVLAGGF RRVAVHCEDE ARLKE----R 
Magnetospirillum   --IKVFMGSS TGNLLVADDE ---------- ----TLGRVL AQGFRRVAVH  
Ralstonia   --VKIFMGSS FGDLLADDDE ---------- ----VLCRIL AHGRRRMAVH  
Xanthomonas   --IKVFMGAS TGNMLVDNPE ---------- ----TLDAIF RDAPTPIITH  
Xyllela    --IKVFMGAS TGNMLVDNET ---------- ----TLEGIF RHAPTPIITH  
P. flourescens --VKVFMGAS TGNMLVDDPH ---------- ----TLERLF AEVPTILLAH  
Cytophaga   --IKIFMGSS TGDMLVDNSA ---------- ----MLDEIF SQVKMLIAIH  
Saccharomyces   --VKCYPAGV TTNSAAGVDP ------ND-F SAFYPIFKAM QEENLVLNLH 
Schizosacch. --VKSYPKGA TTNSESGVES ---------Y EPFYPTFAAM QETGMILNIH 
Ustilago maydis   --VKSYPRGV TTNSDSGIED ---------Y ETYYPIFEEM QKHDMVLNLH 
Helicobacter   --LKLYPKGM TTNAQNGTSD ------LLG- EKTLEVLENA QKLGFILCIH 
Chloroflexus   --IKLYPEGV TTNSAGGVSD ------LTAI EPTLAMME-- -ELGIPLLVH 
Neisseria   --FKLYPAGA TTNSDSGVTD ------LF-- -KLIPVLEEM AKQGILFLVH 
Beta vulgaris   --VKLYPAGA TTNSQDGVTD ------LLG- -KCLPVLEEM AEQDMPLLVH 
Arabidopsis   --VKLYPAGA TTNSQDGVTD ------LFG- -KCLPVLEEM VKQNMPLLVH 
Oryza    --VKLYPSGA TTNSQDGVTD ------IFG- -KCLPVLEEM ARQEMPLLVH 
Vibrio    --AKLYPAGA TTNSDSGVTS ------AK-- -NIYPVLQAM QEVGMLLLVH 
Shewanella   --AKLYPAGA TTNSDSGVTD ------LK-- -NIYPALEAM QEVGMLFLVH 
Microbulbifer   --CKLYPAGA TTNSDSGVTD ------IK-- -NCYDALAAM QEHNIKLLVH 
P. flourescens --AKLYPAGA TTNSDSGVTS ------ID-- -KIFPVLEAM AEAGMPLLIH 
P. syringae v. --AKLYPAGA TTNSDSGVTS ------ID-- -KIFPALEAM ADVGMLLLVH 
P. aeruginosa  --AKLYPAGA TTNSDSGVTR ------ID-- -NIFEALEAM AEVGMPLLVH 
Azotobacterium   --AKLYPAGA TTNSDAGVTR ------ID-- -NIFPILEAM AEAGLPLLVH 
Ralstonia   --VKLYPAGA TTNSDAGVTD ------LR-- -RCAKTLEAM QDVGMPLLVH 
Burkholderia   --VKLYPAGA TTNSDAGVTD ------IM-- -KCAKTLEVM QELGMPLLVH 
A. tumefaciens --VKLYPAGA TTNSHGGVRD ------FN-- -KAMPVLERM AKIGLPLCVH 
Sinorhizobium   --VKLYPAGA TTNSSSGVRD ------ID-- -KAMPVLERM AEIGLPLCVH 
Rhodobacter sp. --VKLYPAGA TTNSASGVRD ------FD-- -RVRGVLETM AEIGLPLCVH 
E. coli    --AKLYPANA TTNSSHGVTS ------ID-- -AIMPVLERM EKIGMPLLVH 140 
Shigella   --AKLYPANA TTNSSHGVTS ------ID-- -AIMPVLERM EKIGMPLLVH 
S. typhimurium  --AKLYPANA TTNSSHGVTS ------VD-- -AIMPVLERM EKLGIPLLVH 
S. enterica   --AKLYPANA TTNSSHGVTS ------VD-- -AIMPVLERM EKLGMPLLVH 
Yersinia   --AKLYPANA TTNSTHGVSD ------IP-- -AIYPLFEQM QKIGMPLLIH 
Novosphingobium   --AKLYPAHA TTGSAHGVTD ------IR-- -NIYPVLEKM QEIGMPLLIH 
Buchnera   --AKFYPNGC TTNSKTGIKK ------IS-- -DITPVLECM EKIGMPLLIH 
Wigglesworthia   --AKMYISNT TTNSEKGIKN ------FE-- -NIFHILEIM QKIGMILSVH 
Pl. falciparum   --VKIYPSNV TTNSSDGITS ------LEP- --YYKVFHAL EKLNKSIHIH 
Pl. yoelii   --IKIYPSNV TTNSNDGVSN ------LEP- --YYKIFSTL EKINKSLHIH 
Toxoplasma gondii   --IKSYPKGV TTNSDQGVES ------YEQ- --YYGIFEAM QELGLTLHLH 
Sulfolobus   -VTKEIEKID TLPIAGYKIY PEDLDRTETK VLLE------ ---------H 
Streptococcus   ---KAGAVGF SDDGIPLTSS KVVKEALDLA ---------- KKNDTFISLH  
Geobacter   ---KESGCVA VSDDGHPVTN SELMRRALEY ---------A KGMGIMVISH  
Clostridium   ---KFAGAVA ISDDGKPVKS SSLMKRALEY ---------S SMFDIAVISH  
Thermoanaerobacter ---KAGVVAL SDDGFPIMSA GIMKRVMTYG ---------- KMYDLLMITH  
Magnetococcus   ---KCVAFSD DGLPIMNSGL MRRALDYSRA FG-------- ----GLIIQH 
Thermobifida   ---KGERLAE LGAMADSPAV RVFSDDGMCV SDAQLMRRAL EYVKAFDAQH 
Streptomyces   ---KCVHDAV IMRRALEYVK AFN------- ---------- ----GVVAQH 
Corynebacterium   ---KCVDDPQ VMRRALEYAK GMD------- ---------- ----VLIAQH 
Desulfovibrio   ---KGEELAP MGELAAAGCV AFSNDGLPVG GAEMFRRCME YAADKIVIDH 
Bifidobacterium   ---KTPAMLT HPITAISDDG SAVTPEILDQ VLENVKASD- ----LYLIEH 
Chlorobium   --VKAVSDDG TAIQSSQIMR LAIEYAANFD ---------- ----LLLIQH 
Thermus aquaticus   ---KTLTPAG LLQEAGAVLL TDDGRTNEDA GVLAAGLLMA APLGLPVAVH 
Bacillus   ---KELGAFA FTDDGVGVQD ASMMLAAMKR ---------A AKLNMAVVAH 
Enterococcus   ---KLVDQEA LIEEGAFAFT NDGVGVQTAG –TMYLAMKEA AKNNKALVAH 
Oceanobacillus   ---KGEERTD IQSLIDAGAF AFTDDGVGIQ TADQMYQAMK ARHNTTIVAH 
Fusobacterium   ---KAGVFAF TDDGRGVQSA NVMY EAMLM ---------G AKLNKAIVAH 
Lactobacillus   ---KAFALSN DGHGVQTAQT MYLAMQKAKE ---------- --NNLIIATH 
Oenococcus   ---KIDNIPA LSALGAIAFT NDGKGVQTAD –TMYQAMLAA KAAGKVLVAH 
Clostridium   --VKAITDDG KGVSDSKIMM EAMKIAKENN ---------- ----WIVMSH 
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Trichodesmium   KKQFAGISDP AIHSQIQDNE AALLATKMAL KLSKKYERR- ---------L 
Nostoc    RQEFANIHDP AVHSQIQDNQ AALLATQLVL KLSQKYHRR- ---------L 
Thermosynecoccus   REQFAGITDV AIHSQIQDEI AALNATQLAV TLSRKYERR- ---------L 
Rhodopseudomonas    KGERIEGD-P RSHPVWRDDV AALQATQRLV AIARETGKR- ---------I 
Brucella   EGLRVEGD-P SSHPVWRDEI AALQCTQRLV RIARETGAR- ---------I 
Rhodospirillum   KALVADGASV ALHPEWRDVE TALAATRRLL ALARQAGRK- ---------V 
Magnetospirillum   KHVAEEGAHP RVHHLWRDEE TALMASKRLI ALAETARRR- ---------V 
Ralstonia   RIIAESSGDV RQHPVWRDAR SALLATQRIV KLAGDTGRR- ---------L 
Xanthomonas   KEKYGDALTP EMHPDIRSRQ ACLKSSQLAV SLARKHNTR- ---------L 
Xyllela    HSRYGNTLSA EQHPDIRSRQ ACLKSSQLAV SLAKKNGTR- ---------L 
P. flourescens   RERYGNQLPP DAHAQIRNAD SCFRSSSLAV DLAKRHGTR- ---------L 
Cytophaga   KALYGDKLNA THHHLIRSEE ACYASSSKAV ALAKKHGTR- ---------L 
Saccharomyces   GEKPSVHDGD KEPIHVLNAE EAFLP-ALKK LHNDFPNLK- ---------I 
Schizosacch. GEVPPSKDN- ----TVFTAE PKFLP-TLLD LHQRFPKLK- ---------I 
Ustilago maydis   GELPSNADAG ---ICVLNAE EKFLT-HLFK MHGEFPKLK- ---------I 
Helicobacter   AE------QT G---FCLDKE FLCHS-VLET FALSFPKLK- ---------I 
Chloroflexus   GE------SH G---FVLDRE AEFLP-VYER WARTFPRLR- ---------I 
Neisseria   GE------VT DPEIDIFDRE AAFIGRVMKP VLAQVPNLK- ---------V 
Beta vulgaris   GE------VT DPDVDIFDRE KVFIESVLRP LIQKLPQLK- ---------V 
Arabidopsis   GE------VT DPSIDVFDRE KIFIETVLQP LIQRLPQLK- ---------V 
Oryza    GE------VT DQHVDTFDRE KVFIEKILAP LVQRLPQLK- ---------I 
Vibrio    GE------VT THEVDIFDRE KTFLDTVLAP IVNDFPQLK- ---------I 
Shewanella   GE------VT DSSIDIFDRE RVFIENILSK IVTDFPNLK- ---------I 
Microbulbifer   GE------VT DADIDIFDRE ATFLSRTMEQ LVKDFPTLK- ---------I 
P. flourescens GE------VT RGDVDVFDRE KIFIDEHMRR VVERFPTLK- ---------V 
P. syringae  GE------VT RGEIDVFDRE KVFIDEHLRR VVERFPSLK- ---------V 
P. aeruginosa  GE------VT RAEVDVFDRE KQFIDEHLRR VVERFPTLK- ---------V 
Azotobacterium   GE------VT HSEVDVFDRE KRFIDENLVR IIEHFPTLK- ---------V 
Ralstonia   GE------VT DPTVDIFDRE AVFIDTVMQP LRRDFPALK- ---------V 
Burkholderia   GE------VT DASIDLFDRE KVFIDRVMTP LRRAFPALK- ---------V 
A. Tumefaciens GE------VT TPDVDIFDRE KAFIDTVLEP LRQRLPELK- ---------V 
Sinorhizobium   GE------VT TAEVDIFDRE AVFIETVLDP LRRRLPDLR- ---------I 
Rhodobacter sp. GE------VT DPAVDIFDRE AVFLDRVLDP IRRATPGLR- ---------V 
E. coli    GE------VT HADIDIFDRE ARFIESVMEP LRQRLTALK- ---------V 174 
Shigella   GE------VT HADIDIFDRE ARFIESVMEP LRQRLTALK- ---------V 
S. typhimurium  GE------VT HADVDIFDRE ARFIDTVMEP LRQRLTALK- ---------V 
S. enterica   GE------VT HADVDIFDRE ARFIDTVMEP LRQRLTALK- ---------V 
Yersinia   GE------VT DAAVDIFDRE ARFIDQILEP IRQKFPELK- ---------I 
Novosphingobium   GE------VT DSHVDIFDRE AVFIERTLTR LVADMPALR- ---------I 
Buchnera   GE------EI NQNIDIYDRE AKFIEKTLDP LRKKFPKLK- ---------I 
Wigglesworthia   GE------IS DEKTDIFDRE AKFIEKVMIP IRKNFPKLK- ---------I 
Pl. falciparum   CE-------- EPNINPLYAE EKYLP-HIHD LAIKFPGLN- ---------I 
Pl. yoelii  CE-------- EPNINPVYAE KEYLQ-HIHD ISIKFPHLK- ---------I 
Toxoplasma gondii   GE-------- VPGVAPLDAE EAFIP-FFEQ IHSRFPSLK- ---------I 
Sulfolobus   KSKKLKVLHP EIPLALKVPR KLR-NIWMEI AALHYVQGN- ---------V 
Streptococcus   KIA-----KE HFKICGATGV AEYSMIARDV MIAYDRQAH- ---------I 
Geobacter   GFV-----ST ELGLKGIPWA AEDAATARDV YLAEFTDSP- ---------L 
Clostridium   GYW-----ST VMGLKGIPSA AEEIMVARDI ILSEYTKVP- ---------I 
Thermoanaerobacter GII-----AT MLGLKGIPRE AEEVMLARNI ILAKATGAK- ---------L 
Magnetococcus   GEV-----AT RLGLSGICNA AEDILVERDI RLVELTGGR- ---------Y 
Thermobifida   GVV-----SD RLGLAGWPAV AEEAIIARDC LLAEHVGSR- ---------L 
Streptomyces   GVV-----SA ELGLGGWPAV AEESVIARDV LLAEHVGSR- ---------V 
Corynebacterium   GEN-----AA RLGLRGWPRV AEESIVVRDA IMARDYGNR- ---------V 
Desulfovibrio   GVT-----SG RLGVKGQSVV AESVQVARDI LLAEYLGIP- ---------V 
Bifidobacterium   GPV-----SR ELGVPGIPED TELKIVARDI EAARRTGVH- ---------V 
Chlorobium   GAV-----SA MLGLKGIPEV AEPIMIARDL QLIAWLKKHK LNGAVAEPRY 
Thermus aquaticus   GPL-----AD LLGLPGNPPE AEAARIARDL EVLRYALRR- ---SPATPRL 
Bacillus   GKF-----SE KHGLNGIPSV CESVHIARDI LLAEAADCH- ---------Y 
Enterococcus   GKK-----AE ELGLPGILSV TESSQIARDL LLAEATGVH- ---------Y 
Oceanobacillus   GEV-----SE RLSLPGIPSL SESVQIARDV LLAEATGCH- ---------Y 
Fusobacterium   GKR-----SA ELGIKGIPSI CESTQIVRDV LLAEAANCH- ---------Y 
Lactobacillus   GVA-----AK KLDLPPVTEL AETTQIARDL LLAQKTGVH- ---------Y 
Oenococcus   GLA-----SK NLGFPGAKKL SETSQLARDL MIAKATGAQ- ---------Y 
Clostridium   ---------- ---------L AENMMTWRDI TLAKFVDCR- ---------L 
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Trichodesmium   HILHTSTGDE AELLR----- ---QDKPSWV TAEVTPQHLF LN-TSAYEKI 
Nostoc    HILHMSTAEE ADLLR----- ---QEKPSWV TAEVTPQHLV LN-TSAYEKI 
Thermosynecoccus   HILHLSTGIE VDFLR----- ---EHKRPWI TVEVTPQHLL LT-TEAYAKI 
Rhodopseudomonas    HVLHVSTRQE MEFLR----- ---EHK-DVA SVEVTPHHLT LVAPDCYERL 
Brucella   HVLHISTAEE IDFLK----- ---DYK-DVA TCEATPHHLT LS-ADDYKAL 
Rhodospirillum   HVLHVTTAEE MALLQ----- ---DNR-DIA SVEVTPQHLT LAAPDCYEGL 
Magnetospirillum   HVLHVTTAEE MEFLA----- ---GHK-DVA TVETTPQHLT LAAPECYERL 
Ralstonia   HILHVSTAEE IAFLA----- ---DRK-DRV TVEVTPHHLT LEAPECYERL 
Xanthomonas   HVLHISTADE LSLFEAGPLV DADGKLRKRI TAET-CIHFL RFDRSDYARL 
Xyllela    HVLHISTADE LRLFEAGPLV DAAGKRRKQI TAET-CIHFL HFDRMDYARL 
P. flourescens HVLHLTTARE LALFEDKPLT ------QKRI TAEVCLHHLL FD-ERDYPNL 
Cytophaga   HILHISTAKE LDLFTNTIPL E-----EKKI TAEACIHHLW FS-NEDYATK 
Saccharomyces   ILEHCTSESA IKTIEDINKN VK-KATDVKV AATLTAHHLF LT-IDDWAG- 
Schizosacch. VLEHCTTADA VEAVK----- ----ACGESV AGTITAHHLY LT-QKDWQD- 
Ustilago maydis   VLEHATTRKA VEAVK----- ----QCGDTV GCTITPHHLE LI-VDDWAG- 
Helicobacter   IIEHLSDWRS IALIEKHDN- ---------L YATLTLHHIS MT-LDDLLGG 
Chloroflexus   VMEHITTAAA LDLLDRYPN- ---------L FATVTLHHLL IT-LDDVAGG 
Neisseria   VFEHITTAEA ARLVLEAG-D N--------V AATVTPQHLL LN-RNDLLVG 
Beta vulgaris   VMEHITTADA VKFIESCNGG N--------V AATVTPQHLV LN-RNSLFQG 
Arabidopsis   VMEHITTMDA VNFVESCKEG S--------V GATVTPQHLL LN-RNALFQG 
Oryza    VMEHITTMDA VNFVESCKEG H--------V AATVTPQHLL LN-RNALFQG 
Vibrio    VLEHITTADA VTFVQQAGDN ---------V AATITAHHLL FN-RNHMLVG 
Shewanella   VLEHITTKDA VDFVTQASDN ---------V AATITAHHLL YN-RNHMLAG 
Microbulbifer   VLEHITTEDA VKFVLKSGPN ---------V AATITAHHLL YN-RNHMLAG 
P. flourescens   VFEHITTGDA VQFVNEASAN ---------V GATITAHHLL YN-RNHMLVG 
P. syringae VFEHITTGEA VQFVNEASAN ---------V AATITAHHLL YN-RNHMLVG 
P. aeruginosa VFEHITTGDA AQFVREAPAN ---------V GATITAHHLL YN-RNHMLVG 
Azotobacterium   VFEHITTRDA VQFVETSSSN ---------V GATITAHHLL YN-RNHMLVG 
Ralstonia   VFEHITTKHA AEYVRDAQGP ---------V GATITAHHLL YN-RNALFVG 
Burkholderia   VFEHITTKDA VDYIREAGVA PE------VL GATITAHHLL YN-RNAIFQG 
A. Tumefaciens TMEHITTRDG VDYIKSSNAN ---------L AGSITTHHLI IN-RNAILVG 
Sinorhizobium   TMEHVTTKDG VDYIREHAAN ---------L AGSITTHHLI IN-RNAILVG 
Rhodobacter sp. VLEHVTTREG LDYVRGGGPD ---------M AGTLTTHHLI IN-RNHILAG 
E. coli    VFEHITTKDA ADYVRDGNER ---------L AATITPQHLM FN-RNHMLVG 214 
Shigella   VFEHITTKDA ADYVRDGNER ---------L AATITPQHLM FN-RNHMLVG 
S. typhimurium  VFEHITTKDA AQYVRDGNDY ---------L AATITPQHLM FN-RNDMLVG 
S. enterica   VFEHITTKDA AQYVRDGSYN ---------L AATITPQHLM FN-RNDMLVG 
Yersinia   VFEHITTKDA ADYVLAGNRF ---------L GATVTPQHLM FN-RNHMLVG 
Novosphingobium   VFEHITTEEA AQFVEGAGDS ---------I AATITPQHLH IN-RNAMLVG 
Buchnera   VLEHITTKES VEYIKNNDVN --------YL SATITPHHLM LN-RNDMFYG 
Wigglesworthia   VFEHISTKIA VEYVISEDS- --------LL GATITPHHLM FN-YNDMLSN 
Pl. falciparum   VLEHISSSES INVIKEFR-- --------NV AGSITPHHLY LT-IDDVVNM 
Pl. yoelii   VLEHISTENM IEMVKKYP-- --------NV AGSITPHHLH LT-IDDVVDI 
Toxoplasma gondii   VLEHVSTAAA IQAVKRMPA- --------NV AATITPHHLM LT-VDDVVKP 
Sulfolobus   HVTHITNYET VKIAKELG-- ---------F STDITPHHLL VNGERDCITK 
Streptococcus   HIQHLSKAES VKVVAFAQKL G------AQV TAEAAPQHFS KT-ENLLL-- 
Geobacter   HIAHVSTKGS LRIIRNAKAR G------VKV TCETA-PHYF SLT-DDAVRG 
Clostridium   HIAHVSTELS VELIRNAKKR G------VKV TCETC-PHYF VLT-DEACKD 
Thermoanaerobacter HIAHVSTKGS VELIRRAKEE G------VSI TAEVTPHHLT RT-DEAVYN- 
Magnetococcus   HVAHISSAGA VASVAKAREK G------LRV SCEAAPHHLV LN-DTHVGN- 
Thermobifida   HVCHVSTKGS VQIIRWAKSR G------CDV TAEVTPHHLL LT-DELAES- 
Streptomyces   HICHLSTAGS VEIVRWAKSR G------IDV TAEVTPHHLL LT-DELVRS- 
Corynebacterium   HICHASTEGT VELLRWAKSQ G------IPI TAEVTPHHLT LT-DERLET- 
Desulfovibrio   HLAHISCRQS VELIAWAKQR G------VRV TAETC-PHYL LLDDLALEQ- 
Bifidobacterium   HFQHVSTAIS FEAIRRAKAE G------LPI TCETA-PHYL ALSDEALLK- 
Chlorobium   HVAHISTAES VALVRKAKAA G------LKV TCEVTPHHFT LT-EHDLSSS 
Thermus aquaticus   HVQHLSTKRG LELVREAKRA G------LPV TAEATPHHLT LT-EEALRT- 
Bacillus   HVCHVSTKGS VRVIRDAKRA G------IKV TAEVTPHHLV LC-EDDIPSA 
Enterococcus   HVCHVSTKES VRVIRDAKKA G------IHV TAEVSPHHLI LI-DEDIPED 
Oceanobacillus   HVCHVSTKES VRVIRDAKKA G------IHV TAEVSPHHLL LN-ETDIPDD 
Fusobacterium   HVCHISAKES VRAVREGKKN G------IKV TCEVTPHHLL SC-DEDIKED 
Lactobacillus   HICHVSTKTS VELVRLAKAR G------INV TCEVAPHHIL LT-DSDIPKD 
Oenococcus   HMAHVSAAES VELIRIAKEH R------IDV TAEVSPHHLL LD-DSMITND 
Clostridium   HMSHVSTKEA MKYIIEGKND G------VKV TCEITPHHLA LN------NK 
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Trichodesmium   G--------- ---------- ---------- ---TLAQMNP PLKSAGDNDI 
Nostoc    G--------- ---------- ---------- ---TLAQMNP PLRSPHDNEV 
Thermosynecoccus   G--------- ---------- ---------- ---SLAQMNP PLRTAVDNKK 
Rhodopseudomonas    G--------- ---------- ---------- ---TKAQMNP PVRDAWHRDG 
Brucella   G--------- ---------- ---------- ---NLIQMNP PVRDKRHREG 
Rhodospirillum   G--------- ---------- ---------- ---TFAQMNP PIREARHREA 
Magnetospirillum   G--------- ---------- ---------- ---TYAQMNP PIRGTRHRDA 
Ralstonia   G--------- ---------- ---------- ---TLAQMNP PVRERCHRNA 
Xanthomonas   G--------- ---------- ---------- ---NLIKCNP AIKDAEDRLA 
Xyllela    G--------- ---------- ---------- ---NLIKCNP AIKEASDREA 
P. flourescens G--------- ---------- ---------- ---NLIKCNP AIKSRSDRDA 
Cytophaga   G--------- ---------- ---------- ---NYIKWNP AVKTVADREA 
Saccharomyces   ---------- ---------- ---------- --NPVNFCKP VAKLPNDKKA 
Schizosacch. ---------- ---------- ---------- --DPYCFCKP VAKTERDRRA 
Ustilago maydis   ---------- ---------- ---------- --KPLNFCKP VAKYPDDRQA 
Helicobacter   SL-------- ---------- ---------- --NPHCFCKP LIKTKKDQER 
Chloroflexus   LL-------- ---------- ---------- --QPHLFCKP IAKRPTDRDA 
Neisseria   GV-------- ---------- ---------- --RPHHFCLP VLKRETHRQA 
Beta vulgaris   GL-------- ---------- ---------- --QPHNYCLP VLKREIHRQA 
Arabidopsis   GL-------- ---------- ---------- --QPHNYCLP VLKREIHREA 
Oryza    GL-------- ---------- ---------- --QPHNYCLP VLKRETHRQA 
Vibrio    GI-------- ---------- ---------- --RPHFYCLP ILKRATHQHA 
Shewanella   GI-------- ---------- ---------- --RPHFYCLP ILKRNTHQQA 
Microbulbifer   GI-------- ---------- ---------- --RPHYYCLP ILKRSSHQQA 
P. flourescens GI-------- ---------- ---------- --RPHFYCLP ILKRNTHQEA 
P. syringae GI-------- ---------- ---------- --RPHFYCLP ILKRNTHQTA 
P. aeruginosa  GI-------- ---------- ---------- --RPHFYCLP ILKRNTHQEA 
Azotobacterium   GI-------- ---------- ---------- --RPHFYCLP ILKRRTHQEA 
Ralstonia   GI-------- ---------- ---------- --RPHYYCLP VLKRETHRLA 
Burkholderia   GI-------- ---------- ---------- --RPHYYCLP VLKRETHRVA 
A. Tumefaciens   GI-------- ---------- ---------- --KPHYYCLP VAKREEHRLA 
Sinorhizobium   GI-------- ---------- ---------- --KPHYYCLP VAKREAHRLA 
Rhodobacter sp. GI-------- ---------- ---------- --RPHYYCLP VAKRETHRLA 
E. coli    GV-------- ---------- ---------- --RPHLYCLP ILKRNIHQQA 234 
Shigella   GV-------- ---------- ---------- --RPHLYCLP ILKRNIHQQA 
S. typhimurium  GI-------- ---------- ---------- --RPHLYCLP ILKRNIHQQA 
S. enterica   GI-------- ---------- ---------- --RPHLYCLP ILKRNIHQQA 
Yersinia   GI-------- ---------- ---------- --RPHLFCLP ILKRSTHQQA 
Novosphingobium   GI-------- ---------- ---------- --RPHAFCLP VAKREKHRLA 
Buchnera   GI-------- ---------- ---------- --QPYLYCLP ILKKNKHRMA 
Wigglesworthia   KI-------- ---------- ---------- --KPHLYCFP ILKKKIDQFA 
Pl. falciparum   DIYDHAIDNT Y--------- ------IEKY IKNTYHYCKP LPKLLEDKIA 
Pl. yoelii   KNYDYSFNNT D--------- ------IEKY VKNVYNYCKP LPKTLDDKIA 
Toxoplasma gondii   DAIKRAMETA AHRGLC---- ------CAEA VEKPHNFCKP LAKTKRDRDA 
Sulfolobus   VN-------- ---------- ---------- ---------P PIRDYLTRLG 
Streptococcus   -------EKG ---------- ---------- ---ANAKMNP PLRLEADRLA 
Geobacter   ---------- ---------- ---------- -YDTNAKMNP PLRTADDVTA 
Clostridium   ---------- ---------- ---------- -FNTLAKVNP PLRTRRDVEA 
Thermoanaerobacter ---------- ---------- ---------- -YDTNTKVFP PLRTREDVEA 
Magnetococcus   ---------- ---------- ---------- -YDTNAKMAP PLRNQRDVNA 
Thermobifida   ---------- ---------- ---------- -YDPVYKVNP PLRTAEDVEA 
Streptomyces   ---------- ---------- ---------- -YNPVYKVNP PLRTERDVMA 
Corynebacterium   ---------- ---------- ---------- -YDAVNKVNP PLRESRDAEA 
Desulfovibrio   ---------- ---------- ---------- -YSTAAKVNP PLRTPDDVAA 
Bifidobacterium   ---------- ---------- ---------- -YGTLAKMNP PLRSEADRKA 
Chlorobium   I--------- ---------- ---------- -EKGNFIMKP PLASVENRDA 
Thermus aquaticus   ---------- ---------- ---------- -FDPLFKVAP PLRGEEDREA 
Bacillus   D--------- ---------- ---------- ---PNFKMNP PLRGKEDHEA 
Enterococcus   F--------- ---------- ---------- ---GFWKMNP PLRGREDREA 
Oceanobacillus   N--------- ---------- ---------- ---ADWKMNP PLRSTEDQQA 
Fusobacterium   N--------- ---------- ---------- ---GMWKMNP PLRSREDRNA 
Lactobacillus   N--------- ---------- ---------- ---GYFKMNP PLRNKEDQAA 
Oenococcus   N--------- ---------- ---------- ---SLMKMNP PLRSPDDRAA 
Clostridium   I--------- ---------- ---------- ---SNYRVNP PIREEEDVNF 
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Trichodesmium   LWRALL--DG VIDFIATDHA PHTLAEKG-- ---------- ---------- 
Nostoc    LWQALR--DG VIDFIATDHA PHTLEEKA-- ---------- ---------- 
Thermosynecoccus   LWQGLL--DG VIDFIATDHA PHTLEEKA-- ---------- ---------- 
Rhodopseudomonas    IWHGLA--QG VVDVLGSDHA PHTLEEKA-- ---------- ---------- 
Brucella   VWKGID--QG IVDVLGSDHA PHTLEEKQ-- ---------- ---------- 
Rhodospirillum   LWRALE--QG VVDIIGSDHA PHTLKEKS-- ---------- ---------- 
Magnetospirillum   LWKAIA--DG TVDVLGSDHA PHTREEKD-- ---------- ---------- 
Ralstonia   LWQAIR--EG VGDVIGSDHA PHTPKEKS-- ---------- ---------- 
Xanthomonas   LIDALA--ED VIDVLATDHA PHTWEEKQ-- ---------- ---------- 
Xyllela    LIAALA--KD VIDVLATDHA PHTWEEKQ-- ---------- ---------- 
P. flourescens LRQALL--SN RLDVIGSDHA PHTWAEKQ-- ---------- ---------- 
Cytophaga   IWQAVL--DN RIDVIATDHA PHTIEEKE-- ---------- ---------- 
Saccharomyces   LVKAAV-SGK PYFFFGSDSA PHPVQNK--- ---------- ---------- 
Schizosacch. LIEAAT-SKN PKFFFGSDSA PHPRSSK--- ---------- ---------- 
Ustilago maydis   LRDVIR-QGH PRFFLGSDSA PHPLANKYPS AVTHGAPGTK ASDSGSDHLE 
Helicobacter   LLSLAL-KAH PKISFGSDSA PHFISKK--- ---------- ---------- 
Chloroflexus   LLAAAL-AGH PKLMFGSDSA PHPIDRK--- ---------- ---------- 
Neisseria   LVAAVTGEKA HKFFLGTDSA PHAKSAK--- ---------- ---------- 
Beta vulgaris   LVSAVT-SGS KQYFLGTDSA PHERRRK--- ---------- ---------- 
Arabidopsis   IVKAVT-SGS KKFFLGTDSA PHERSRK--- ---------- ---------- 
Oryza    IVSAVT-SGS KQYFLGTDSA PHDKRRK--- ---------- ---------- 
Vibrio    LVAAAT-SGS KKFFLGTDSA PHAKGRK--- ---------- ---------- 
Shewanella   LLAAAA-SGN KKFFLGTDSA PHAKDRK--- ---------- ---------- 
Microbulbifer   LISAAI-SGN PKFFLGTDSA PHAKSKK--- ---------- ---------- 
P. flourescens   LLDAAT-SGS AKFFLGTDSA PHAQHAK--- ---------- ---------- 
P. syringae LLDAAT-SGS GKFFLGTDSA PHAQHAK--- ---------- ---------- 
P. aeruginosa  LLDAAV-SGN PKFFLGTDSA PHARHAK--- ---------- ---------- 
Azotobacterium   LLDAAT-SGN TKFFLGTDSA PHARHAK--- ---------- ---------- 
Ralstonia   LVAAAT-SGH PRFFLGTDSA PHAKGLK--- ---------- ---------- 
Burkholderia   LVEAAT-SGN PRFFLGTDSA PHPKGLK--- ---------- ---------- 
A. Tumefaciens   LRAAAT-SGD ARFFLGTDSA PHVDPLK--- ---------- ---------- 
Sinorhizobium   LRQAAI-SGD VRFFLGTDSA PHVDPLK--- ---------- ---------- 
Rhodobacter sp.   LRAAAT-GGE ACFFLGTDSA PHVDAAK--- ---------- ---------- 
E. coli    LRELVA-SGF NRVFLGTDSA PHARHRK--- ---------- ---------- 260 
Shigella   LRELVA-SGF NRVFLGTDSA PHARHRK--- ---------- ---------- 
S. typhimurium  LRELVA-SGF TRAFLGTDSA PHSRHRK--- ---------- ---------- 
S. enterica   LRDLVA-SGF TRAFLGTDSA PHSRHRK--- ---------- ---------- 
Yersinia   LRAAVA-SGS DRFFLGTDSA PHAKHRK--- ---------- ---------- 
Novosphingobium   LRKLAT-SGF SRVFLGTDTA PHAKHLK--- ---------- ---------- 
Buchnera   LRKAIS-NGD KHFFLGSDTA PHLHKNK--- ---------- ---------- 
Wigglesworthia   LHKAIS-GNC NRFFLGTDSA PHVLKNK--- ---------- ---------- 
Pl. falciparum   LQDVIK-DDF PRVFLGSDSA PHYKVMK--- ---------- ---------- 
Pl. yoelii   LCNIIK-EGN PKVFLGSDSA PHYQKFK--- ---------- ---------- 
Toxoplasma gondii   LRQVIQ-DGD THFFLGSDSA PHPRLAK--- ---------- ---------- 
Sulfolobus   LW-KAL---F EVDTVVSDHA PHSKEEKN-- ---------- ---------- 
Streptococcus   VIEGLK--SG VISVIATDHA PHHADEKN-- ---------- ---------- 
Geobacter   VKEALK--DG TIDAIATDHA PHHIDEK--- ---------- ---------- 
Clostridium   VIEGLK--DG TIDIIATDHA PHHADEK--- ---------- ---------- 
Thermoanaerobacter LIEGLK--DG TIDAIATDHA PHTKDDK--- ---------- ---------- 
Magnetococcus   IQEALA--RG VISVIATDHA PHEEDSK--- ---------- ---------- 
Thermobifida   LREGLA--DG TIDIVATDHA PHPSEAK--- ---------- ---------- 
Streptomyces   LREALA--DG TIDIVATDHA PHPHEDK--- ---------- ---------- 
Corynebacterium   LKKALL--DG TIDVVATDHA PHGSEDK--- ---------- ---------- 
Desulfovibrio   MRRAVA--DG TIDILVTDHA PHAAHEK--- ---------- ---------- 
Bifidobacterium   TIAAIA--DG TVDLLATDHA PHTLAEK--- ---------- ---------- 
Chlorobium   LIEGLR--DG TIDAIATDHA PHAKHEK--- ---------- ---------- 
Thermus aquaticus   LLEGLL--DG TLDAIATDHA PHTQAEK--- ---------- ---------- 
Bacillus   LIEGLL--DG TIDMIATDHA PHTAEEK--- ---------- ---------- 
Enterococcus   LIEGLL--DG TIDCIATDHA PHGLEEK--- ---------- ---------- 
Oceanobacillus   LFDGLM--DG TIDLIATDHA PHATEEK--- ---------- ---------- 
Fusobacterium   LIVGIL--DG TIDIIATDHA PHTMEEK--- ---------- ---------- 
Lactobacillus   LLVGLL--DG TIDLIATDHA PHAKSEK--- ---------- ---------- 
Oenococcus   LLAGLL--DG TIDIVATDHA PHTKEEK--- ---------- ---------- 
Clostridium   LIKAIK--MN YVDCIGTDHA PHSKEDK--- ---------- ---------- 
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Trichodesmium   ---KGYPNTP SGMPGVETSL PLMLTQAIEG R--CSVAQVS NWMSTAVAKG 
Nostoc    ---QEYPNSP SGMPGVETSL ALMLTAAMEG K--CTVSQVV NWMSKNVAVA 
Thermosynecoccus   ---QPYPQSP SGMPGVETSL PLMLTQAMAG R--CTVPQVV RWMSTAVAAA 
Rhodopseudomonas    ---KTYPASP SGMTGVQTLV PTMLDHVNAG R--LSLARFV DLTSAGPARL 
Brucella   ---KSYPASP SGMTGVQTLV PIMLDHVNAG K--LSLERFV DLSSHGPNRI 
Rhodospirillum   ---LPYPKSP SGMPGVQTLV PVMLDHVNTG K--LSLERFV DLTSAGPARV 
Magnetospirillum   ---KPYPQSP SGMTGVQTLV PLMLDHVNQG R--LSLERLV DLTSAGPARI 
Ralstonia   ---RPYPASP SGMTGVQTLV PVMLDHVHRG Q--LSLQRFV DLTSAGPARI 
Xanthomonas   ---KPYAQAP SGLPLVQYAL VAALELVHEG K--LPITRIV QKFAHAPAQL 
Xyllela    ---QPYAQAP SGLPLVQYAL VAALELVHAG R--LSVTEIV RKFAHAPAQL 
P. flourescens ---QAYEQAP SGLPLVQHAL PALLELVADG V--LPITTLV AKTSHRVADL 
Cytophaga   ---LPYIDAP SGGPLVQHSL VAMLEKYHQG K--ISLERIA EKMSHNVAKL 
Saccharomyces   ---ANYEGVC AGVYSQSFAI PYIAQVFE-E Q--NALENLK GFVSDFGISF 
Schizosacch. ---LKTP-PA AGVFTQPFAA SYLAEVFD-K E--GRLDALK DFACIFGRKF 
Ustilago maydis   ATGVVSCGCA AAVYTSSILV PLWPTLLE-A F--GALDQLA NYVSINGRNF 
Helicobacter   ----HSANIP AGIFSAPILL PALCELFE-K H--NALENLQ AFISDNAKTI 
Chloroflexus   ----EAAFCA AGVFSAPVLL PMLVELFE-R H--NALDRLP DFVSGNARRI 
Neisseria   ----ENACGC AGMFSAMTAI ELYAEVFE-K A--GALDKLE AFASKNGARF 
Beta vulgaris   ----ECSCGC AGIYNSPVAL SLYAKVFE-E A--GALDKLE AFTSFNGPDF 
Arabidopsis   ----ESSCGC AGIYSAPIAL SLYAKVFD-E A--GALDKLE AFTSFNGPDF 
Oryza    ----ECSCGC AGIYSAPVAL SLYAKVFE-Q A--GALDKLE AFTSFNGPDF 
Vibrio    ----EAACGC AGSYTAHAAL ELYAEVFE-K E--GKLENLE AFASFNGPDF 
Shewanella   ----EAACGC AGSYTAHAAI ELYAEAFE-S V--NALDKLE AFASFNGPDF 
Microbulbifer   ----EAACGC AGSYTAFAAL PLYAEAFE-E A--GALDKLE DFASHFGPDF 
P. flourescens   ----EAACGC AGCYTAYAAI ELYAEAFE-Q R--NALDKLE AFASLNGPRF 
P. syringae   ----ENACGC AGCYTAYAAI ELYAEAFE-Q R--NALDKLE GFASLHGPAF 
P. aeruginosa  ----EAACGC AGCYSAYAAI ELYAEAFE-Q R--NALDKLE GFASLHGPDF 
Azotobacterium   ----EAACGC AGCYTAYAAI ELYAEAFE-Q R--SALDRLE AFASHHGADF 
Ralstonia   ----EHACGC AGCYTALHAM ELYAEAFE-D A--NALDKLE GFASLHGPDF 
Burkholderia   ----EHACGC AGCYTALHAL ELYTEAFD-K A--GALDKLE GFASFFGADF 
A. Tumefaciens   ----ECACGC AGIYTSINTM SCLAHVFE-D E--NALDKLE AFASLNGPAW 
Sinorhizobium   ----ECACGC AGIYTSINTL SCLAHVFE-E E--GALDRLE AFTSLNGPAW 
Rhodobacter sp.   ----ESGCGC AGCFTAPNTL SILAHVFE-E E--GALDRLE GFVSLHGPAF 
E. coli    ----ESSCGC AGCFNAPTAL GSYATVFE-E M--NALQHFE AFCSVNGPQF 303 
Shigella   ----ESSCGC AGCFNAPTAL GSYATVFE-E M--NALQHFE AFCSVNGPQF 
S. typhimurium  ----ETSCGC AGCFNAPSAL GSYAAVFE-E M--NALAHFE AFCSLNGPQF 
S. enterica   ----ETRCGC AGCFNAPSAL GSYAAVFE-E M--NALAHFE AFCSLNGPQF 
Yersinia   ----ESSCGC AGVFNAPAAL PAYASVFE-E L--NALQHLE AFCALNGPRF 
Novosphingobium   ----EAACGC AGIFNAPFAL ESYVTVFD-E E--GALDRFE AFASLNGPAF 
Buchnera   ----INMLGC AGIFNAPSSL LSYVKVFE-E M--RALKYLQ SFCSENGPKF 
Wigglesworthia   ----ESSMGF AGIFNSPIAL EMYATVFD-N L--NILNKLE NFCSINGANF 
Pl. falciparum   ----RKPYYK PGIYTQPFLI NYVAHILN-K F--DALDKME NFTSKNASLF 
Pl. yoelii   ----QEPHYK PGIFTQPFLL SYLAHIFN-K F--NSLDKIE NFACKNAAQF 
Toxoplasma gondii   ----ESSPPA AGVFTQPLLL AYLVSIFA-E L--GCISKLR EFADGHAAAF 
Sulfolobus   ---LNYDLCP PGIAAVSFTT PFIYSLVFKD L--LNIERAV NLLSKNPAKI 
Streptococcus   --VADVTKAP SGMTGLETSL SLGLTYLVEA G-HLSLMDFL AKMTINPAQL 
Geobacter   --DLEFNEAL NGIVGLETSL TLSLR-LVEE G-VLTLPVLV DKMACNPAKI 
Clostridium   --NVEFNLAA NGMVGFETAL PLAITYLVKP G-HLTISQLV EKMCVNPSKL 
Thermoanaerobacter --KVPYDMAP FGISGLETAF SVINTFLIQT G-IITMKALV NYMSMNPARI 
Magnetococcus   --RVPFCQAA NGVVGLETLL PITLE-LVEA G-VLPLAKAL AAISCNPARL 
Thermobifida   --ETEWNQAA MGMIGLETAL SVVQHTMVDT G-LLDWAGVA QRMSATPARI 
Streptomyces   --DCEWAAAA MGMVGLETAL SVVQETMVDT G-LLDWAGVA DRMSFKPAKI 
Corynebacterium   --CCEFENAK PGMLGLETSL SIIVDTFVAT G-LADWRFVA RVMSERPAEI 
Desulfovibrio   --DTPLDEAP NGISGLDTAV ALTWR-LVQE G-LLTEADMV RLWCHAPGSL 
Bifidobacterium   --ELGFLEAP NGIIGLECAY GVCHKVLVDG G-FISDERLI ELMSVGPAEL 
Chlorobium   --ECPPDQAA FGIIGLETSL GLTITELVDK G-VITLSQAI ELLSTNPRRI 
Thermus aquaticus   --EMDLLRAP FGIPSLEVAF PLLYTELHLK R-GFPLRRLV ELFTDGPRRV 
Bacillus   --AQGIERAP FGITGFETAF PLLYTNLVKK G-IITLEQLI QFLTEKPADT 
Enterococcus   --SQSFMKSP FGIVGSETAF QLIYTHFVET G-RFTLEQVI NWLAVKPAEI 
Oceanobacillus   --AVGFKEAP FGIVGLETAF PLLYTHLVLK G-KMTLYQLV ERMTEKPAAT 
Fusobacterium   --IRGIEKSS FGIVGSETAF AQLYTKFVKT D-IFSLEMLV KLMSENVAKI 
Lactobacillus   --QGGMKNAA FGITGSETAF STLYTKFVKE EKVLSLEQLL ALLSDKPAKV 
Oenococcus   --AQSILTAP NGVTGIETSF QLLYTHLVKP G-IMSLRQLL KAMNQRPADI 
Clostridium   ------EKGA PGMIGIEQAF SICYTKLVKE N-HISLNKLS QLMSGNAAKL 
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Trichodesmium   YGILKKG--- ---------- ---------- ---------- ---------A 
Nostoc    YGIPNKG--- ---------- ---------- ---------- ---------V 
Thermosynecoccus   YEIPNKG--- ---------- ---------- ---------- ---------K 
Rhodopseudomonas    FGIACKG--- ---------- ---------- ---------- ---------R 
Brucella   FGMARKG--- ---------- ---------- ---------- ---------R 
Rhodospirillum   YDIAGKG--- ---------- ---------- ---------- ---------R 
Magnetospirillum   YNIAGKG--- ---------- ---------- ---------- ---------R 
Ralstonia   FGVEGKG--- ---------- ---------- ---------- ---------R 
Xanthomonas   FDVEERG--- ---------- ---------- ---------- ---------F 
Xyllela    FDVIERG--- ---------- ---------- ---------- ---------F 
P. flourescens FAIPDRG--- ---------- ---------- ---------- ---------Y 
Cytophaga   FHD------- ---------- ---------- ---------- ---------- 
Saccharomyces   YEVKDSE--- ---------- ---------- ---------- ---------V 
Schizosacch. YCIP------ ---------- ---------- ---------- ---------L 
Ustilago maydis   YGYND-D--- ---------- ---------- ---------- ---------Q 
Helicobacter   YGLEN----- ---------- ---------- ---------- ---------- 
Chloroflexus   HGLN------ ---------- ---------- ---------- ---------- 
Neisseria   YGIPE----- ---------- ---------- ---------- ---------- 
Beta vulgaris   YGLPR----- ---------- ---------- ---------- ---------- 
Arabidopsis   YGLPR----- ---------- ---------- ---------- ---------- 
Oryza    YGLPR----- ---------- ---------- ---------- ---------- 
Vibrio    YGLPR----- ---------- ---------- ---------- ---------- 
Shewanella   YNLPR----- ---------- ---------- ---------- ---------- 
Microbulbifer   YGLPR----- ---------- ---------- ---------- ---------- 
P. flourescens   YGLPA----- ---------- ---------- ---------- ---------- 
P. syringae   YGLPA----- ---------- ---------- ---------- ---------- 
P. aeruginosa  YGLPR----- ---------- ---------- ---------- ---------- 
Azotobacterium   YGIPR----- ---------- ---------- ---------- ---------- 
Ralstonia   YGLPR----- ---------- ---------- ---------- ---------- 
Burkholderia   YGLPR----- ---------- ---------- ---------- ---------- 
A. Tumefaciens   YGLAP----- ---------- ---------- ---------- ---------- 
Sinorhizobium   YGLPA----- ---------- ---------- ---------- ---------- 
Rhodobacter sp.   YRLPA----- ---------- ---------- ---------- ---------- 
E. coli    YGLPV----- ---------- ---------- ---------- ---------- 308 
Shigella   YGLPV----- ---------- ---------- ---------- ---------- 
S. typhimurium  YGLPM----- ---------- ---------- ---------- ---------- 
S. enterica   YGLPV----- ---------- ---------- ---------- ---------- 
Yersinia   YGLPV----- ---------- ---------- ---------- ---------- 
Novosphingobium   YRMPV----- ---------- ---------- ---------- ---------- 
Buchnera   YNMPI----- ---------- ---------- ---------- ---------- 
Wigglesworthia   YNLPI----- ---------- ---------- ---------- ---------- 
Pl. falciparum   LNLAEK---- ---------- ---------- ---------- ---------- 
Pl. yoelii   LNLEPKS--- ---------- ---------- ---------- ---------I 
Toxoplasma gondii   FGFEAAT--- ---------- ---------- ---------- ---------L 
Sulfolobus   LNIPYG---- ---------- ---------- ---------- ---------E 
Streptococcus   YDF------- ---------- ---------- ---------- ----DVGY-- 
Geobacter   LGI------- ---------- ---------- ---------- ----DRGT-- 
Clostridium   LGI------- ---------- ---------- ---------- ----NKGT-- 
Thermoanaerobacter LGI------- ---------- ---------- ---------- ----SNG--- 
Magnetococcus   LGM------- ---------- ---------- ---------- ----PRGT-- 
Thermobifida   GRL------- ---------- ---------- ---------- ----TDQGRP 
Streptomyces   GQA------- ---------- ---------- ---------- ----TGHGRP 
Corynebacterium   TRL------- ---------- ---------- ---------- ----PGQGRP 
Desulfovibrio   FRL------- ---------- ---------- ---------- ----PVN--R 
Bifidobacterium   MGHVPTDVAA LVEDYAEPAP TGDDPDGVIA GESDAQPQRE GVNRLLDLSR 
Chlorobium   MG-------- ---------- ---------- ---------- -----LETIL 
Thermus aquaticus   LG-------- ---------- ---------- ---------- -----LPPLH 
Bacillus   FGLE------ ---------- ---------- ---------- -------AGR 
Enterococcus   FGLN------ ---------- ---------- ---------- -------AGT 
Oceanobacillus   FQLP------ ---------- ---------- ---------- -------YGK 
Fusobacterium   FDLP------ ---------- ---------- ---------- -------YGK 
Lactobacillus   FGIEN----- ---------- ---------- ---------- -------AGV 
Oenococcus   FALKDV---- ---------- ---------- ---------- -------ARE 
Clostridium   LNIN------ ---------- ---------- ---------- -------KGK 
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Trichodesmium   IAPGFDADLV LVDLNNY--- ---RPVLREE LMTKCRWSPF EGWSLTGWPV 
Nostoc    IAPGYDADLV LVDLNTY--- ---RPVRREE LLTKCHWSPF EGWNLTGWAT 
Thermosynecoccus   IAPGYDADLV LVDLHTY--- ---RPVRREE LLTKCGWSPF EGWSLTGWPV 
Rhodopseudomonas    IAAGFDADFT VVDLKRS--- ---ETITNDW VASRAGWTPY DGVRVTGWPV 
Brucella   IAVGYDADLT IVDMKRR--- ---ETITHEQ AGSKAGWTPY HGKTVTGWPV 
Rhodospirillum   IAAGYDADFT VVDMNAE--- ---RTITNEW IASKCGWTPF HGLSVRGWPV 
Magnetospirillum   IAVGYDADFT IVDMKAE--- ---RIITNDW IESRCGWTPF DGRKVTGWPV 
Ralstonia   IALGYDADLT LVDLAAR--- ---RTIRNDW IASVSGWTPY DGIGVTGWPI 
Xanthomonas   LREGYFADLV MIDNTP---- ---FTVKREQ VLSKCGWSPF EGTTFRSRIA 
Xyllela    LREGYWADLV LVEDTP---- ---FTVKRQE ILSKCGWSPF EGTTFRSRIA 
P. flourescens LREGYWADLV LIQPEPKG-- ---VAVSRQP VLSQCGWTPF AQRSFRHRVS 
Cytophaga   ---------- ---------- ---------- ---------- ---------- 
Saccharomyces   ASSDKAILFK KE-------- --QVIPQVIS DGKDISIIPF KAGDKLSWSV 
Schizosacch. DFKESNIVLK KES------- --FRVPESVA N----DLVPF HPNEVLQWHC 
Ustilago maydis   HAKHGSIKLR KVRSRSCISP AAATVPAVYV HP-EFREVPD SDRSKVQVVP 
Helicobacter   --LPSKKARL SK-------- -KPFMIPTHT LCLNEKIAIL RGGETLSWNL 
Chloroflexus   --PPPRTVRL VE-------- -DPWQVPMR- ---YGDVVPF AAGQTLRWQV 
Neisseria   --NTDTITLV KQ-------- -SQTVPASVP YGDG-ELVPM RAGGEIGWTV 
Beta vulgaris   --NTSKIKLK KE-------- -PWKVLERIP FPSG-EIIPM FAGQMLDWKP 
Arabidopsis   --NSSKITLK KS-------- -PWKVPDVFN FPFG-EIVPM FAGETLQWQP 
Oryza    --NTSKIVLR KS-------- -AWKVPDTYS YSSG-EIVPM FTGNTLEWLP 
Vibrio    --NQETVTLT KQ-------- -AWPVAESMP FGSD-IVVPI RAGENIEWTV 
Shewanella   --NSDTITLV KK-------- -AWDIPASYP LGDT-NVVPI RAGEQIDWQV 
Microbulbifer   --NTTKVTLT KQ-------- -AWTVPSNLP FGSD-TLVPV KAGETLNWTL 
P. flourescens   --NTDRITLV RD-------- -EWTAPTSLP FGEL-TVIPL RAGEKLRWRL 
P. syringae   --NQDTITLV RD-------- -EWTAPASLP FGEL-TVIPL RAGETLRWR- 
P. aeruginosa  --NTDRITLV RE-------- -EWQAPASLP FGDF-DVVPL RAGETLRWKL 
Azotobacterium   --NTDHITLI RE-------- -EWTAPACMT FGEH-SLVPL RAGEKLRWRL 
Ralstonia   --NAGTLTLT RS-------- -QWQLPAEVP FGEQ-MLVPL RGGEMLRWKT 
Burkholderia   --NEEKVTLR RE-------- -EWTLPAELP VGDT-PVVPL RGGESIGWRL 
A. Tumefaciens   --NDETITLV KRE------- EAVAFPEKIE TGAG-PVTVF DPMFPLHWDV 
Sinorhizobium   --NEETITLR KQE------- EPVSYPARIE TEAG-PVTVF DPMFPLHWAV 
Rhodobacter sp.   --NEERITLR KG-------- AALALPGKIE TGAG-PVTVF DPGFPLLWHV 
E. coli    --NDTFIELV RE-------- -EQQVAESIA LTDD-TLVPF LAGETVRWSV 346 
Shigella   --NDTFIELV RE-------- -EQQVAESIA LTDD-TLVPF LAGETVRWSV 
S. typhimurium  --NTGWVELV RD-------- -EQQIPGNIA LADD-SLVPF LAGETVRWSV 
S. enterica   --NTGWVELV RD-------- -EQQIPENIA LADD-SLVPF LAGETVRWSV 
Yersinia   --NDDVVELV RT-------- -PFLQPEEIP LGNE-SVIPF LAGQTLNWSV 
Novosphingobium   --NEDRIVLE RA-------- -PIEVPEVID CNGT-AIVPF HAGETLGWRI 
Buchnera   --NKETITII KKP------- CKIIKK--IN VGRN-VIIPF LSGEILNWSI 
Wigglesworthia   --NKEHITFF KET------- FYPNKKQIIK INKNNYLSPI FFEKKLNWKI 
Pl. falciparum   KKLAKYYICV EKHP------ ------FKLP -REYNGVVPF LAGKTLDYDI 
Pl. yoelii   ENNQNSIIYI QKKN------ ------LTIP -NDYFGVVPF LANQTIDFTA 
Toxoplasma gondii   EENLECAVIQ PTPQR----- --VPSIFKFP GQENEGVVPF MASLELPYTV 
Sulfolobus   IRIGYVANFT IISKN----- -DWKYRTKFS KVTETPLDNF PLEAKVEFTI 
Streptococcus   LAENGPADLV IFADK----- -EDRLVS-NH FASKAANSPF IGETLKGQVK 
Geobacter   LKPGSVADIT VIDPK----- -ATWTVDADK LASKSKNSPF LGWEVKGAAA 
Clostridium   LETGRSADIT IVDLN----- -EEFVVDVNK FKSKSKNSPF HGFKLNGSVY 
Thermoanaerobacter IRVGATADIV IVNPH----- -EEYTVDKEK FKSKGKNTPY HGMKLKGVVE 
Magnetococcus   LSLNAVGDVV LFDPQ----- -QSWTVDALA LHGSSKNTAF AGRQVKGRVK 
Thermobifida   IAVGEPANLT LYDPT----- -ATRVIDPAT MVSKSRNTPF AGMTLPGRVL 
Streptomyces   VSAGEPANLT LVDAA----- -YRGQVDPAG FASRSRNTPY EGRELPGRVT 
Corynebacterium   IAEGEPANLA IVDPG----- -KTWTASGAD FASKAENTPF EGQEFSAKVT 
Desulfovibrio   FTAGDPADFF LFDPA----- -HEWTVTPEA MHSKGKNTPF TGWKLTGKVT 
Bifidobacterium   VDDADNVDLV VLNAA----- -EEWTVDPEQ FHSKARNTPF GGWQVTGRPL 
Chlorobium   FRAGRKANLT IIDPD----- -CEWIVSESD FGSKSRNTPF MGRKLKGRAL 
Thermus aquaticus   LEEGTEASLV LLDPK----- --ERPVDPQG FASKARFSPW TGWRLGGWPV 
Bacillus   LKEGRTADIT IIDLE----- -QEEEIDPTT FLSKGKNTPF AGWKCQGWPV 
Enterococcus   LTVGAPADVA VFDIT----- -QTCTIDKED FLSKGENTPF IGWKVKGETQ 
Oceanobacillus   LEEDSVADIT VIDLE----- -KEETIHRET FYSKGKNTPF DNWKVKGIPV 
Fusobacterium   LEENSFADIV VIDLE----- -KEITINPNN FLSKGKNTPY INEKINGIPV 
Lactobacillus   LEPGKNADVA IFDIE----- -HKNEIKEAD FKSKGVNTPF TGQKVYGETV 
Oenococcus   IAIGQVADLA LFDIR----- -HLHEIKANE FASKASNSPF IGWKVYGQTE 
Clostridium   LQPGFLGDLV LIDLN----- -KKRIFKEED IVSRSKNTPF NGMEFYGDVV 
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Trichodesmium   VTIVGGEVAF NRGEFN-SEV RGRALIFSEI A--------- - 
Nostoc    TTIVGGEIVY DKGQVN-TQV RGQALTFL-- ---------- - 
Thermosynecoccus   YTFVNGEVVF SQGRVN-TSV RGRALKFGLG ---------- - 
Rhodopseudomonas   GTFVRGAKVM WQGELT-TPS RGEPVRFLET LKP------- - 
Brucella   GTFVRGIKVM WEAEIV-NPH KGEPVEFLEA LPRR------ - 
Rhodospirillum   MTIIRGAIVM RDGALQ-GRP LGAPVRFHPL PPLTKESAVL R 
Magnetospirillum   ATIVRGSTVM RDGQLL-GQA SGEPVRFQEC P--------- - 
Ralstonia   HTVVRGHIVV RDEALVGTTP LGRPLRFLEA PPRVPAGV-- - 
Xanthomonas   ATWVNGQQVW DGEQLV-GSA AGQRLTFDR- ---------- - 
Xyllela    STWVNGNHVW DGNRLV-GVP NGQRLEFDR- ---------- - 
P. flourescens TTIVSGQIAW HDHRIH-DSC QGLPLRFMR- ---------- - 
Cytophaga   ---------- ---------- ---------- ---------- - 
Saccharomyces   RWEPR----- ---------- ---------- ---------- - 
Schizosacch. SWE------- ---------- ---------- ---------- - 
Ustilago maydis   FWAVSAGIVR S--------- ---------- ---------- - 
Helicobacter   QEIA------ ---------- ---------- ---------- - 
Chloroflexus   VAE------- ---------- ---------- ---------- - 
Neisseria   QY-------- ---------- ---------- ---------- - 
Beta vulgaris   SF-------- ---------- ---------- ---------- - 
Arabidopsis   LK-------- ---------- ---------- ---------- - 
Oryza    SDQLEE---- ---------- ---------- ---------- - 
Vibrio    K--------- ---------- ---------- ---------- - 
Shewanella   E--------- ---------- ---------- ---------- - 
Microbulbifer   TPAE------ ---------- ---------- ---------- - 
P. flourescens   LEEHA----- ---------- ---------- ---------- - 
P. syringae   LEEHA----- ---------- ---------- ---------- - 
P. aeruginosa  LEAGA----- ---------- ---------- ---------- - 
Azotobacterium   LEEKM----- ---------- ---------- ---------- - 
Ralstonia   V--------- ---------- ---------- ---------- - 
Burkholderia   V--------- ---------- ---------- ---------- - 
A. Tumefaciens   N--------- ---------- ---------- ---------- - 
Sinorhizobium   TQA------- ---------- ---------- ---------- - 
Rhodobacter sp.   EP-------- ---------- ---------- ---------- - 
E. coli    KQ-------- ---------- ---------- ---------- - 348 
Shigella   KQ-------- ---------- ---------- ---------- - 
S. typhimurium  KK-------- ---------- ---------- ---------- - 
S. enterica   KK-------- ---------- ---------- ---------- - 
Yersinia   KR-------- ---------- ---------- ---------- - 
Novosphingobium   AAA------- ---------- ---------- ---------- - 
Buchnera   ESD------- ---------- ---------- ---------- - 
Wigglesworthia   KLKEY----- ---------- ---------- ---------- - 
Pl. falciparum   HYVSKF---- ---------- ---------- ---------- - 
Pl. yoelii   SYKYDVV--- ---------- ---------- ---------- - 
Toxoplasma gondii   EVRRFSPSLL KECDEI---- ---------- ---------- - 
Sulfolobus   VQGKIAFDGK NVLPIRGVNA FDKSSRYPV- ---------- - 
Streptococcus   YTICSGEVIY QA-------- ---------- ---------- - 
Geobacter   FTIVGGKVVY KR-------- ---------- ---------- - 
Clostridium   YTLVNGNVVV REKVLL---- ---------- ---------- - 
Thermoanaerobacter YTIVEGQIRY QKNKKFEKVE I--------- ---------- - 
Magnetococcus   YTILAGRIVH QEA------- ---------- ---------- - 
Thermobifida   ATFLRGVPTV LDGKIQ---- ---------- ---------- - 
Streptomyces   HTWLRGKATL VDGKLT---- ---------- ---------- - 
Corynebacterium   HTVLRGKVTC ADGVAQNA-- ---------- ---------- - 
Desulfovibrio   SHWMGGHRIA ---------- ---------- ---------- - 
Bifidobacterium   ATIIGSQLMF SRL------- ---------- ---------- - 
Chlorobium   GIYHNSKLIM R--------- ---------- ---------- - 
Thermus aquaticus   LTLVEGRIVH EALE------ ---------- ---------- - 
Bacillus   MTIVGGKIAW QKESALV--- ---------- ---------- - 
Enterococcus   MTLSTENLCG RRENKSMERL LILEDGTVFE GKAFGA---- - 
Oceanobacillus   LTMVNGVVVY EEAKQHEEA- ---------- ---------- - 
Fusobacterium   LTISNGKIAY IDKEEINL-- ---------- ---------- - 
Lactobacillus   MTLVDGEVVY QRGTK----- ---------- ---------- - 
Oenococcus   RTWVNGQQVY AKGDEK---- ---------- ---------- - 
Clostridium   VTIKNGKIVY NGEF------ ---------- ---------- - 
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